DebRA Events and Photos Debra - Care,Research,Cure Please Donate Now  
  | Home | Logout |
 
11th Annual Mats Wilander Classic
TITLE SPONSOR
Hollister Wound Care
GOLD SPONSOR
Molnlycke Health Care
SILVER SPONSOR
National Rehab

Search Box


Main
· About Us
· About EB
· Informacion en Espanol
· Programs and Services
· New Parents
· Nurse Educator
· News Room & Newsletter Archive
· Support and Resources
· Special Events
· Advocacy Campaign
· Insurance Issues
· Symposiums
· EB Products
· 11th Annual Mats Wilander Classic
· 10th Annual Mats Wilander Classic
· Patient Care Conference 2008
· PCC Resources
· Donate

Make a Difference this Valentine's Day
175 Reads Printer friendly page
Posted by: Debra on Jan 21, 2010 - 03:37 PM


Celebrate Valentines Day with a heartfelt donation to DebRA

This Valentine’s Day give a gift of hope by making a special contribution to DebRA in honor of your loved ones.

Your gift is a wonderful tribute to those you love and enables DebRA to continue its mission of finding a cure, while providing medical, emotional and financial support to families living with EB.

Your loved ones—husband, wife, significant other, mother, father, friend, aunt, uncle—will receive a special card notifying them of your heartwarming gift. Click here to make your gift online.

On behalf of the DebRA family thank you for your thoughtful generosity. We wish you and yours a Happy Valentine's Day!



DebRA
 
  



Dance Relief and Envision Environmental Support DebRA
173 Reads Printer friendly page
Posted by: Debra on Jan 15, 2010 - 04:42 PM


Dance Relief, a Dancers Inc. event, is held each season, as an opener for the dance competition year. Dancers from several states come together to not only compete for cash, prizes, and scholarships, but to help other children and dancers in need. The event was held December 5 & 6 at Pleasantville High School in Pleasantville, New Jersey.

Dance Relief

Dance Relief was created by Dan Barris, and the crew at Dancers Inc. immediately following Hurricane Katrina in 2005. "It was a way for all of us to help, and do what we do best......dance," Dan says. Within hours of the storm, people were banding together in New Jersey and New York to help raise money for the dancers, studios, and families of the Gulf Coast. Especially those hardest hit in Louisiana. After raising over $50,000.00 in just a few hours with cash, and donations, Dancers Inc. went to New Orleans and donated the goods and services of the crew, and purchased costumes for dancers, and sound equipment and other goods for studios and teachers throughout the area.

When the crew returned, they vowed to have the opening event for each new dance competition season be for a worthy cause, and have since helped three more organizations. The crew is excited to say that Dance Relief has contributed at least $5,000.00 to worthy causes with each event, and this year along with Envision Environmental it raised about $9,000.00 for DebRA.

Alexandra RomanThis year's event was very special to us since one of our dancers, Alexandra Roman, has Epidermolysis Bullosa (EB). Although dancing at times is quite painful for Alex, her love for dance, along with the support of her dance family at Ocean Dance Force in NJ helps her realize her passion. We realize every step that Alex takes requires a lot of courage and strength. We hope our efforts at this year's event will help more people understand EB and the difficulties that Alex and other children like her deal with on a daily basis. Due to the efforts of Dance Relief, Envision Environmental, Inc. and M&I Dancewear, as sponsors and hosts, several of the cast and crew working the event volunteered, and donated their time and monies raised to this worthwhile cause. In addition, Envision Environmental, Inc. hosted an information table on DebRA, which included materials on EB, how people can help, and fundraising items. DebRA sponsored videos were also shown during the event.

"We can't wait to write a big check to Debra , it's a great way to have the kids learn, and give a little something of themselves at the Holidays. It is a valuable lesson for all of us, don't you think?"

DebRA wants to thank everyone involved in this event especially the Roman Family and Dance Relief who dedicated this year's events to DebRA. We'd also like to thank all of the dancers, parents, volunteers and all of those who made this event such a success.


DebRA
 
  



Faraone Mennella bracelet designed for DebRA of America
377 Reads Printer friendly page
Posted by: Debra on Dec 18, 2009 - 11:23 PM


Beautiful sterling silver butterfly suspended on a delicate leather string bracelet designed by Faraone Mennella exclusively for DebRA of America. Delicate enough for a woman but still classic enough for a man. At only $30.00 it is a unique designer way to raise EB awareness and support DebRA.

Butterfly Bracelet worn by woman Butterfly Bracelet worn by man

To order please call our offices at (212) 868-1573 with your credit card, or click here to purchase online.



DebRA
 
  



EB Products
708 Reads Printer friendly page
Posted by: Debra on Dec 18, 2009 - 08:50 PM


We will be adding to this page in 2010, so please visit again.

Tasty Tees-Intrikit Wings by Angie SmithButterfly Tee Helps DebRA

Angie Smith, NYC t-shirt designer has created a special Butterfly tee, "intrikit wings t-shirt". A portion of the proceeds will support DebRA.

Click here to purchase your t-shirt »



Life with Epidermolysis Bullosa (EB)

Life with Epidermolysis Bullosa Book
This new book will surely become the primary resource for EB information in the medical community to increase knowledge of this painful, complex disease. It is also very readable and offers solid information for EB sufferers, caregivers and families. A must have.

Click here to order this informative new book from Amazon and help DebRA »



DebRA
 
  



EB Symposiums
772 Reads Printer friendly page
Posted by: Debra on Nov 05, 2009 - 03:24 PM


Columbia University EB Research Symposium – February 2009

On February 20, 2009, a Symposium was held at Columbia University to bring together experts from around the world to discuss the clinical challenges of EB, and to present their latest work on therapies for EB. Learn more »


18 year old RDEB patient
Chile Symposium – December 2008

Thanks to Hollister Wound Care for their generous support of DebRA's first time attendance and for providing supplies. We also thank Byram Healthcare and National Rehab for their donations of wound care supplies.

DebRA Chile serves 160 EB "Ninos piel de cristal" – Crystal Skin Children – providing medical services at their new EB House, and wound care supply distribution nationwide to impoverished rural communities. This year's Symposium focused on hand surgery – techniques, occupational therapy, anesthesia, and pain management strategies. We felt very fortunate to be able to participate and learn.

Please click here for photos »



DebRA
 
  



Columbia University EB Research Symposium
1891 Reads Printer friendly page
Posted by: Debra on Jun 26, 2009 - 10:21 PM


RESEARCH SUMMARY
By Angela Christiano, PhD
Columbia University
College of Physicians & Surgeons
Richard & Mildred Rhodebeck Professor
Departments of Dermatology and Genetics & Development
Director of Basic Science Research, Department of Dermatology

On February 20, 2009, a Symposium was held at Columbia University entitled "Genetics, Stem Cell Biology and Stem Cell Transplantation in Epidermolysis Bullosa".
The purpose of the meeting was to bring together experts from around the world to discuss the clinical challenges of EB, and to present their latest work on therapies for EB, in particular, protein and cell-based therapies using fibroblasts and bone marrow derived cells. There were a lot of new ideas exchanged and an excellent stimulating duscussion followed each lecture. Below is a brief overview of the topics covered.

The Symposium opened with Introductory Remarks from Dr. Angela Christiano, Columbia University. She welcomed everyone to the meeting and thanked them for traveling from both near and far to attend the meeting. For perspective, Dr. Christiano presented the title and abstract of a grant she submitted to the NIH in 2002, from one of the first times she attempted (and failed) to get funding for bone marrow transplantation for EB. She was basically told by the review panel that turning bone marrow into skin simply couldn't be done. Thankfully, scientific progress using cell based therapies, such as bone marrow transplantation for other non-hematopoietic diseases, has emerged in the past decade as an innovative way to treat genetic diseases in other tissues and organs. One of the goals of the Symposium was to plan for undertaking transplantation in RDEB patients at Columbia University.

Dr. Christiano was very pleased to announce her collaboration with Dr. Mitchell Cairo of Columbia University, and their intent to begin using Reduced Intensity Conditioning (RIC) for Umbilical Cord Blood Transplant in RDEB at Columbia. IRB Approval was received in March 2009, and the first patients are expected to enroll by summer 2009.

Dr. Mitchell Cairo then gave an introductory lecture and overview of Reduced Intensity Conditioning and Umbilical Cord Blood Transplant for non-malignant diseases, such as the sickle cell disease, for which he is running a clinical trial at Columbia. The risks and benefits of undertaking this therapy were discussed, as were the special considerations for performing transplantation in RDEB patients.

Dr. Yanling Liao from Columbia University focused on human umbilical stem cells and their application on tissue regeneration. In addition to hematopoietic stem cells, human cord blood also contains pluripotent stem cells that have the ability to differentiate into cell types of different lineages, similar to embryonic stem cells. Dr. Liao's collaborative work on EB is to differentiate these pluripotent stem cells into epithelial cells for the regeneration of skin.

Dr. Jouni Uitto of Thomas Jefferson University then gave an overview and history of RDEB, including the identification and cloning of the type VII collagen gene, the discovery of mutations, and implementation of prenatal and preimplantation genetic diagnoses. He also presented an overview of the different therapies that have been attempted in past years, including vector-based gene therapies, and the various challenges that resulted from this approach. He also presented a summary of the pre-clinical animal work that has been performed on bone marrow transplantation, using Col7a1-/- mice, in three different laboratories around the world. Clearly, the independent demonstrations of increased survival in these RDEB mice provide a basis for clinical trial on bone marrow transplantation in RDEB patients.

Dr. Anne Lucky from Cincinnati Children's Hospital spoke next about her decades-long experience in the clinical care of RDEB patients. She highlighted the special considerations and precautions that are taken at her institution when caring for RDEB children, and highlighted the intradisciplinary care model. Emphasizing the numerous serious medical and surgical issues faced in the care of these patients, she outlined which other members of the care team are needed and listed more than twenty medical specialists and health professionals that participate in the care of RDEB patients in Cincinnati.

Dr. Susanne Krämer, DebRA Chile's dentist, gave a talk on oral considerations when planning RIC in patients with RDEB. Her talk was focused on three main areas: 1) the oral features patients with RDEB present as part of their condition, for example oral ulcers, microstomia, ankyloglossia, absence of tongue papillae and extensive decay; 2) Changes that can be expected during the conditioning stage, mainly difficult oral access, pain and infection. The importance of trying to prevent adverse events (mainly infection) was stressed and the value of preventive dental care was emphasized. 3) Finally, specific monitoring and treatment assessment criteria for interventions in patients with RDEB were suggested.

Dr. Evangelos Badiavas from the University of Miami, Miller School of Medicine presented his work on bone marrow derived stem and progenitor cells in chronic wounds. His findings illustrate the potential of bone marrow to heal recalcitrant chronic wounds and remodel the wound bed in areas of scarring. These findings may have a considerable impact on EB patients as the extensive scarring associated with their disease leads to re-wounding and significant associated morbidity. Correcting both the epidermal and dermal defects seen in EB could lead to a durable closure of wounds and prevention of the life altering consequences due to the scarring.

Dr. Elizabeth Hillman of Columbia University's Department of Biomedical Engineering then presented her innovative methodologies aimed at detecting and identifying proteins in the skin without the need for skin biopsy. She is planning to evaluate whether her methods are capable of detecting type VII collagen at the basement membrane, initially in mouse models and ultimately in clinical subjects. As part of the clinical trial, she will be working side by side with the clinical team to come up new ways to perform non-invasive skin imaging so that we can monitor both wound closure and healing of blisters, as well as detecting new type VII collagen, all without the need for a biopsy.

Drs. Mei Chen and Dr. David Woodley at the University of Southern California discussed various therapeutic approaches they have developed in mouse models for RDEB. They developed three primary strategies called Vector Therapy, Protein Therapy and Cell Therapy. Dr. Chen discussed their recent studies in type VII collagen knock-out mice that recapitulate features of RDEB. These mice lack type VII collagen and anchoring fibrils and have profound blistering of the skin and die within days after birth. Dr. Chen showed that injection of human type VII collagen into these mice restored type VII collagen and anchoring fibrils at the basement membrane zone. This corrected the RDEB-like skin changes in the mice. Skin fragility and new skin blisters ceased and the survival of the animals increased from days to months. Dr. Chen also discussed the possible autoimmune responses of the animals and showed how these could be abrogated with immunosuppressing agents or by the induction of oral or intravenous tolerance. These experiments in a pre-clinical animal model demonstrate that protein therapy may be a feasible treatment for human patients with RDEB.

Dr. David Woodley then discussed the possibility of gene correcting RDEB patient fibroblasts so that the cells can synthesize and secrete type VII collagen and then using these cells for therapy in patients. The investigators showed that gene corrected cells could be injected intradermally into the skin of a mouse, and the human cells would act like small factories in the mouse skin secreting human type VII collagen, which would incorporate into the basement membrane zone and create human anchoring fibrils. This experiment created "chimeric" mice that had human anchoring fibrils. Further, this type of cell therapy proved to be just as efficacious as protein therapy when they were administered to the RDEB-like, type VII collagen knock-out mice. That is, the cells established themselves in the skin of the mice and secreted type VII collagen that incorporated into the basement membrane zone of the mice, created human anchoring fibrils, reversed the skin RDEB skin blistering and greatly prolonged the survival of the mice.

Drs. Chen and Woodley made the point that with regard to FDA regulations and safety, the first patient clinical trials should probably be done with Protein Therapy since no live cells or viral vectors would be administered to the patients and the clinical trial would answer many of the essential questions that would be raised no matter what type of therapy was given to RDEB patients.

Dr. John McGrath from King's College London (UK) presented a study on the use of cultured fibroblast cells as a potential treatment for recessive dystrophic EB. Fibroblasts are cells in the dermis that can generate various skin proteins, including type VII collagen. His study looked at injecting fibroblasts from an unrelated donor into the skin of 5 people with recessive dystrophic EB. These "foreign" cells did not induce any adverse effects such as inflammation but did not appear to survive in the skin for more than 2 weeks. However, the fibroblast injections did result in a topping up of type VII collagen at the dermal-epidermal junction which led to better adhesion between the epidermis and the dermis. The improvements seemed to occur only in the local sites that were injected with the cells and the benefits were sustained for at least 3 months. Precisely how the cells help the recessive dystrophic EB skin, however, is still a mystery. It is not clear whether the top up of collagen VII comes directly from the injected fibroblasts or whether the individual's own skin cells (keratinocytes and fibroblasts) switch on production of collagen VII. His study represents the first look-see work in humans to determine whether cultured fibroblasts from an unrelated donor might have clinical benefits. This is important because cultured fibroblasts represent here and now technology - they are available from commercial sources at clinical grade and ready for clinical use. His research group in London is currently is looking at whether the cells might help treat bigger areas of skin and with longer follow up. Dr. McGrath also reported observations on the utility of injections of cultured fibroblasts to improve wound healing in recessive dystrophic EB. He showed clinical pictures of wounds before and after injections of fibroblasts into the wound margins. It was clear that accelerated wound healing occurred. How long this might last, however, is not yet known. In the future, it is likely that researchers will identify the chemical "juice" in the cells that strengthens the dermal-epidermal junction and boosts wound healing but for now, clinical use of cultured fibroblasts from unrelated donors does appear to be a useful approach in improving localized areas of fragile or wounded skin in some people with recessive dystrophic EB.

Dr. Francis Palisson from University of Desarrollo in Santiago, Chile, showed that intradermal administration of allogeneic Mesenchymal Stem Cells (MSC) in a clinical trial of 3 RDEB patients (with separation at the base membrane zone and negative immunofluorescence for type VII collagen) showed continuous dermal-epidermal junction, type VII collagen expression along the basement membrane zone one week after intervention. Importantly, he saw no evidence of inflammatory cell infiltration in sites of MSC administration. This is also the first evidence that intradermally injected MSC can produce and produce type VII collagen and partially restore the dermal-epidermal junction, also accelerating wound healing was observed in chronic wounds (non-healing for 4 and 16 months before intervention) around which MSC and vehicle were injected. Re-epithelialization initiated from the sites where MSC were injected but not from the vehicle controls. Eight weeks after intervention, the wound was almost healed except for the regions where vehicle was administered. For 12 weeks, the regenerated epidermis remained firmly adhere to dermis, did not itch and did not blister, even after induced mechanical stress. This clinical picture remained stable for up to 4 months.

Dr. Mohammad El-Darouti from Cairo University in Egypt is also already involved in clinical trials in RDEB patients using cell based therapies. Dr. El-Darouti has performed intravenous administration of specialized cells, called non-hematopoetic bone marrow stem cells (BMNHSC), from allogeneic matching donors into a series of 10 patients with RDEB, again with promising results.

Both Dr. Palisson and Dr. El-Darouti showed that there are some clinical improvements in RDEB patients by administering different types of allogeneic cells, providing a sense of optimism that cell therapies seem to be a promising new avenue of research toward new treatments for RDEB.


DebRA
 
  



CT Bill Requires Insurance Coverage For EB Care
1413 Reads Printer friendly page
Posted by: Debra on Jun 22, 2009 - 12:34 PM


Connecticut passes first groundbreaking bill requiring EB wound care coverage »

Connecticut House Bill Number #5023, May 21, 2009 »

The co-sponsors of Connecticut H.B. #5023:

Rep. Russell A. Morin, 28th Dist.

Sen. Paul R. Doyle, 9th Dist.

Rep. Thomas Kehoe, 31st Dist.

Rep. Peter F. Villano, 91st Dist.

Rep. Henry J. Genga, 10th Dist.

Sen. Edith G. Prague, 19th Dist.

Rep. Timothy D. Larson, 11th Dist.

Rep. Hector L. Robles, 6th Dist.

Rep. Elizabeth B. Ritter, 39th Dist.

Rep. Barbara L. Lambert, 118th Dist.

Rep. Maryanne Hornish, 62nd Dist.

Rep. David. A. Baram, 15th Dist.

Rep. Christopher A. Wright, 77th Dist.

Rep. Christopher L. Caruso. 126th Dist.

Rep. Patricia B. Miller, 145th Dist.

Rep. Michelle L. Cook, 65th Dist.

Rep. Catherine F. Abercrombie, 83rd Dist.

Rep. Joe Aresimowicz, 30th Dist.

Rep. Gary A. Holder-Winfield, 94th Dist.

Sen. Donald J. DeFronzo, 6th Dist.

Sen. Andrea L. Stillman, 20th Dist.

Sen. Mary Ann Handley, 4th Dist.


DebRA
 
  



EB Survivors Camp
599 Reads Printer friendly page
Posted by: Debra on May 19, 2009 - 06:36 PM


We are pleased to announce our first season of EB Survivors Camp, which will be hosted this August 9th-15th in Park City, Utah. Applications are not yet available on the DebRA website but you can access a request form through the links in this announcement. (links are best viewed through Internet Explorer)

This season of EB Survivors Camp is designed to provide a safe fun environment for teens with EB to gain personal Independence, explore their interests, and develop their talents through our mentoring program and self reliance workshops. There will be plenty of fun for sure, in the serene setting of the beautiful Wasatch mountains. Camp is staffed by people with EB and also medical professionals who have experience with EB. Applications for those who wish to attend as a camper or as staff are now available.

Campers

To request an application, click http://www.garrettshouse.org/camper

Counselors

Counselors are part of our volunteer staff and must be 19 years of age or older and able to pass screening and legal background checks performed at the expense of DebRA. Counselors will be asked to provide their own airfare to the Salt Lake City Airport August 8th (one day prior to camp) and airfare from the Salt Lake City Airport August 15th. To request an application, click http://www.garrettshouse.org/staff

Medical Staff

We will staff camp primarily with doctors and nurses who volunteer in the Northern Utah area. If you are interested in volunteering, click http://www.garrettshouse.org/medicalstaff



DebRA
 
  



DebRA Joins "Health 1st - America's Charities"
1319 Reads Printer friendly page
Posted by: Debra on May 15, 2009 - 08:51 PM


America's Charities Health First logoWorkplace Giving - Dystrophic Epidermolysis Bullosa Research Association #11990

DebRA has joined Health 1st - America's Charities, a federation for workplace giving campaigns. Through this federation, DebRA will gain increased exposure in hundreds of workplace campaigns across the country.

Charitable employee campaigns provide an easy way to donate to DebRA. Donations are automatically deducted from paychecks, so there are no checks to write, no envelopes to address, and no stamps to lick.

Simply fill out a campaign pledge card indicating the amount of your gift and designate DebRA as the charity of your choice, our number is 11990.

Look for DebRA in your employee-giving guide under Health 1st - America's Charities. If you cannot find DebRA or Health 1st - America's Charities in your guide, contact anyone on the DebRA staff at (212) 868-1573.


DebRA
 
  



Winos and Dinos - March 7, 2009
735 Reads Printer friendly page
Posted by: Debra on Feb 04, 2009 - 10:24 PM


Winos and Dinos charity event

Winos & Dinos
A Wine Tasting and Art Gala featuring prehistoric drawings by Maxx Gregg
March 7, 2009 @ 7:00pm

Taffy's Coffee Company, Eaton, Ohio

Tickets: $15

Call 937-533-7516 or email doughela@yahoo.com

This is a charity event for Debra of America



DebRA
 
  



Butterfly Benefit - April 11, 2009
916 Reads Printer friendly page
Posted by: Debra on Feb 04, 2009 - 10:08 PM


Butterly Benefit flyer

Fashion Show Luncheon and Silent Auction
April 11, 2009
The Olmsted
3701 Frankfort Avenue
Louisville, Kentucky 40206

11:00 Silent Auction
12:00 Lunch with Fashion Show to follow
Tickets: $30

Contact: Leslie Rader to purchase your tickets
leslie.rader@insightbb.com
502-299-0862
All Proceeds Benefit Debra of America


DebRA
 
  



The Greening of Debra - March 16, 2009
534 Reads Printer friendly page
Posted by: Debra on Feb 03, 2009 - 06:52 PM


The Greening of Debra, Monday, March 16, 2009, $25 in advance, $30 at the door, includes Irish Buffet Dinner

Join Debra as we warm up for St. Patrick’s day with an evening at our neighborhood Irish pub celebrating the "Greening of Debra." New York’s O'Casey's and Debra, will host an evening of music, drinks and an Irish buffet dinner as we fundraise and raise awareness for EB.

Location: O'Casey's, 22 East 41st Street, New York (1 1/2 blocks from Grand Central). Doors Open 5:00pm - 7:00pm.

Please click here to purchase your tickets or to make an online donation in support of the event. Your donation will go toward the EB Family Crisis Fund.

You can also secure your reservation by contacting Jepi at 212-868-1573 or email jrios@debra.org.Thank you for your support!



DebRA
 
  



Super Sunday for Debra
380 Reads Printer friendly page
Posted by: Debra on Jan 21, 2009 - 08:38 PM


Help DebRA kick off the year by hosting a Super Sunday for Debra”.

Please open your homes for DebRA of America by inviting your friends and family to watch the Super Bowl on February 1, 2009, while raising awareness and support for DebRA of America.

Please download the flyer for your event and the donation sheet. You can edit the flyer to include your name and address. If you need help customizing your event or your flyer please contact the Debra office. For those that are interested, you can sell EB awareness bracelets ($2). We also have limited number of Butterfly pins ($75).

Please get creative and make this event your own, have a raffle, host a contest, or auction off something fun during half time.

The top 10 “Super Sunday for Debra”  fundraisers will receive a beautiful custom designed butterfly pin.

To become involved please contact:
Jepi
Phone: 212-868-1573
Email: jrios@debra.org
All donations are 100% tax deductible.

EB stands for Epidermolysis Bullosa, a painful disorder that causes blistering both inside and outside the body. Your donation will help heal the families that are physically, emotionally, and financially devastated by this horrific disease. Debra of America is the only national non-profit offering programs and services to EB patients and their families. Along with our programs Debra works with researchers to find a cure.



DebRA
 
  



Have a Heart for EB - February 12-15, 2009
2198 Reads Printer friendly page
Posted by: Debra on Dec 22, 2008 - 09:43 PM


Through a generous grant from National Rehab, Debra of America was able to distribute free passes to over 55 EB families from all over the country. Currently we are expecting almost 200 people to be joining us in Orlando to celebrate Have a Heart for EB.

  • Now that all of the free passes have been distributed there is a waiting list, if a family cancels their tickets will be given to the next family on the wait list.
  • If you would like to be placed on the waiting list, the rules are still the same. Each EB family can request a maximum of 3 FREE 2-day passes by emailing us at haveaheartforEB@gmail.com . In the email include your name, address and phone number.
  • If you would like to purchase 2-day passes at our discounted rate of $103.00 per pass, please call Pennie at 212-868-1573 extension 101 or email us at haveaheartforEB@gmail.com
  • The deadline to order discounted passes is January 23, 2009 – NO EXCEPTIONS!
  • In order to get the $78.00 rate, hotel reservations at the Best Western Lakeside must be made by February 1, 2009. Call 1-800-848-0801, option 3, and ask for the Debra of America group rate.
  • Tickets will be distributed from the Best Western Lakeside.
  • Please direct all questions and orders to haveaheartforEB@gmail.com

Debra has set up a block of rooms at the Best Western Lakeside at a nightly rate of $78.00, this rate includes all taxes. Debra chose the Best Western Lakeside because of their willingness to accommodate the special needs that some of the children have. Each family should make their own reservation by calling the hotel directly at 1-800-848-0801, option 3, and ask for the Debra of America group rate and inform them of any special requirements that you have. The special rate will be available until February 1, 2009. The hotel’s website is www.bestwesternlakeside.com. The Best Western Lakeside has a shuttle bus that can accommodate one wheelchair per run. Unfortunately their shuttle schedule is staggered to go to all of the attractions in the Orlando area. However the hotel is less than 2 miles from the main gates of Disney , a taxi to the main gate costs approximately $8.00.

We have heard from several families who are staying at the three Disney All Star Hotels because of transportation issues. Everyone should stay at whatever hotel best suits their own needs, but please let us know where you will be staying and how we can contact you while in Florida. We will be putting together a contact sheet that will be distributed to each EB family to make it easier for you to get in touch with each other to set up activities on your own.

A group photo will be taken sometime over the weekend, as soon as the details are worked out we will let you know the exact date, time and location

We look forward to seeing all of you in Orlando!



DebRA
 
  



Champagne & Chocolates Appeal
918 Reads Printer friendly page
Posted by: Debra on Dec 01, 2008 - 12:48 PM


Champagne & Chocolates; Until There is a Cure...There is Debra

Together, we honor the heroism and hope shown by EB families in their daily struggles with this painful and devastating disease.

On behalf of those we serve, we are grateful to you for your generosity. It allows Debra to support the only programs and services offered to EB patients and their families nationally as well as funding international research to seek a cure.

In this spirit we invite you to join our Champagne & Chocolates non-event. There will be no event to attend. Instead, Debra will use 100% of the funds raised to improve the lives of EB families through programs, services, research and eventually, a cure.

Please click here to make your donation. Thank you for your kind gift and best wishes this holiday season from all of us at Debra.



DebRA
 
  



10th Annual Mats Wilander Celebrity Tennis and Golf Classic
5538 Reads Printer friendly page
Posted by: Debra on Nov 24, 2008 - 10:34 PM


The 10th Annual Mats Wilander Celebrity Tennis and Golf Classic

Dave Graham, John McEnroe, Mats Wilander, Thomas Blake
Left to right: Dave Graham, John McEnroe, Mats Wilander, Thomas Blake
October 20th proved to be a beautiful Fall day perfectly suited for the record number of tennis players, golfers and guests at the 10th Annual Mats Wilander Celebrity Tennis and Golf Classic. Mats Wilander was joined by John McEnroe and Thomas Blake among others on the courts. A fast-paced exhibition game between Mats and John, often including humorous moments by the famous pros, held the avid attention of the tennis players and made it obvious why the two are rated among the best to ever play the sport.

After 18 rounds of golf on the famous Westchester Country Club course, golfers joined additional evening guests for a reception and silent auction followed by dinner, dancing and a live auction. The evening, punctuated by lively music supplied by the Stingers, allowed the guests to enjoy the beautiful surroundings and festivities while raising funds to support the programs and services offered by DebRA.

kids at the event
Even the youngest party goers had a good time at the event  
Mats and Sonya Wilander with their son Erik (EBS) in attendance, celebrated 10 years of lending their name and efforts to make this event grow and expand over the years. We are grateful to all of the guests and supporters that worked to make this event possible. We thank them for their continued support and dedication to DebRA and EB families.


Jassamine Domino, Spirit Award Winner
Jassamine Domino, Spirit Award Winner
Jassamine Domino was selected as our 2008 Mats Wilander Celebrity Tennis and Golf Classic Spirit Award Winner. We were first introduced to Jassamine in 2004 at the Patient Care Conference and were immediately impressed with her ability to rise above the affects of her disease. As we got to know Jassamine, we learned of her involvement with Camp Wonder as well as her interest in visual communications graphic design, now her major in college. We had the pleasure of seeing Jassamine again at the 2008 Patient Care Conference where she shared two videos she created honoring EB patients. We had the opportunity to once again share these videos at the event to an impressed and moved audience. The Board of Directors and staff of DebRA of America would like to extend a heartfelt congratulations to Jassamine Domino and her family.



Mats Wilander
Mats Wilander


DebRA
 
  



Limited Edition DebRA Butterfly Pin
3481 Reads Printer friendly page
Posted by: DebRA on Nov 24, 2008 - 07:51 PM


Limited edition DebRA Butterfly Pin


This beautiful limited edition Butterfly pin was specially designed for DebRA by Liztech. Each pin is signed and numbered by the artist and at $75.00 they make a wonderful holiday gift.

To order please call our offices at (212) 868-1573, or click here to purchase online.



DebRA
 
  



Lawyers Alliance Honors Debra Board of Trustees Vice-President
1926 Reads Printer friendly page
Posted by: Debra on Nov 24, 2008 - 04:52 PM


The Lawyers Alliance for New York

Lawyers Alliance Honors Debra Board  of Trustees Vice-President Warren T. Buhle
First row: Warren T. Buhle, Esq.; Second row, left to right: Charlee Miller, Mary Sprague, Faith Daniels; Third row, left to right: Jepi Rios, Abby Meadows, Alecia Baker, Pennie Cannon
On November 10, 2008, The Lawyers Alliance for New York honored Warren T. Buhle, Esq., Vice-President of Debra's Board of Trustees, with their 2008 Cornerstone award in recognition of his work on behalf of Debra.

Lawyers Alliance is the leading provider of business and transactional legal services for nonprofit organizations that are improving the quality of life in low-income neighborhoods throughout New York City.

Warren T. Buhle of Weil, Gotshal & Manges LLP was recognized for his longstanding pro bono commitment as volunteer general counsel to Debra. Elizabeth M. Guggenheimer, Deputy Executive Director of Lawyers Alliance said, "That when law firms encourage and support business and transactional law pro bono, and when accountants provide related pro bono financial guidance, the potential for nonprofits to grow, thrive and serve New York neighborhoods is increased exponentially."



DebRA
 
  



Sponsors of the 10th Annual Mats Wilander Classic
1662 Reads Printer friendly page
Posted by: Debra on Oct 29, 2008 - 10:34 PM


TITLE SPONSOR
Hollister Wound Care

GOLD SPONSOR
Molnlycke Healthcare
Phil & Amy Duff

SILVER SPONSOR
National Rehab
Kenneth Fisher

EXCLUSIVE SPONSOR OF THE COCKTAIL RECEPTION
THOMPSON REUTERS

EXCLUSIVE SPONSOR OF THE HOLE IN ONE CONTEST
Tom & Kathy Shannon/T-Bird Restaurant Group

EXCLUSIVE SPONSOR OF THE CLOSEST TO THE PIN CONTEST
Vincent & Cora DiFiore

EXCLUSIVE SPONSOR OF THE LONGEST DRIVE CONTEST
The Kopelan Family

TEE SPONSORS
The Coughlin Family
Allison & David Sachs
Catherine Shaffer


DEBRA OF AMERICA THANKS
Curry Automotive
For the generous donation of a 2008 Mustang Convertible for the Hole-In-One Contest

BLOOMIN’ HOLE
Outback Steakhouse

THANKS TO OUR VOLUNTEERS
Jennifer Harbuck
Geri Kelly-Mancuso, RN
Charlee Miller
Leslie Rader
Paul Riemer
Scott Riemer
Babe Rizzuto
Beth Sandri
Christina Santorsola
Frank Santorsola
Jackie Smith
Lisa Stumpf

FRIENDS
Gian Andrea & Moyra Botta
Warren Cassidy
Dwight Hilson
Pete Maniscalco
James Mossman

DebRA would like to thank the following Celebrities:
John McEnroe
Joe Pagignatano
Ralph Branca
Karel Novacek
Tony Viteri
The Honorable David Dinkins
Thomas Blake



DebRA
 
  



Support DebRA
9097 Reads Printer friendly page
Posted by: DebRA on Jun 12, 2008 - 11:34 PM


Ways You Can Support DebRA 

EB Patient Donate by Mail: Make your check payable to DebRA of America and mail to 16 East 41st Street, 3rd Floor, New York, NY 10017.

Donate by Phone: You can make a donation by calling DebRA at 212-868-1573.

Donate OnlineClick here to make a secure online donation. Donations also can be made in honor or memory using this link.

Matching Gifts – Many employers offer a dollar-for-dollar matching gift or a percentage match when you give to your favorite charity. Contact your human resources representative for more information.

Gifts of Securities – If you plan to make a gift of stock, please contact DebRA at 212-868-1573 for the necessary information.


Supporting DebRA’s Mission

EB PatientDebRA of America was established more than 25 years ago to provide programs and services to people with Epidermolysis Bullosa and their families and to support EB research. DebRA is the only national EB organization that both funds research and provides programs and services to the EB community.

Today, DebRA’s programs reach more than 10,000 families across the United States. From the time a baby is born with EB, DebRA provides professional and peer support to the parents through the EB Hotline staffed by two Nurse Educators and the New Family Advocate Program, respectively. Health professionals treating the infant also consult the Nurse Educators on the specific techniques and products needed to care for the infant with EB.

DebRA also provides emergency assistance for medical needs through its Family Crisis Fund and Wound Care Clearinghouse. Its free biennial Patient Care Conference enables families to have direct access to EB experts and to gather for mutual support. The new EB En Español program enables Spanish-speaking families access to a Spanish-speaking Nurse Educator and to information in their own language.

DebRA provides accurate and up-to-date information through this web site and its quarterly “Currents” Newsletter and a variety of print materials.

In its mission to find effective treatments and a cure for EB, DebRA supports an international peer review research grants program that funds the most promising projects exploring the causes and consequences of and treatments for EB.

When you support DebRA you are supporting a financially responsible organization that devotes 89.4 cents of every dollar it raises to programs, services and research.



DebRA
 
  



DebRA Sponsors
2504 Reads Printer friendly page
Posted by: DebRA on Jun 12, 2008 - 11:07 PM


Patient Care Conference 2008 Sponsors

TITLE SPONSOR
Hollister Wound Care

GOLD SPONSOR
Molnlycke Healthcare

SILVER SPONSOR
National Rehab

We would also like to acknowledge the generous support of:
Byram Healthcare
Direct Medical
Mr. & Mrs. Mark McCaughtry
Pedors
Smith & Nephew
The Brotman Foundation
Wayne Westland Friends of EB

10th Annual Mats Wilander Celebrity Tennis & Golf Classic Sponsors

TITLE SPONSOR
Hollister Wound Care

GOLD SPONSOR
Molnlycke Healthcare
Phil & Amy Duff

SILVER SPONSOR
National Rehab
Kenneth Fisher

EXCLUSIVE SPONSOR OF THE COCKTAIL RECEPTION
THOMPSON REUTERS

EXCLUSIVE SPONSOR OF THE HOLE IN ONE CONTEST
Tom & Kathy Shannon/T-Bird Restaurant Group

EXCLUSIVE SPONSOR OF THE CLOSEST TO THE PIN CONTEST
Vincent & Cora DiFiore

EXCLUSIVE SPONSOR OF THE LONGEST DRIVE CONTEST
The Kopelan Family

TEE SPONSORS
The Coughlin Family
Allison & David Sachs
Catherine Shaffer


DEBRA OF AMERICA THANKS
Curry Automotive
For the generous donation of a 2008 Mustang Convertible for the Hole-In-One Contest

BLOOMIN’ HOLE
Outback Steakhouse

THANKS TO OUR VOLUNTEERS
Jennifer Harbuck
Geri Kelly-Mancuso, RN
Charlee Miller
Leslie Rader
Paul Riemer
Scott Riemer
Babe Rizzuto
Beth Sandri
Christina Santorsola
Frank Santorsola
Jackie Smith
Lisa Stumpf

FRIENDS
Gian Andrea & Moyra Botta
Warren Cassidy
Dwight Hilson
Pete Maniscalco
James Mossman

DebRA would like to thank the following Celebrities:
John McEnroe
Joe Pagignatano
Ralph Branca
Karel Novacek
Tony Viteri
The Honorable David Dinkins
Thomas Blake


DebRA
 
  



Patient Care Conference 2008
12636 Reads Printer friendly page
Posted by: DebRA on May 13, 2008 - 11:24 PM


Patient Care Conference 2008, presented by Hollister Wound Care
June 19-22, 2008
Denver, Colorado

Renaissance Denver Hotel
3801 Quebec Street
888-238-6762

Every two years DebRA's PCC provides the opportunity to gather and attend educational sessions about various medical issues in EB and to ask questions of the expert presenters. It is also a great way to meet and reunite with friends in the EB community.

More than 300 people visited Denver for DebRA’s 2008 Patient Care Conference (PCC) entitled “New Heights, New Hopes”. Denver, the capital of Colorado, played host to the free biennial conference that featured presentations from leading authorities on Epidermolysis Bullosa (EB). Denver was chosen as the 2008 venue due to its strong connection to the EB community through the EB Clinic at Colorado Children’s Hospital.

Mary Sprague, the Executive Director of DebRA, opened the conference with a welcome to all families and medical professionals that traveled to attend this one-of-a-kind meeting of families and doctors from around the nation. The four-day conference provided the unique opportunity for experts in the field and families to come together to share information and an open forum to ask questions. It also allows families to meet in person and share their experience and suggestions with each other.

The agenda covered topics including wound care, nutrition, research, physical therapy, entering the schools, stem cell treatment, dental care and pain management among many others. National Rehab generously offered to record the sessions and have made them available to the EB community.

PCC Kid's Room While the adults were immersed in the sessions, the children had the opportunity to spend time together working on projects and playing in the Kid’s Room. It is due to the amazing volunteers. Their time and seemingly limitless amounts of energy kept the room filled with laughter and the children entertained.

The PCC is free to all attendees and was supported in part, through the generosity of Title Sponsor Hollister Woundcare. Support provided by Gold Sponsor Molnlycke Healthcare and Silver Sponsor National Rehab also helped to make this conference possible. In addition, the conference received general support from Byram Healthcare, Direct Medical, Mr. & Mrs. Mark McCaughtry, Pedors, Smith & Nephew, The Brotman Foundation and Wayne Westland Friends of EB.

The next Patient Care Conference will be held in 2010 with the date and location to be determined. Details will be shared as they are available.

Click here to view the 2008 PCC agenda.

This Conference would not have been possible without all of the Doctors, Nurses, and other wonderful medical professionals and volunteers who worked so closely with us to make this year’s Patient Care Conference happen . We will never be able to thank you enough.


PCC Conference DVD Available Now - DebrRA of America's 2008 Patient Care Conference was filmed by National Rehab in collaboration with DebRA. National Rehab is a specialist in advanced wound care supplies and service. National Rehab has had a long standing commitment to the EB community. If you would like to receive a copy of DebRA's 2008 Conference DVD, please click here.



DebRA
 
  



DebRA Welcomes New Executive Director
1784 Reads Printer friendly page
Posted by: DebRA on Mar 24, 2008 - 06:11 PM


Mary Sprague will join DebRA of America as Executive Director on May 12, 2008, President Faith Daniels announced. "Mary brings an important mix of success as an entrepreneur and outstanding non-profit experience to help DebRA develop and expand to meet the growing needs of the EB community," Daniels said.

Prior to joining DebRA, Sprague was Director of Managed Work Services of New York, LLC (MWS), a workforce development initiative placing hardest to serve adults in private sector permanent employment. MWS operates as an LLC wholly owned by VIP Community Services, of which Sprague also held the title Vice President. MWS was cited by New York State as the program model that should be adopted state-wide to create successful employment outcomes.

Prior to her work in the non-profit sector, Sprague was a successful manager and business owner in the food service, hospitality and retail industries. She was honored with the New York State Entrepreneur of the Year Award.

Sprague earned her bachelor of arts from Sarah Lawrence College and her master’s degree from New York University.

After 3 years of committed work at DebRA, Former Executive Director Suzanne Cohen will remain involved in the organization as a DebRA volunteer, according to Daniels. "We want to thank Suzanne for her dedication over the last three years and her passion for the cause," Daniels said.


DebRA
 
  



Sponsors of the 9th Annual Mats Wilander Classic
5371 Reads Printer friendly page
Posted by: DebRA on Nov 01, 2007 - 10:46 PM


GOLD SPONSOR
Molnlycke Healthcare

SILVER SPONSORS

National Rehab
Hollister Wound Care
Brian & Lisa Stumpf & Family


EXCLUSIVE SPONSOR OF THE COCKTAIL RECEPTION
Tom & Kathy Shannon/T-Bird Restaurant Group

EXCLUSIVE SONSOR OF THE HOLE IN ONE CONTEST

Tom & Kathy Shannon/T-Bird Restaurant Group

EXCLUSIVE SPONSOR OF THE CLOSEST TO THE PIN CONTEST

Vincent & Cora DiFiore

TEE SPONSORS
The Coughlin Family
Roger & Nancylee Matles/Smith Barney Purchase


DEBRA OF AMERICA THANKS

Curry Automotive
For the generous donation of a 2008 Acura MDX for the Hole-In-One Contest

BLOOMIN’ HOLE

Outback Steakhouse

FRIENDS
Allcare Medical
American Express
Chris & Ann Marie Chambers
Kenneth I. Chenault
Patrick & Barbara Gogan
James Mossman
Organogenesis Inc.
Chris & Silvana Pascucci
Herman & Joan Riemer
Thomas M. Ryan
Suzanne Tobak

DebRA would like to thanks the following
Celebrities:
John McEnroe
Patrick McEnroe
Jim Courier
Joe Pagignatano
Bill McCreary
Ralph Branca
Karel Novacek
Tony Viteri
The Honorable David Dinkins

DebRA of America would like to thank the following businesses & individuals for their generous donations to the Live & Silent auctions:
Alan Kalter • Alex Gould • Angelic & Jim Belle • Angus Vail • Ann Tanksley • Armonk Wine & Spirits • Babe Rizzuto • Conair • Barbara Flamm • Charlee Miller • Christina & Frank Santorsola • ClubCorp® • Cory Gould • Country Sports • Curry Automotive • David Bernacchia • Dawn Veilleux • DermAvance• Advanced Skincare • Blue Ribbon Restaurant • Emeril Lagasse • Faige Timeless Portraits • Geraldine Kelly-Mancuso• RN • Telerep Cougar Sales • Go Figure Studios • Greg & Tony Ouidad Salon • Hugg-a-Planet • James Hoffman • Jennifer & Andrei Achim • Jennifer Harbuck • Kathy Kirkland • Kelly Duignan • Ken Dorros • Leslie Rader • Linda Talt • Loews Corporation • Lorene Roccon Thompson • Margaret’s Tennis Corner • Marie Misisco • Mathe Roux Skincare • Mats & Sonya Wilander • Maureen Langan • Megan Isaacs Jewelry Designs • Michele Mosko • MTV • Ovation • Peter Thomas Roth Clinical Skincare • Peter Dooney • Ralph Branca • RèVive Skincare • Robert Meirowitz,MD • Roger Waters • Ron Duckstein • Ruder Finn PR Firm • Ruth Riemer • Savoy Restaurant • Scott Riemer • The Sea Shore Restaurant • Thomas & Karen Misisco • Tom & Kathy Shannon • Woody & Kathy Jay

THANKS TO OUR VOLUNTEERS
Babe Rizzuto • Brynn Scully • Collette Hall • Christina Santorsola • EJ Carfi • Geri Kelly-Mancuso,RN • Ian Morgan • Jackie Forte • Jake Misisco • Linda O’Neil • Janet Chan • Jeanne Humphrey • Jody Carfi • Kristen Gorman • Leslie Rader • Lisa Stumpf • Lorene Thompson • Scott Riemer • Zoë Oper


DebRA
 
  



What is EB and Your Welcoming Classroom DVD
5470 Reads Printer friendly page
Posted by: DebRA on Sep 18, 2007 - 05:12 PM


This two-part DVD was developed by the multidisciplinary Epidermolysis Bullosa Team at The Children’s Hospital of Colorado, and is endorsed by DebRA of America. It is a guide for making the school experience supportive and academically challenging for students with Epidermolysis Bullosa.

The first part of the DVD, What is EB, is designed to familiarize students and teachers with some of the issues facing children with dystrophic EB. This kid friendly segment is hosted by a child with EB and other children with EB and their classmates and teachers share their perspectives about EB in the school environment. The goal is to help students with EB feel more accepted and less isolated in the classroom.

The second part of the DVD, Your Welcoming Classroom, is specifically designed to provide teachers, school nurses, therapists and administrators with the information and tools to better understand EB. It is designed to improve communication between the child, family, medical and educational communities.

This free DVD is available by clicking here to place an order.

The following is an overview of the content of Your Welcoming Classroom (for School Personnel Only):

  • What is EB?
  • Genetic, not contagious
  • Different types
  • Integrating the student into Classroom
  • Special needs
  • Interview with parents
  • Develop plan
  • Classroom Management
  • Socialization
  • Welcome EB students and involve them in activities
  • Educate other students about EB (i.e., go to different classrooms)
  • Educate other students about abilities and limitations
  • How can other students help?

Understanding the Issues of Importance for students with EB

  • Swallowing
    Esophageal blisters or scarring
    Respect “no” if unable to eat
    Have snacks available (i.e., puree foods, liquids)

  • Bandages
    Protect skin
    Help heal skin
    Overheating

  • Odor
    Help other students understand
    Speak with nurse and/or parent
    Be aware of infections

  • Depression
    Be aware of psychiatric symptoms (i.e., withdrawn, isolated, sadness)
    Talk with parents
    May need psychiatric evaluation and support

  • Pain
    Pain control and management
    Rate pain, on scale 0 – 10
    Pain medications

  • Bathroom
    Set up bathroom time (i.e., 10 minutes)
    Reward program or goal sheets

  • Parents
    Communicate regularly
    Written back and forth log
    Common knowledge and goals

  • Control
    Need sense of control
    Self-advocacy
    Recognize talents and strengths

  • Good Days and Bad Day
    Status fluctuates
    Pain
    Schedule time to check in with the nurse
    Allow breaks


DebRA
 
  



RDEB Gene Transfer Trial Screening Open
5671 Reads Printer friendly page
Posted by: DebRA on Aug 21, 2007 - 11:56 AM


As part of DebRA’s ongoing commitment to keep patients apprised of the latest information, DebRA has agreed to provide the following for information purposes only.

RDEB Gene Transfer Trial Screening Open

Stanford University in California is currently looking for patients to participate in a preliminary screening for possible gene transfer trial for recessive dystrophic epidermolysis bullosa (RDEB).

They are looking for patients who meet the following criteria:

  • Have a clinical diagnosis of RDEB by a local dermatologist
  • Are 18 years of age or more, and willing to give consent
  • Estimated to have at least 100 to 200 cm 2 areas of open erosions on the trunk or extremities
  • Able to undergo adequate anesthesia to allow grafting procedures to take place
  • Parents alive, do not have EB, and are willing to give consent for genetic testing.
  • Medically stable to travel to Stanford University Medical Center
  • No medical illnesses expected to complicate participation.
  • Currently this study is limited to residents in the USA

If you meet the above criteria, you may be eligible to come to Stanford University and participate in the screening phase of our trial. The screening will involve skin biopsies, blood tests, and genetic testing. We will pay their travel expenses related to this trial.
 
For more information or any questions regarding this study and/or the eligibility criteria, please contact the Clinical Trial Coordinator, Emily Gorell, at (650) 725-4302 or at egorell@stanford.edu.



DebRA
 
  



Support Mechele's walk to raise funds for EB
2647 Reads Printer friendly page
Posted by: DebRA on Jun 06, 2007 - 11:04 PM


Ryska Family

My name is Mechele Ryska. My daughter, Isabel, (4 years old), and her brother, Carter, (3 years old), are affected by Epidermolysis Bullosa Simplex. My husband, Jason, and his father, David, also suffer from this disease.

On Isabel and Carter’s best days – you would not know that they have a problem, but on their worst days – their feet are covered in blisters and they are in so much pain that running or playing like normal children is virtually impossible. They cannot walk. They try to crawl, and it breaks my heart that there is nothing that I can do except to carry them. They also get painful blisters on their hands, and any other place where there is any friction against their skin.

Our son's right footI have committed to walk the Detroit Free Press/Flagstar Bank Marathon (26.2 miles!) from Detroit to Windsor and back on October 21, 2007. I am taking on this endeavor to raise money and awareness for DebRA of America, so that someday we will find a cure for this disease, and all of these children will be able to run and play without the pain of blisters.

Pleae click here to support Mechele and DebRA with an online donation.
Or, call 212-868-1573. Checks can be mailed to:
DebRA of America
5 West 36th Street, Suite 404
New York, NY 10018



DebRA
 
  



Informacion en Espanol
12576 Reads Printer friendly page
Posted by: DebRA on Feb 27, 2007 - 12:38 PM


Bienvenidos a
DebRA (Dystrophic Epidermolysis Bullosa Research Association of America)

EB PatientEste sitio de internet es su punto de entrada a la unica organización nacional sin fines de lucro dedicada a promover la investigación para encontrar nuevos tratamientos y una cura para Epidermolysis Bullosa y proporcionar informacion y apoyo a las personas con EB y sus familias.

El programa EB En Español fue establecido para proveer información en Español y una comunidad para nuestras familias hispano-hablantes. Mas informacion sera agregada cuando sea disponible.

Información en Español :

Enfermera Educadora de EB
La enfermera educadora de EB de DebRA, Geraldine Kelly-Mancuso, RN, esta disponible para asistir familias hispano-hablantes. Usted puede ponerse en contacto con Geri por telefono (513-636-7931) ó por e-mail debranursec@yahoo.com.

Foro de la Comunidad EB En Español
Conectese a otras familias aqui
No se ha registrado todavía? Haga clic aquí para registrar. Como usuario registrado, usted podrá anunciar a nuestros foros.

Links a otra informacion sobre EB en Español:

EB PatientDebRA Chile
www.debrachile.cl

DebRA Costa Rica
www.debracr.org

DEBRA Spain
www.aebe-DebRA.org

Nuestras gracias a las siguientes personas por su ayuda en el desarollo de este proyecto: Geraldine Kelly-Mancuso, RN, Elisabete Gaspar, RN, Maria Oliveira, Antonio Campana, Sally Contreras-Mata, DebRA Costa Rica, DebRA Chile, DebRA Spain y Dr. Moise Levy.


EB En Español ha sido posible en parte por el apoyo de Fund for the Poor, Integra Foundation, New York Board of Trade Futures and Options for Kids, New York Mercantile Exchange Foundation, y Schering-Plough Foundation.


DebRA
 
  



Cuidado del bebé con Epidermolysis Bullosa
5665 Reads Printer friendly page
Posted by: DebRA on Feb 27, 2007 - 12:07 PM


Prevención de Ampollas

Como cargar al bebé: Evite levantar el bebé o niño por debajo de los brazos. En su lugar, ponga una mano debajo del trasero y la otra debajo de la cabeza/cuello para levantar. Una almohada, cojín de espuma, o piél de oveja puede ser utilizada debajo de el bebé para prevenir fricci ó n hacia la piél al levantar o sostener el bebé.

No frote la piél: Porque las ampollas pueden ser causadas por la fricci ó n, la piél debe de ser palpada suavemente en vez de ser frotada. Antes del análisis de sangre o inmunizaciones, la piél puede ser purificada usando almohaditas con alcohol y suavemente presionando contra la piél —sin frotar.

Use ropa suelta: Ropa que frote la piél puede causar ampollas. Evite ropas con elasticos apretados, ziperes, y botones o broches asperos. Pañales de tela pueden ser usados. Pañales desechables que no ajusten mucho pueden ser usados y los elásticos de las piernas pueden ser cortados para reducir las ampollas.

Evite el calor excesivo: Demasiado calor tiende a aumentar la fragilidad de la piél. Mantenga una temperatura ambiental moderada (incluso en su carro) y no vestir muy arropado.

No use adhesivo en la piél: Ningún tipo de adhesivo (incluyendo curitas) debe de ser pegado en la piél porque pueden causar ampollas.

Lubricar la piél: Aquaphor o vaselina puede ayudar a reducir la fricci ó n.

Acolchonar prominencias huesudas: Esponjas de gasa, aseguradas con gasa enrollada pueden ser usadas para alcochonar los codos, talones y rodillas si la piél de el bebé se ampolla por el hecho de dar patadas en su cuna. Medias suaves pueden ser puestas sobre manos y pies lubricados para reducir ampollas.

Cuidado de Ampollas y Prevención de Infección

Lave las manos antes de administrar cuidado de la piél. Lavando las manos es la manera mas eficáz de controlar infecciones.

No quite ropa o vendas que esten pegadas a la piél: Materiales que se han pegado a la piél deben ser remojados hasta que se desprendan. Esto se puede hacer a la hora del baño (en la bañera) o aplicando agua templada o una compresa mojada directamente sobre la venda o material.

Lavar la piél diariamente: La piél se puede limpiar con un jabón suave, como Dove.

Drene las ampollas: Ampollas normalmente aumentan en tamaño si se permiten permanecer intactas. For esta razón, la mayoría de las ampollas deben ser drenadas cuando son de el tamano de una moneda de diez centavos o si aparecen estar apretadas o rígidas. Agujas esterilizadas o lancetas pueden ser usadas para perforar la orilla del techo de la ampolla. Pequeños agujeros pueden sellarse de nuevo y permitir que la ampolla se rellene. Por esta razón es necesario abrir el techo de la ampolla adecuadamente. El techo de la ampolla debe ser dejado intacto para facilitar la curación y alívio. Un antibiótico tópico suave puede ser aplicado al area para la prevención de i nfección .

Aplique antibióticos tópicos en las lesiónes: Los antibióticos suave como Polysporin o Bacitracin son efectivos en prevenir la infección y pueden ser alternados cáda mes o dos para disminuir la resistencia de la bacteria. Bactroban, como todos los antibióticos por receta médica, deben ser usados solamente cuando hay i nfección activa o presente (síntomas de i nfección incluyen enrojecimiento, inflamación, dolor, y calor).  Uso prolongado de Bactroban ha sido asociado con el desarrollo de infecciones de Estafilococo Resistente.  

Ponga o use vendajes no-adhesívos:  Después de la aplicación del antibiótico topico, un vendaje no-adhesivo como Mepitel*, Linitul o Telfa debe de ser aplicado sobre las heridas abiertas o las áreas no protegidas. El vendaje no-adhesivo puede ser asegurado con gasa enrollada y finalmente con un retenedor tubular de vendaje como Spandage o Surgilast. Estos retenedores pueden prevenir los accidentes de cintas adhesívas.

*El antibiótico topico puede ser aplicado directamente sobre el Mepitel para facilitar la aplicación de este medicamento. Esto es posible porque Mepitel es una hoja de silicona con pequeñas perforaciones que permiten la penetración del antibiótico.

Cambio diario de vendajes: C ambio diario de vendajes es recomendado y puede ser coordinado con un baño o con la limipieza de la piel.  Hay unos tipos de vendajes, como Mepitel (Molnlycke Health Care), un apósito de silicona, que puede permanecer en su lugar por unos días aun permitiendo evaluación de la herida.  El vestuario secundario debe de ser cambiado diariamente, igual que las heridas deben de ser evaluadas diariamente.

Nutrición

Leche materna es la mejor para los bebé s, pero el amamantamiento presenta un desafió unicó para bebés con EB. Bebés con ampollas y lesiones en la boca pueden tener dificultades amamantando o chupando un biberon comun. Las madres pueden extraer su leche para ofrecerle a su bebé. El "Haberman Feeder" (http://www.medela.com) es un biberon diseñado especialmente para bebés con la condición de Fisura Palatina que incorpora una válvula que facilita la succión de la leche. Este metodo ha sido exitoso para bebés con fragilidad bucal.

El cuidado de la boca del bebé puede incluir limpieza cuidadosa con una esponjita diseñada para limpieza de dientes (toothette).

Un chupón seco se puede pegar a los labios y en areas ampolladas causando mas daño y dolor. El chupón se puede humedecer con agua o lubricar con Vaselina antes de ofrecerlo al bebé.

Mantenga indices de crecimiento : Es importante marcar el desarollo de un niño con EB. Estos indices proveen información importante para evaluar si su dieta es adecuada. Si los padres tienen preocupaciones o preguntas, lo mejor es consultar a un nutricionista para evaluar correctamente sobre su desarollo. Muchos bebés con EB necesitan fórmulas enriquecidas para alcanzar las calorías y proteínas que sus cuerpos necesistan.

Consuelo y Bienestar: No es exraño que enfermeras o padres eviten manipular un bebé que tiene EB con el deseo de reducir las ampollas. Aprender la manera correcta de sujetar al bebe puede inculcar la confianza en el vigilante y permitir que el bebé reciba el soporte emocional y cercanía que el o ella necesita.

Es buena idea que use la cuna para un lugar seguro. Toda los cambios de vendajes y otras actividades desagradables deben de ser realizadas en otro lugar, que no sea la cuna, por ejemplo la mesa de cambio. El bebé debe aprender a conectar su cuna como un lugar de consuelo y bienestar.  



DebRA
 
  



Programas y Servicios
3465 Reads Printer friendly page
Posted by: DebRA on Feb 27, 2007 - 11:55 AM


Proporcionando Acceso hacia Cuidado de Salud de Calidad e Información

Buscando un proveedor de salud que tenga conocimiento sobre EB es uno de los grandes retos que enfrentan las familias que estan lidiando con esta enfermedad. DebRA ayuda a familias con la información mas adjetiva y precisa atravez de sus dos enfermeras educadoras que estan dedicadas a proporcionar informacion a las familias y a los profesionales de salud por via de la Linea Directa de EB (EB Hotline).

Las enfermeras educadoras tambien pueden conectar los pacientes con profesionales de salúd en sus comunidades atravez del Servicio Nacional de Referencia de Medicos.

El acceso de información correcta es especialmente dificil cuando hay poca disponibilidad en su lenguaje. El nuevo programa de DebRA, EB En Español, le dará a familias hispano-hablantes mayor acceso a la información de EB atraves de literatura y de la pagina de internet de DebRA.

La conferencia bienal y gratuita de DebRA sobre “Cuidado al Paciente” provee una tribuna para que las familias de EB puedan unirse y aprender sobre las últimas investigaciones y avances medicos en el tratamiento de EB. La conferencia ofrece una oportunidad única para escuchar y hacer preguntas a los mas grandes expertos mundiales sobre EB.

El boletín trimestral de DebRA “Currents” (Corriente) provee información oportuna sobre avances en el tratamiento de EB y da a conocer a familias y personas haciendo una diferencia, asi tambien como programas que conocen las necesidades de la comunidad de EB.

La pagina de internet de DebRA, www.debra.org, provee pacientes, cuidadores y profesionales de salud con la información mas reciente sobre EB, mientras ofrece un lugar donde la comunidad de EB puede unirse sobre la linea.

Ofreciendo Una Mano Que Ayuda

Cuando un bebé nace con EB, la experiencia es inundante para los padres nuevos. Con “El Programa de Defensores de Familia” padres voluntarios y entrenados ofrecen su apoyo sobre el teléfono y tambien brindan visitas personales para enseñar la familias sobre lo basico en el cuidado de su niño/niña. Este programa tambien provee familias con ropas especiales y productos médicos básicos.

Materiales especializados para EB son costosos y dificil de obtener. El centro conocido como “El Banco de Liquidación del Cuidado de Heridas” colecta donaciones de materiales para el cuidado de heridas y los distribuyen a las familias mas necesitadas.

El costo de cuidado medico y materiales usado diariamente para vendar causan un cargo financiero muy grande para las familias. DebRA tiene dos programas para ayudar las familias necesitadas con una mano que ayuda. El Fondo de Crísis Familiar proporciona asistencia de emergencia para aliviar algunos cargos financieros hacia el costo de materiales médicos, procedimientos y aparatos que no son reembolsados. El Fondo de Eric Lopez ofrece la oportunidad para que la gente que tienen EB puedan conseguir un máximo nivel de independencia y/o mejorar las actividades en sus vidas diarias.

Solucionando el rompecabeza de EB pieza por pieza

DebRA de América es parte de el esfuerzo mas grande sobre la investigación internacional sobre las causas, consecuencias y tratamientos posibles para los tres tipos de EB. Los científicos para la fundacion de DebRA estan trabajando para conseguir nueva información en genéticas, terapia genética, cancer, curación de heridas, administración del dolor y temas psicósociales.

El Registo Nacional de EB es el más grande base de datos médico de su estilo en el mundo y fue establecido por DebRA con fondos del Instituto de Salud Nacional (Nacional Institute of Health-NIH) para colectar información de pacientes con EB para caracterizar las muchas formas de esta enfermedad y determinar la frecuencia de varias manifestaciones de EB. El registro esta localizado en la Universidad Vanderbilt en Nashville, Tennessee.

La Fundacion de Dermatología/DeBRA Concesion de Investigación de Epidermolysis Bullosa, provee ayuda financiera para proyectos de investigación en dermatología y biología cutanea, especificamente sobre Epidermolysis Bullosa.



DebRA
 
  



Art Exhibit
6160 Reads Printer friendly page
Posted by: DebRA on Jan 29, 2007 - 03:29 PM


The Society for Investigative Dermatology (SID) is sponsoring a 5th annual patient art exhibit at its meeting in Los Angeles this May.

This is an opportunity to translate your experience with skin disease into very personal terms. Please use the submission form to enter. The SID will pay to ship the art and have it professionally framed and the piece will be returned to the artist after the exhibit.

Please click here for the submission form.



DebRA
 
   39 Comments



Sponsors of the 8th Annual Mats Wilander Classic
4482 Reads Printer friendly page
Posted by: DebRA on Oct 31, 2006 - 07:45 PM


GOLD SPONSORS
National Rehab
Molnlycke Healthcare
Brad Rasmussen


SILVER SPONSORS
Direct Medical
Cambrex



EXCLUSIVE SPONSOR OF THE HOLE-IN-ONE CONTEST
Tom & Kathy Shannon & Family and the T-Bird Restaurant Group

EXCLUSIVE SPONSOR OF TOURNAMENT BAGS
Loews Corporation

EXCLUSIVE SPONSOR OF THE COCKTAIL RECEPTION
Tom & Kathy Shannon & Family and the T-Bird Restaurant Group

TEE SPONSORS
Gus’ Franklin Park Restaurant
Nottingham Advisors
Allcare Medical


DEBRA OF AMERICA THANKS
Curry Automotive
For their generous donation of a 2007 Acura for the Hole-In-One Contest

FRIENDS
Allcare Medical•American Express•Chris & Ann Marie Chambers•Curry Automotive Group•Charles & Ingrid Davis•Darrien Automotive Group•Vincent & Cora DiFiore•Philip & Amy Duff•James & Leigh Everitt•Don & Joyce Hoffman•Dooney & Bourke•Larry Lunt•Herman & Joan Riemer•Anthony Malkin•Metric Construction•James Mossman•Mr. & Mrs. Doug Millett•Thomas and Karen Misisco•Nottingham Advisors•Gerald & Suzanne Soderlund•Tahari ASL LLC•Wentworth Hauser•Wiggin & Dana•Scott & June Wood

DebRA of America would like to thank the following businesses & individuals for their generous donations to the Live & Silent auctions:

Adele Jones Westbrook•Al Udow•Alan Kalter•Alease Fischer•Andy & Jennifer Moszinski•Angelica & Jim Belle•Armonk Wines & Spirits•Barbara Flamm•Biotherm•Brillstein Grey Entertainment•Bulova•Carson International Inc.•Casa Irie•CBS•Charlee Miller•Coco Reef Hotel•Conair•Cory Gould•Chris Santorsola•Curry Automotive•David Bernacchia•Debbie Wilson•Donna Meyers•Dooney & Burke•Elizabeth Arden•Emeril Lagasse•Estee Lauder•Faige Timeless Portraits•Fisher Family•Go Figure Studios•Jeanne Humphrey•Kelly Duignan•Kate Mara•Ken Dorros•Kit Kittles•Ladenburg Thalmann•Leslie Rader•Liebert Royal Green Appliances•Linda Talt•Loews Corporation•Lynne Haven, MD• MacMenamin’s Grill & Chefworks•Margaret’s Tennis Corner• Mathe Roux Skincare•Mats & Sonya Wilander•Maureen Langan•Michelle Mosko Miller•Morton’s Restaurant Group•MTV•National Rehab•Nestle Purina Pet Care•NBC•New York Board of Trade•New York Jets•Octagon•Patty Ryan•Paul & Ruth Riemer•Peter Thomas Roth• Clinical Skin Care•Ralph & Ann Branca•Reinstein/Ross•Robert Meirowitz MD•Ron Duckstein•Schoenhut Family•The Mara Family•Tom & Kathy Shannon & family•T-Bird Restaurant GroupThomas & Karen Misisco•Warren Tricomi•Woody Jaye

Thanks to our Goody Bag Donors
Biotherm•Bravo Brands•Conair•Curry Automotive•Debbie Wilson/Wilson Productions•Johnson & Johnson•Leslie Rader•Moetleh Messages•National Rehab•Neutrogena•Pez•Purdue•Seed Magazine•Traveling Pez Dispenser•Unilever




DebRA
 
  



DebRA Expands Nurse Educator Program; Registry to Reopen
2107 Reads Printer friendly page
Posted by: DebRA on Aug 31, 2006 - 03:05 PM


This summer, DebRA expanded its most vital program by funding two EB Nurse Educators based at prestigious institutions, according to Executive Director Suzanne Cohen. “There was an overwhelming demand for the services of our Nurse Educator so we doubled the staffing to meet that need. Along with the expansion, we decided it was to the benefit of our families to have these positions based with EB experts.”

Adele Jones Westbrook, RN joined as the DebRA Nurse Educator based at Vanderbilt University in Nashville, TN and Geri Kelly-Mancuso, RN is the DebRA EB Nurse Educator based at Cincinnati Children’s Hospital Medical Center. Both positions are funded by grants from DebRA of America to Cincinnati Children’s Hospital Medical Center and Vanderbilt University. The entire DebRA Nurse Educator Program is made possible through the generosity of National Rehab, Inc., the Pascucci Family Foundation, the Jennifer DePrizio Memorial Golf Tournament, NYBOT Futures and Options for Kids, Michael and Madeline Weiner, Connie and Paul Flowers, and other DebRA supporters.

Second Nurse Helps Reopen EB Registry

In the newly created second EB Nurse Educator position, Ms. Westbrook will spend 30 hours per week on patient and family calls and emails and the remaining 10 hours helping her supervisor, Jo-David Fine, MD, with the National Epidermolysis Bullosa Registry. Dr. Fine, a DebRA Trustee and Scientific Advisory Board Member, is a world-class clinical and scientific expert on EB and Principal Investigator and Project Head of the National Epidermolysis Bullosa Registry.

The EB Registry was developed by Dr. Fine with support from DebRA of America and the N.I.H. and is the largest medical database of its kind in the world. The Registry collects information from patients with EB, characterizes the many forms of this disease, establishes the frequency of various manifestations of EB and determines the risks of specific clinical outcomes within EB types. It has yielded a great deal of knowledge about the disease and many of its findings have been published in peer-reviewed scholarly journals. The Registry was closed temporarily when Dr. Fine moved from University of North Carolina at Chapel Hill to Vanderbilt University.

Ms. Westbrook was already a Vanderbilt University employee whose prior position was as a Dermatology MOHS Micrographic Surgical Unit Nurse. She has extensive experience in dermatology, pediatrics, plastic surgery, oncology and orthopedic nursing. She attended Vanderbilt University School of Nursing and is a Magna Cum Laude graduate of Aquinas College, Nashville, TN.

“Adele brings nursing experience from several fields that are directly relevant to the varied and complex issues that arise in EB,” Dr. Fine said. “This Nurse Educator position presents unique challenges as it demands someone with a range of nursing skills and a strong research orientation married with an overriding sense of caring for the EB community. This is not an easy combination to find but Adele possesses all these qualifications.”

Cincinnati Children’s Hosts Nursing Position

The other EB Nurse Educator position will benefit from DebRA’s partnership with Cincinnati Children’s Hospital. Ms. Mancuso is working under the supervision of DebRA Scientific Advisory Board Member Anne Lucky, MD, the co-director of the hospital’s Epidermolysis Bullosa Center.

“Basing the position at Cincinnati Children’s will enable us to access the depth of EB knowledge in their outstanding program,” Cohen said. “Geri will be working in tandem with Adele to assist our families and together they will give us a strong nursing team.”

Ms. Mancuso has extensive pediatrics experience as a school nurse and nurse at South Bronx Children's Health Center . Prior to joining Cincinnati Children’s Hospital, she was the Clinical Nurse Manager of the Hope Center at St. John's Riverside Hospital in Yonkers NY, where she managed the facility’s outpatient AIDS clinic. In addition, Ms. Mancuso speaks Spanish and will help DebRA meet the growing demand for outreach to Spanish-speaking families, according to Cohen. Ms. Mancuso earned a bachelor’s degree in nursing from Hunter College in New York City.

“Geri’s pediatrics background and skills in managing the cases of people of all ages with a serious, chronic disease gives her a strong grounding in the issues EB families face,” Dr. Lucky said.

To contact a Nurse Educator, please call 866-DEBRA76 Monday to Friday from 9 a.m. to 5 p.m. Eastern Time or write nurse@debra.org.



DebRA
 
  



Patient Care Conference 2006 Resources
4122 Reads Printer friendly page
Posted by: DebRA on Jul 26, 2006 - 09:10 PM


These materials were presented at the 2006 DebRA Patient Care conference and are provided for information purposes only for people with EB, family members, and health professionals interested in learning more about EB. Any other copying or distribution in part or full must be done with the express permission of each author/presenter.
Get the free Adobe Reader  You will need the free Adobe Reader to open the conference documents.
CONFERENCE TOPICS SPEAKERS / AUTHORS
Anemia and Other Non-Cutaneous Manifestations of EB
requires broad-band Internet
Jo-David Fine, MD, MPH &
Vanderbilt University
Dr Jemima Mellerio, MBBS
St John's Institute of Dermatology
Cancer and EB

Click here for full presentation - requires broad-band Internet
Dan Siegel, MD, FAAD &
Long Island Skin Cancer & Dermatologic Surgery, P.C.
Jo-David Fine, MD, MPH
Vanderbilt University
Dental Manifestations & Care
requires broad-band Internet
Tim Wright, DDS, MS
University of North Carolina Dentistry
Entering the School System Cynthia Leatherwood
Educational Advocate, Disability Law and Advocacy
Center of Tennessee
Hand Manifestation of EB Jo-David Fine, MD, MPH,
Vanderbilt University
Madeline Weiner, RN & Sally Contreras-Mata
Genetic Counseling in EB Ellen G. Pfendner, PhD
Gene DX  
GI Manifestations of EB
requires broad-band Internet
Richard G. Azizkhan, MD
Cincinnati Children’s Hospital
Independent Living for Young Adults Floyd Stewart. Jr.
Independent Living Specialist and Program Coordinator
Center for Independent Living of Middle Tennessee
Insurance & Reimbursement of Products & Dressings Bill Cornman
National Rehab
Mobility and PT
requires broad-band Internet
Faye Dilgen, MS, PT &
Ben Norton, MPT  

Molecular Analysis:
Is There A Clinical Correlation?

requires broad-band Internet

Ellen G. Pfendner, PhD
Gene DX
Nutrition and EB Part I & II Cathy Breedon, PhD, RD
MeritCare
Pain Management in EB:
Medication is not the only answer
Candace J. Erickson, MD
Psychosocial Adjustment of Individuals and Families with EB:
· Behavioral Management
· Anxiety - Helping Children & Adolescents
· Power of Language
Candace J. Erickson, MD
Understanding EB

Jo-David Fine, MD, MPH
Vanderbilt University

Wound Care & Product Use Madeline Weiner, RN &
Ben Norton, MPT



DebRA
 
  



DebRA Hires EB Nurse Educator, EB Registry to Reopen
1979 Reads Printer friendly page
Posted by: DebRA on Jun 29, 2006 - 03:50 PM


Adele Westbrook, RN, will be joining DebRA of America on July 1, 2006 as the DebRA EB Nurse Educator who will be based at Vanderbilt University in Nashville, TN, Executive Director, Suzanne Cohen announced. With Ms. Westbrook in place, it will be possible to reopen the National Epidermolysis Bullosa Registry, which is key resource for EB research. Her first weeks will be spent in orientation and training and she will begin to work on patient and family inquiries the week of July 24.

In this newly created second EB Nurse Educator position, Ms. Westbrook will spend 30 hours per week on patient and family calls and emails and the remaining 10 hours helping her supervisor, Jo-David Fine, MD, with the National Epidermolysis Bullosa Registry. Dr. Fine, a DebRA Trustee and Scientific Advisory Board Member, is a world-class clinical and scientific expert on EB and Principal Investigator and Project Head of the National Epidermolysis Bullosa Registry.

This position is funded by a grant from DebRA of America to Vanderbilt University. The entire DebRA Nurse Educator Program is made possible through the generosity of National Rehab, Inc., the Pascucci Family Foundation, the Jennifer Deprizio Memorial Golf Tournament, NYBOT Futures and Options for Kids, Michael and Madeline Weiner, Connie and Paul Flowers, and other DebRA supporters.

Ms. Westbrook is a current Vanderbilt University employee whose prior position was as a Dermatology MOHS Micrographic Surgical Unit Nurse. She has extensive experience in dermatology, pediatrics, plastic surgery, oncology and orthopedic nursing. She attended Vanderbilt University School of Nursing and is a Magna Cum Laude graduate of Aquinas College, Nashville, TN.

“Adele brings nursing experience from several fields that are directly relevant to the varied and complex issues that arise in EB,” Dr. Fine said. “This Nurse Educator position presents unique challenges as it demands someone with a range of nursing skills and a strong research orientation married with an overriding sense of caring for the EB community. This is not an easy combination to find but Adele possesses all these qualifications.”

The EB Registry was developed by Dr. Fine with support from DebRA of America and is the largest medical database of its kind in the world. The Registry collects information from patients with EB, characterizes the many forms of this disease, establishes the frequency of various manifestations of EB and determines the risks of specific clinical outcomes within EB types. It has yielded a great deal of knowledge about the disease and many of its findings have been published in peer-reviewed scholarly journals. The Registry was closed temporarily when Dr. Fine moved from University of North Carolina at Chapel Hill to Vanderbilt University.

“This new position will enable Dr. Fine to continue his essential work to collect and analyze data about the course of EB,” Cohen said “This information is crucial in research efforts, the diagnosis and management of EB and is vital to health care professionals and EB families.”

Meanwhile, recruiting for the other EB Nurse Educator position continues with a new hire targeted to be in place during July, according to Cohen.

To contact the Nurse Educator, please call 866-DEBRA76 Monday to Friday from 9 a.m. to 5 p.m. Eastern Time or write nurse@debra.org.


DebRA
 
  



Message from Madeline Weiner, RN
3230 Reads Printer friendly page
Posted by: DebRA on Mar 15, 2006 - 04:21 PM


Dear Friends,

After over a decade of working with EB on more than a full time basis, I have decided to take a bit of a break. I am thankful to DebRA of America for providing me with the means and opportunity to do the work I love so much. It has been an honor to represent our organization and you, our patients, families and members.

My intention is to remain a helpful force to the EB population and to continue to support DebRA of America. I am hoping my personal and family commitments will be more manageable with a part-time schedule.

I will be consulting on a couple of exciting EB projects. National Rehab, Inc., DebRA’s long time sponsor and friend, wishes to enhance the services and support it offers its EB clients, as well as others in the EB community. They have asked me to work with them to build an educational (EB) website and to help educate insurance companies about the special needs of people with EB. RegeneRx Biopharmaceuticals, Inc. has contracted with me to provide consulting services as they take their new EB wound healing drug, Thymosin Beta 4, through clinical trials. I’ll be balancing my 3-4 days a week work schedule between these two projects, and spending time with my family.

I wish to extend my gratitude and warm wishes to each of you. Please welcome the new DebRA Nurse Educator to our family. I ask you to offer the support and assistance you’ve always given me. This will afford her the same opportunity I’ve had for a successful, rewarding work and life experience.

With kind regards and much love,

Madeline Weiner



DebRA
 
  



Patient Care Conference 2006
23438 Reads Printer friendly page
Posted by: DebRA on Mar 14, 2006 - 02:11 PM


Patient Care Conference 2006

PCC Materials and Presenter Bios   PCC Agenda  

More than 250 people attended the free DebRA 2006 "Tune Into EB" Patient Care Conference in Nashville, Tennessee from June 1 to 4, 2006. The conference offered in-depth educational sessions on a variety of topics related to Epidermolysis Bullosa.

DebRA acknowledges the following supporters that made this free Patient Care Conference possible:

Gold Sponsors
Molnlycke
National Rehab, Inc.

Grants
Organogenesis
Pascucci Family Foundation
RegeneRx

Silver Sponsor
Tyco Healthcare/Kendall

Kids Room Sponsor
Smith & Nephew

Kids Room Supporters
Forever Young Foundation
Hudson ’s Hope Foundation
Wayne-Westland Friends of EB

Other Supporters
William and Sarah Baum
William and Cathleen Donnelly
Winfield Laboratories
Pedors Footwear

DebRA acknowledges the following people, without whom this conference would not have been possible:

Jo David Fine, MD
Madeline Weiner, RN
Leslie Rader and Bryan Rader
Nansi Greger-Holt, RN
Emily Renfrow Guthrie and George Guthrie
BeFriend EB
EBMRF
Kisses for Katie
Lynn Anderson
DebRA New Family Advocate Program
Medline
Direct Medical
Tim Brown
Traveling Pez Dispenser
James Hargraves
Stacy Maxwell and Bobby Maxwell
Gwynne Oates
Christy Norton
Jerri Rader
Terri Lynn Weaver
Ivan Medina
Ivan Medina, Jr.
Erica Rivera
Lorena Whittington
Suzanne Johns


DebRA
 
  



Support Samantha's walk to raise funds for EB
4516 Reads Printer friendly page
Posted by: DebRA on Mar 07, 2006 - 08:11 PM



Samantha HotchMy name is Samantha Hotch and I am 38 years old. Last July I saw the program "The Boy whose skin fell off" and have never been so moved by what I saw. Jonny Kennedy lived in so much pain all his life and yet still managed to make a difference and keep his sense of humor.

This made me want to do something. I have registered to do the 5 1/2 K Emerald Nuts Walk on 19th March 2006 in Los Angeles. The walk is in Conjunction with the L.A Marathon, though as I will be almost 7 months pregnant, decided the Marathon might be a bit ambitious for me!

I was born in London, England and moved to Santa Monica, California four years ago. I work as a part time Massage Therapist and am working on my first novel, which I hope to complete this year. I am married with a daughter Eden aged 20 months and am currently 6 months pregnant, my little boy being due on June 2nd.

I hope to raise as much money as possible for Debra and would like to think that Jonny Kennedy will be looking down on me smiling on the 19th March.

Best Regards
Samantha Hotch

To contribute as a sponsor and to help the continued efforts of DebRA, please click the "Sponsor" button below to donate online, or call 212-868-1573. Checks can be mailed to:
DebRA of America
5 West 36th Street, Suite 404
New York, NY 10018
Sponsor Samantha



DebRA
 
   702 Comments



DebRA New York Support Group
4618 Reads Printer friendly page
Posted by: DebRA on Dec 14, 2005 - 03:50 PM


NY Support Group Meeting, Spring 2005
New York Support Group Meeting, Spring 2005

Since our inception in the spring of '03 with three members meeting at the Chat 'n' Chew in Union Square, the DebRA New York Support Group has grown to over 100 EB patients, friends and family.

The NY Support Group is committed to supporting EB adults, children, and caregivers in the New York Metropolitan Region, including the tri-state area of NY, NJ and CT. We meet approximately six times per year. While we try to rotate location, we most often meet at Queens College Fitzgerald Gymnasium.

Our next meeting will be TBD late January or early February.

Officers

Co-leader: Kathy Twible, rjt516@optonline.net
Co-leader: Michele Disco, ebnysg@yahoo.com
Treasurer: Jane Rode
Secretary: Theresa Purpura
Supplies Coordinator: Juliann Morabito, jules218@optonline.net

Directions to Meeting

Queens College Fitzgerald Gymnasium

By Car: Exit the Long Island Expressway at Exit 23 Main St, and head south on Main. Take a left on Reeves Avenue. Take your first right into Queens College, which will be after passing the gym. There's a sign that says 153rd St, and you will go through a gate. Go up a small hill, and the building will be on your right. Turn into the first right to go past the front doors, take the first left, and you can enter the parking garage on the right to park. There will be signs to direct you to the room where the meeting will be, starting at the far right when you go in the front doors.

By Subway: Take the #7 Train or Long Island Railroad to Main St. Flushing. On Main St., take the Q25, Q25-34, Q34 or Q17 bus to the campus. You can see a campus map at www.qc.cuny.edu/Map/. Please note - the map on the website is not oriented north/south (turn map 90 degrees counter-clockwise.)

Past Events

The NY Support Group has hosted lectures by Sharon A. Glick on Gene Therapy, Madeline Weiner on Oral Manifestations and Management, and Suzanne Cohen on the status of EB Research. Meetings have also included crayons for the kids, supply swaps and a moving talk by a 76 year-old with RDEB; and always, homemade sweets!

We are proud to have sponsored "Research Update 2004" hosted by Columbia University Dept. of Dermatology as well as an annual Holiday Party. Through raffle sales, Yankee Candle sales, and donations the NY Support Group has raised the funds to donate $14,000 to research, supported an office assistant for Madeline Weiner (which DebRA has committed to continuing,) and sent EB-affected families to the Mats Wilander Celebrity Tennis and Golf Classic.

Meeting Notes

For an update on our activities, please see the following links to our meeting notes:



DebRA
 
  



Sponsors of the Seventh Annual Mats Wilander Classic
4473 Reads Printer friendly page
Posted by: DebRA on Nov 21, 2005 - 03:26 PM


MAJOR SPONSORS

Gold Sponsor
National Rehab

Silver Sponsors
Molnlycke Health Care
Direct Medical
Smith & Nephew


EXCLUSIVE SPONSOR OF THE TOURNAMENT HAT
Molnlycke Healthcare

EXCLULSIVE SPONSOR OF THE TOURNAMENT SHIRT
Loews Corporation

EXCLUSIVE SPONSOR OF THE LONGEST DRIVE CONTEST
Robert & Stephanie Alphin

EXCLUSIVE SPONSOR OF THE HOLE IN ONE CONTEST
Vincent & Cora DiFiore

EXCLUSIVE SPONSOR OF THE CLOSEST TO THE PIN CONTEST
A&T Healthcare

TEE SPONSORS
Coastal Finance Company
Roger & Beth Stern

DEBRA OF AMERICA THANKS
Curry Automotive
For their generous donation of a 2005 Thunderbird for the Hole-In-One Contest

BLOOMIN’ HOLE
Outback Steakhouse

FRIENDS
Allcare Medical
American Express
Chris & Ann Marie Chambers
Christie Turlington Burns
Ed & Sue Dumke
Greenwich Media Management
Herman & Joan Riemer
James & Sheila Mossman
Janet Chan
Jeff & Risa Pulver
Metric Construction
Paul Ira Moskowitz
Philip Fox
Pistello Agency, Inc.
Ryan & April McDonald
Spencer Construction Corporation
Stephanie Minardi
Wiggin & Dana

DebRA of America would like to thank the following businesses & Individuals for their generous donations to the Live & Silent auctions:
Andrew & Sue Robertson
Armonk Wines & Spirits
Avanzi
Barbara Flamm
Barbara Rothman
Barbour
Bliss
Bulova
Cassie Brandow
CBS
Charlee Miller
Cory Gould
Curry Automotive
Donna Meyers
Dooney & Burke
Elizabeth Arden
Faige Timeless Portraits
Frank & Christina Santorsola
Go Figure Exercise
Hugg-a-Planet
Intrepid Sea, Air & Space Museum
James McDaniel
Joseph Flamm
Keith Nonnon
Ken Dorros
Leslie Rader
Liebert Royal Green Appliances
Linda Talt
Loews Corporation
MacMenamin’s
Mashomack Premier Club
Mats & Sonya Wilander
Morton’s Restaurant Group
MTV
NBC
Paul & Ruth Riemer
Peter Thomas Roth Clinical Skin Care
Ralph & Ann Branca
Reinstein/Ross
Robert Meirowitz MD
Ron Duckstein
Thomas & Karen Misisco


DebRA
 
  



National Epidermolysis Bullosa Awareness Week
6163 Reads Printer friendly page
Posted by: DebRA on Sep 26, 2005 - 01:24 PM


On September 21, 2006 The Senate gave unanimous consent to pass S. Res. 180 ATS to declare the last week in October as “National Epidermolysis Bullosa Awareness Week”.

Our thanks to Co-sponsors Senators Schumer and Clinton for their support in making this a reality. This represents an important step on the road to greater support in Washington for EB research funding.

Now, we need your continued help to get a similar resolution passed in the House.

The only way a resolution like this can be brought up for a vote, is if Leadership in the House chooses to do so. Let the Leaders know you are requesting that they bring our resolution to a vote by contacting Speaker Dennis Hastert, Majority Leader Roy Blunt, and Minority Leader Nancy Pelosi.

These resolutions bring to fruition the hard work of the Peshkur Family and will be the first important step as we work towards increased funding at NIH for EB.

To date your efforts have increased the number of co-sponsors. Please look at the list of sponsors below. If your representative is not on the list, now is the time to email (sample emails are below). It is important to ask the legislator to officially sign on as a co-sponsor rather than just supporting the Resolution when it comes up for a vote,

Please note at this time email is the quickest way to get your message in as regular mail will take up to 30 days to reach your representative. Each legislator has a place on his/her own website to send an email.

If your representative is on the list, a thank you note to this official is good idea.

CO-SPONSORS ALPHABETICAL

Rep. Ackerman, Gary L. [NY-5]
Rep. Baird, Brian [WA-3]
Rep. Baldwin, Tammy [WI-2]
Rep. Beauprez, Rob [Co-7]
Rep. Berman, Howard L. [CA-28]
Rep. Bradley, Jeb [NH-1]
Rep. Brady, Robert A [PA-1]
Rep. Butterfield, G. K. [NC-1]
Rep. Ehlers, Vernon J. [MI-3]
Rep. Frank, Barney [MA-4]
Rep. Israel, Steve [NY-2]
Rep. Kildee, Dale E. [MI-5]
Rep. King, Peter T. [NY-3]
Rep. Kuhl, John R. "Randy", Jr. [NY-29] Rep. Maloney, Carolyn [NY-14]
Rep. Marshall, Jim [GA-3]
Rep. McCarthy, Carolyn [NY-4]
Rep. McCotter, Thaddeus G. [MI-11]
Rep. McGovern, James P. [MA-3]
Rep. McNulty, Michael R. [NY-21]
Rep. Meeks, Gregory W. [NY-6]
Rep. Peterson, Collin C. [MN-7]
Rep. Rahall, Nick J. [WV-4]
Rep. Shays, Christopher [CT-4]
Rep. Tiberi, Patrick J. [OH-12]
Rep. Tierney, John F. [MA-6]
Rep. Waxman, Henry A. [CA-30]
Rep. Wexler, Robert [FL-19]
Rep. Wynn, Albert Russell [MD-4]

So, we still need everyone whose lives have been touched by EB to write to their Senators and Congressperson to ask for their support of these resolutions.

These resolutions bring to fruition the hard work of the Peshkur Family and will be the first important step as we work towards increased funding at NIH for EB.


We offer the following text as sample letters to your Congress person and Senators. Please feel free to personalize and add to it but be sure to include the first paragraph in all your communications. You can find your representatives using the Congress and Senate links listed below:

TO CONTACT YOUR U.S. SENATORS:
Click on www.senate.gov

TO CONTACT YOUR U.S. REPRESENTATIVE:
Click on www.house.gov

Download the sample letters in MS Word

SAMPLE LETTER To Your Congressperson

The Honorable ______________
House
Washington, DC 20515

Dear Congressman/Congresswoman______________:

We/I implore you to support The House Resolution (HRES 335) proposed by Rep Tim Bishop for himself and Rep Peter King which advocates for the last week of October as "National Epidermolysis Bullosa Awareness Week" and for a cure for the disease known as Epidermolysis Bullosa (EB). This disease weakens the skin and causes severe wounds and constant pain.

As people whose lives have been touched by EB, we thank you for your consideration and support.

Sincerely,

Mr./Mrs


SAMPLE LETTER To Your Senators

The Honorable ______________
Senate
Washington, DC 20515

Dear Senator______________:

We/I implore you to support The Senate Resolution (SRES 180) proposed by Senator Charles Schumer for himself and Senator Hillary Clinton , which advocates for the last week of October as "National Epidermolysis Bullosa Awareness Week" and for a cure for the disease known as Epidermolysis Bullosa (EB). This disease weakens the skin and causes severe wounds and constant pain.

As people whose lives have been touched by EB, we thank you for your consideration and support.

Sincerely,

Mr./Mrs



DebRA
 
  



"Kayak for a Cure" Fundraiser
14567 Reads Printer friendly page
Posted by: Debra on Aug 22, 2005 - 01:21 PM


Mike Ehrlich

Mike Ehrlich will kayak around Manhattan on September 10, 2005, to raise funds for DebRA in a tribute to his niece Olivia Katz-Dixon.
Kayak for a Cure logo

Please click here to support Mike and DebRA with an online donation.
Or, call 212-868-1573. Checks can be mailed to:
DebRA of America
5 West 36th Street, Suite 404
New York, NY 10018

"Kayak for a Cure" Fundraiser – Olivia's story

On September 10th, 2005, Michael Ehrlich will circumnavigate Manhattan Island in a kayak, in memory of his niece, our daughter, Olivia Katz-Dixon. Michael hopes to raise funds for the research and support efforts of DebRA of America. Once our family was touched by this disease, each of us became determined to help DebRA help people with EB.

Olivia was born with Junctional EB on December 13th, 2004. She was four weeks early, but as soon as we knew she was on her way, her father and I were thrilled. We'd been longing for her arrival, and we were ready to give her all the love in our hearts.

It was a good delivery, and even at 36 weeks gestational age, Olivia was 7 lbs. 7 oz. It took only moments after her birth, however, to see that there was something wrong. Olivia was precious and beautiful, but she had skin missing from her hands and feet, and from parts of her legs and arms. A doctor from nearby Vassar Hospital was called in immediately, and he gave a preliminary diagnosis of Epidermolysis Bullosa. As he explained EB, our hearts sank. The very worst part was that he felt Olivia was in pain. It was unthinkable. Within hours of her birth, our sweet daughter was taken from us, and rushed to the NICU at Albany Medical Center. That first night of her life, when we couldn't be with her, was the darkest and saddest we'd ever known. We would not be absent from her a single day after that night.

Olivia spent only three days at Albany, after which she was transferred to The Children's Hospital at Westchester Medical Center. It was thought that WMC's Burn Center would be a great help in treating Olivia's denuded hands and feet. She was there for the rest of her 39 precious days on this earth. At WMC, Olivia was seen by many different doctors, none of whom had any significant experience with EB. Everyone was learning. It seemed like Olivia was always scheduled for one procedure or consultation or another, and, although everyone was gentle and caring, each time she was handled, she suffered terribly. It was only when she was being held in my or my husband's arms that Olivia was truly at peace. Holding her had the very same effect on us.

It didn't take long before Olivia touched the lives of everyone who met her - nurses, doctors, friends and family. She had such a strong, brave spirit, and an expressiveness to her eyes beyond her very young age. "Brave" seems an unusual word to describe a baby, but Olivia had more courage than I or my husband could ever dream of having. Every day she endured such terrible pain, pain that would crush most people. And yet, she had a presence that was sweet, strong, and determined. She was a fighter, our heroine, and I know she would have lived her whole life that way, had she had the chance.

In addition to being held by us, what Olivia loved most was the sounds of our voices. Don and I would sit by her isolette or crib and talk to Olivia, telling stories and making plans, until she relaxed and fell asleep. Her Papa sang to her all the time, and the sound of his singing was the very best pacifier for our sweet girl. Olivia would even make a face when he stopped singing, as if to say, "More, Papa! More!"

The week before Olivia passed away ("broke free", we like to say) was, ironically, her very best week. All along we knew that the pain meds going down and the volume of feedings going up meant progress. During this week, Olivia was very alert and curious, and she was managing her pain with very tiny amounts of medication. We brought in her crib mobile and a few basic toys to stimulate her, and we began talking with doctors about alternative methods of pain control. Things seemed so hopeful.

This was also the week that Olivia's adult half-sister, Jenny, flew over from England to visit her baby sister. It was a magical week. Many beloved family members and friends came to see Olivia, and they got the chance to know her for her true self. Jenny took nearly 100 photos of Olivia that week, something my husband and I hadn't done much up to that point. Those photographs of our little Olivia are treasures to us now. We had no idea how important they would be. We were making plans to bring our sweet girl home with us...

A few days before she died, Olivia began to have trouble breathing. Her secretions had plagued her for a few weeks, but this was much worse. On one day, before we arrived in the morning, Olivia's heart rate fell dangerously, and she was resuscitated. But the doctors needed to intubate again. Olivia hated having any tube in her mouth. It was agony to see her hooked up to the ventilator again.

All it took was witnessing one "code" response by the medical team for us to know that it was Olivia's time to leave this world. She had fought as hard as she could, but she'd had enough. She had more wisdom than we did in this, and again we were learning from our brave Olivia. We told her that it was okay to go, that we would always be with her, and she was placed in my arms as her heart rate began to fall. She died very peacefully in her Mama's arms, where she belonged.

Olivia has changed our lives, and the lives of all who knew of her, forever.Although losing her has been the hardest, most painful experience either of us has ever known, she was an angel who graced our lives, and we are blessed to have had her. She taught us about what is really important in this life, and her lessons will never be forgotten. We still sing to her every morning as we greet the day, a special song we adapted with her name in it. It feels good and celebratory to do so, much like praying or dancing.

We pray also that the day will come soon when no child or adult has to suffer from EB. We honor the courage and strength of those who live with EB and their familes. The doctors and researchers who are working on gene therapies to cure EB have our constant prayers and support, and we hope our fundraiser can help the many families affected by this brutal disease. In Olivia's honor, we will work toward raising awareness about EB, until there is a cure.

Thank you for reading.

Karen Katz and Don Dixon
Olivia Jayne's parents



DebRA
 
  



Advocacy Campaign - Washington, D.C. 2005
2317 Reads Printer friendly page
Posted by: DebRA on May 23, 2005 - 05:11 PM


Skin Disease Research Day 2005
Skin Disease Research Day – Washington, DC

Members of the Coalition of Skin Diseases made more than 100 visits to their senators and congress people for Skin Disease Research Day 2005 in April. This annual visit to The Hill was to ask for a 6% increase in the NIH budget and to discuss the results of the “Burden of Skin Disease” report that was released the same day. The report’s findings include that skin diseases cost more than $317 billion annually in the U.S. and the most burdensome are skin ulcers and wounds.

The New York group pauses for a moment between visits (left to right) Xeroderma Pigmentosum Foundation Founder Caren Mahar, DebRA Executive Director Suzanne Cohen, DebRA Scientific Advisory Member Dr. Richard Clark; Dr. David Chu of Rockefeller University; and Dr. Daniela Kroshinsky, a dermatology resident at SUNY Downstate. During the visits, Cohen shared the specific burdens experienced by families dealing with epidermolysis bullosa.

Return to DebRA Advocacy Program

DebRA
 
  



Insurance Issues
19448 Reads Printer friendly page
Posted by: DebRA on May 06, 2005 - 01:33 PM


THE KATIE BECKETT WAIVERS AND THE 1115 WAIVERS

Medicaid Waivers are state-run programs that use federal and state funds to pay for health care for individuals with certain health conditions. Each state has different Waivers with different eligibility requirements or services. Two Medicaid statutes are currently waivered: 1915 and 1115.

To find out your state’s Waiver programs go to www.cms.hhs.gov/medicaid/waivers/waivermap.asp.

SOCIAL SECURITY AND SOCIAL SECURITY DISABILITY INCOME

The official website of the Social Security Administration can provide you with a wealth of information relations to Social Security Disability Income (SSDI) such as:

  • How to start and
  • The Disability Planner explains how to qualify for SSDI and the benefits you will receive
  • Help you find your local Social Security Office

To find out more information about Social Security go to www.ssa.gov

To find out more information about Social Security Disability Income go to www.ssa.gov/notices/supplemental-security-income/


INSURANCE REIMBURSEMENT

If your insurance company has denied your claim for certain treatment, including wound care coverage, the following sample letter can be used and edited and sent to an insurance company or your state insurance commissioner. These letters are only intended as an example.

Sample Complaint Letter to State Insurance Commission

Name of State Insurance Commission

Street Address

City, State, Zip Code

Dear Insurance Commissioner:

I have filed the attached insurance claim with _____________(insert name of your insurance company) on _____________ (insert date of claim). My physician has deemed this therapy medically necessary for my medical condition, but my insurance company has denied me access to the standard of care. I have had the following specific problems with this insurance company:

(List all of your problems such as refusal to cover physician prescribed therapy, claim has not been paid or denied, etc.)

Please accept this letter as a formal written complaint against _____________(insert name of your insurance company).

Sincerely,

Your Name

Your Address, City, State, Zip Code, and Telephone Number

cc: Medical Director, _______________ (insert name of your insurance company).

Your Physician

Sample Letter to Insurance Company Contesting A Denial of Coverage

Name of Medical Director

Name of Your Insurance Company

Street Address

City, State, Zip Code

Dear Medical Director:

__________________________ (insert name of your insurance company) has denied my claim for ________________ (insert specific information about the name of the therapy, drug, wound care supplies, etc.). My physician and I disagree with your ruling on my case. Please send me information detailing how I can appeal your denial of my physician prescribed, medically necessary therapy.

Sincerely,

Your Name

Your Address

City, State, Zip Code, Telephone Number

cc: Your Physician


FAMILY AND MEDICAL LEAVE ACT (FMLA)

The following information is presented as a guideline. Individual state laws may affect your eligibility and rights. Please consult the Department of Labor in your state for more information.

Rights:

You are entitled to take up to 12 weeks of unpaid leave for three reasons:

1. The birth or adoption of a child

2. To care for a child, spouse or parent with a serious health condition, and

3. If you have a serious health condition

A serious health condition may include chronic conditions that require periodic and continuing treatments, such as epidermolysis bullosa.

While on leave, your employer must maintain your benefits, but you must continue to pay your portion.

You retain the right to return to the same or equivalent position, pay and benefits upon returning from leave.

Eligibility:

You are “eligible” to take FMLA leave if:

1. You have worked for the same employer for at least 12 months and have worked at least 1,250 hours in the past year, and

2. Your employer employs 50 or more employees within 75 miles of your worksite, and

3. You provide 30 day advance notice to your employer for foreseeable events.

For more information about the Family and Medical Leave Act go to http://www.dol.gov/esa/whd/fmla/



DebRA
 
  



DebRA Advocacy Program
17752 Reads Printer friendly page
Posted by: DebRA on May 05, 2005 - 02:04 PM


There are many ways to help those affected by Epidermolysis Bullosa. One of the most effective ways is to make our community better for those affected by Epidermolysis Bullosa in the long term is legislative advocacy on their behalf. Quite simply, this means supporting laws and policies that are good for those affected by Epidermolysis Bullosa and opposing ones that aren’t.

Too often those affected with Epidermolysis Bullosa don’t have a voice in the decisions that affect them and their families. DebRA’s advocacy efforts are aimed at making sure that the concerns of those affected by Epidermolysis Bullosa are always heard when public policies are made.

In addition, the non-profit organization EB Action Network (EBAN) advocates on behalf of a Wound Care Bill to ensure insurance coverage for the wound care supplies needed in the care of people with EB. DebRA supports EBAN’s efforts to bring this Bill to fruition.

How Does DebRA Advocate For Those Affected By Epidermolysis Bullosa?

DebRA uses two distinct strategies to advocate effectively for those affected by Epidermolysis Bullosa:

  1. Direct Advocacy entails stating a position to policymakers on specific legislation that affects individuals with epidermolysis bullosa.
  2. Grassroots Advocacy involves stating a position on specific legislation and asking the public to contact the policymakers on this issue. DebRA’s Advocacy Network represents a group of people who care about those living with epidermolysis bullosa and want to make a difference. Advocates will send letters, make phone calls and share information when policy making issues arise that affect individuals with epidermolysis bullosa.
Be an Advocate:

JOIN THE ADVOCACY NETWORK!

What is DebRA’s Advocacy Network?

A group of people who are:

  • interested in the health and well-being of those affected with EB.
  • willing to contribute by communicating with state and federal lawmakers about issues that are important to those affected with EB.

How do I join DebRA’s Advocacy Network?

Complete the Legislative Advocacy Survey Form (click here).

What does it mean to be a member?

Joining DebRA’s Advocacy Network does not require you to do anything, but it does give us permission to send you updates on our activities and to contact you when we need your help. Some requests for help might include asking you to contact your legislators or participate in an event we are sponsoring.


HOW TO COMMUNICATE WITH ELECTED OFFICIALS

Your representative in Congress and two senators work for you. As a voting constituent, you have a tremendous ability to influence their legislative agenda and how they vote on specific legislation.

TO CONTACT YOUR U.S. SENATORS:

Click on www.senate.gov

TO CONTACT YOUR U.S. REPRESENTATIVE:

Click on www.house.gov

FOR FEDERAL LEGISLATION INFORMATION:

Click on www.thomas.loc.gov

YOUR STATE LEGISLATURE

You can access proposed bills, track their progress, past bills, testimony, public hearings and contact information for your elected official, click on your state’s link below.

ALASKA
http://w3.legis.state.ak.us/home.htm?

ALABAMA
http://www.legislature.state.al.us/

ARKANSAS
http://www.arkleg.state.ar.us/

ARIZONA
http://www.azleg.state.az.us/

CALIFORNIA
http://www.leginfo.ca.gov/

COLORADO
http://www.leg.state.co.us/

CONNECTICUT
http://www.cga.ct.gov/

DELAWARE
http://www.legis.state.de.us/Legislature.nsf/?Opendatabase

FLORIDA
http://www.leg.state.fl.us/Welcome/index.cfm

GEORGIA
http://www.legis.state.ga.us/

HAWAII
http://www.capitol.hawaii.gov/

IOWA
http://www.legis.state.ia.us/

IDAHO
http://www.legislature.idaho.gov/

ILLINOIS
http://www.legis.state.il.us/

INDIANA
http://www.in.gov/legislative/

KANSAS
http://www.kslegislature.org/legsrv-legisportal/index.do

STATE OF KENTUCKY
http://www.lrc.state.ky.us/home.htm

LOUISIANA
http://www.legis.state.la.us/

MASSACHUSETTS
http://www.mass.gov/legis/legis.htm

MARYLAND
http://mlis.state.md.us/

MAINE
http://janus.state.me.us/legis/

MICHIGAN
http://www.michigan.gov/

MISSOURI
http://www.moga.state.mo.us/

MONTANA
http://laws.leg.state.mt.us/pls/laws05/LAW0200W$.startup

NEBRASKA
http://www.nol.org/billtracker/

NEVADA
http://leg.state.nv.us/

NEW HAMPSHIRE
http://www.gencourt.state.nh.us/ie/

NEW JERSEY
http://www.njleg.state.nj.us/

NEW MEXICO
http://www.state.nm.us/

NEW YORK
http://assembly.state.ny.us/

NORTH CAROLINA
http://www.ncga.state.nc.us/

NORTH DAKOTA
http://www.state.nd.us/lr/assembly/59-2005/

OHIO
http://www.legislature.state.oh.us/

OKLAHOMA
http://www.ok.gov/

OREGON
http://www.oregon.gov/

PENNSYLVANIA
http://www.legis.state.pa.us/

RHODE ISLAND
http://www.rilin.state.ri.us/

SOUTH CAROLINA
http://www.scstatehouse.net/

SOUTH DAKOTA
http://legis.state.sd.us/sessions/2005/index.aspx

TENNESSEE
http://www.legislature.state.tn.us/

TEXAS
http://www.capitol.state.tx.us/

UTAH
http://le.utah.gov/

VERMONT
http://www.leg.state.vt.us/

VIRGINIA
http://legis.state.va.us/

WASHINGTON
http://www1.leg.wa.gov/legislature

WISCONSIN
http://www.legis.state.wi.us/

WEST VIRGINIA
http://www.legis.state.wv.us/

WYOMING
http://legisweb.state.wy.us/


TIPS FOR CONTACTING YOUR LEGISLATORS

Legislators love to hear about issues that matter to their constituents. They deal with hundreds of proposed pieces of legislation a year, and can’t be expected to know that a proposed law is or is not important to you unless you tell them.

Contacting Legislators by Phone:

  • Identify yourself by name and home address
  • Identify the bill you wish to talk about, by name and number
  • Briefly state your position and how you wish your legislator to vote
  • Ask for your legislator’s stance on the bill or issue. Ask for a commitment to vote for your position, but don’t argue if the legislator has an opposing view or is not yet decided.
  • If your legislator needs additional information, call DebRA to get the additional information and get it to your legislator as soon as possible
  • Recognize that legislators are often away from the office, on the floor or in committee; so you may get an aide or be asked to leave a voice mail message. Whoever you speak with use the same basic rules outlined above. If you’d rather leave a message than talk to a live body, call in the evening.

Contacting Legislators by Letter/FAX/Email:

  • Make clear your position and exactly what you want your legislator to do.
  • Personalize your communication be telling how the legislation will affect you and others you know in your own words. Write briefly, on one subject at a time, and refer to your bills name and number
  • Sign your letter with your name and home address so that your legislator knows if you are a constituent. Also include your phone number so someone can contact you if he/she needs more information.
  • When a legislator votes as you asked, send a thank you note.

Requesting an In Person Meeting

If you are interested in arranging a face-to-face meeting with a Senator or Congressperson, please contact DebRA at 212-868-1573 or at staff@debra.org. The DebRA staff can assist you and prepare you for the meeting. These meeting can take place in Washington, DC or in your home district. You may have a better chance of meeting with the Member in person if you call the district office and request a meeting when Congress is not in session. The summer months and the weeks at the end of the year after Congress has adjourned are especially good times to find your Congressional delegation in their districts. A larger number of planned attendees will also make it more likely that the Member will attend and will show that many constituents are concerned about housing.


SAMPLE LETTER

The Honorable ______________

House/Senate (You fill this in)

Washington , DC 20515

Dear Congressman/Congresswoman/Senator______________:

As a constituent who votes, I am writing about an issue that is very important to me, medical research funding. Specifically, I am writing to urge you to support a 6% increase in funding for the National Institutes of Health (NIH) during the fiscal year 2006.

I (my child, friend, etc.) have a rare skin disease called Epidermolysis Bullosa (EB). Research at the NIH is key to making much needed progress in treatments and, hopefully a cure for EB.

EB is a serious and sometime fatal disease, which affects one out of every 500,000 live births in the U.S. EB is a genetic disease characterized by chronic, painful blistering outside and inside the body. Present at birth, EB affects men and women of all races and ethnic groups and sometimes, when there is no family history, it occurs as the result of a spontaneous genetic mutation. Today, there is no cure or treatment for EB, except daily wound care and bandaging to prevent infections and further damage.

Research on the genetics of EB and improved treatments is vitally needed. (Personalize with a few sentences).

Investing in research at the NIH will lead to better treatments and better lives for patients living with rare diseases like EB. Please support a 6% increase in NIH funding in the fiscal year 2006.

Thank you for considering my input.

Sincerely,

 



DebRA
 
  



A Tribute to Tyler
12508 Reads Printer friendly page
Posted by: DebRA on Mar 29, 2005 - 08:18 PM



Abe and Michelle Gates In honor of Tyler's courage and determination, Abe and Michele Gates will race in the Mooseman Half Iron man Triathlon on June 5, 2005 in Bristol, NH.

After losing Tyler we searched for a way to make a difference and to teach others; just like Tyler had taught us for so many years. In loving memory of Tyler as well as those who fight this battle every day, we will push it to the limit on June 5.

To contribute as a sponsor and to help the continued efforts of DebRA, please click the "Sponsor Us" button to donate online, or call 212-868-1573. Checks can be mailed to:
DebRA of America
5 West 36th Street, Suite 404
New York, NY 10018
Sponsor Us

TylerI met Abe in January of 2002, never imagining before that first date that we would be together every day since. It was a bit of a whirlwind romance. We talked about everything- hiking, work, friends, and family. From the beginning, I knew that Abe had a different sort of relationship with his brother, a special connection. Tyler had a serious skin disease with a very long name that I could never quite get right when others asked, Epidermolysis Bullosa, (EB). Tyler had blisters all over his body that needed bandaging and treatment daily. It was hard for him to move and painful for him to be touched. There was blistering internally too, so digestion was difficult and there were always complications. Abe talked about Tyler in a quiet way, never pitying him but always with a sense of respect and pride. What stood out most to me was that Abe made Tyler laugh whenever they were together. That was what he did as a brother and a friend. That was his gift to Tyler and from Tyler, Abe got life lessons in determination, courage and love.

Tyler was cared for every day of his life by his mother, Gloria. Together they worked as a team to help Tyler live a normal life. She understood Tyler like no one else could. Between them there was a bond that is not easily explained in words. I was an outsider looking in and within moments I could see this bond was the great blessing Tyler had in his life. He had a partner helping him through every day with love and compassion. Perhaps that was why the pity was so unfit. His privileges and his gifts came in such a different form than most of us are used to and in such a quiet way that they could be easily missed by outsiders.

I only knew Tyler for two years before he left us in September 2004. Whether people knew him for days, years or a lifetime everyone was changed by his courage. Perhaps in his 22 years, he learned far more that any of us could in a lifetime. His attention was full at every moment when sometimes it is all too easy for most of us to forget to pay attention. He had fewer words to say than most but his actions left me speechless. In the end, it really wasn't about the words. He had unending love for his mother, his family and for the animals that surrounded him every day of his life. He never complained through it all as he completed high school and even continued with college level classes in graphics. He inspired and taught us all.



DebRA
 
   3 Comments



Sixth Annual Mats Wilander Celebrity Tennis & Golf Tournament
6021 Reads Printer friendly page
Posted by: DebRA on Mar 15, 2005 - 07:31 PM


MAJOR SPONSORS

Title Sponsor
Mohegan Sun

Brunch Sponsor
Molnlycke Health Care

Silver Sponsors
Dermik Laboratories
Greenwich Capital
Molnlycke Health Care
National Rehab
Pod John & Susan Stanton
April Ann Stumpf Memorial Fund

Sponsor of the Cocktail Reception
Dr. Meirowitz & the Princeton Gastroenterology Associates, P.A.

Caddy Bibs Sponsor
T-Bird Restaurant Group

Tee/Hole Sponsors
Cushman & Wakefield
Paul Lipshultz
Mark & Debra Nouss
Michael Sukin


DebRA
 
   7 Comments



Special Events
25407 Reads Printer friendly page
Posted by: DebRA on Mar 15, 2005 - 06:07 PM


Florida

One in a Million
Throughout 2010
Miami, Florida
One in a Million is a yearlong celebration at the University of Miami whose mission this year is to raise awareness about EB and raise funds for DebRA of America.
Click here for more information and photos

Ohio

2010 Patient Care Conference
June 16-19, 2010
Cincinnati, Ohio
Click here for details

California

Camp Wonder
June 20-26, 2010
Livermore California
For more information please email info@csdf.org

If you would like to plan a special event to benefit DebRA or raise awareness for EB, please contact Maxine at 212-868-1573, msilent@debra.org.



PAST EVENTS

Dance Relief and Envision Environmental Support DebRA
December 5-6, 2009
Pleasantville, New Jersey
Click here for details and photo

The Maryland Fraternal Order of Eagles honor DebRA
November 7, 2009
Fredericktown, Maryland
Click here for details and photo

Wings for Layla, Walking for EB
October 25, 2009
Shebygan, Wisconsin
Click here for details

The Eleventh Annual Mats Wilander Celebrity Tennis & Golf Classic
October 19, 2009
Westchester Country Club
Rye, New York
Click here for photo gallery

The 1st Annual Tyler Fisher EB Awareness Benefit and Auction
October 10, 2009
Brice, Ohio
Click here for the flyer

Open House for EB
September 19, 2009
Lancaster, Ohio
Click here for details

Wishfest 2009
August 30, 2009
Pontiac, Michigan
Click here for the flyer

Epidermolysis Bullosa 5K Run/Walk
August 15, 2009
LeMars, Iowa

EB Survivors Camp
August 9-15, 2009
Park City, Utah

Rally For Ryan
Playtown Express
May 26, 2009
Hopkinton, MA
Click here for details
Click here to make an online donation for Rally for Ryan

Jaclyn Kuznik's Butterfly Ball
May 17, 2009
Alden, NY

Lindsey Gregg Mrs. Ohio International Pageant
May 17, 2009
Zanesville, Ohio
Click here to learn more

Butterfly Wishes for Ellie
Benefit and Silent Auction
April 23, 2009
Atlanta, Georgia

Butterfly Benefit
Fashion Show Luncheon and Silent Auction
April 11, 2009
Louisville, Kentucky
Click here for photos

Greening of DebRA
New York O'Casey's
March 16, 2009
New York, New York
Click here for photos

Winos and Dinos
Wine Tasting and Art Gala
March 7, 2009
Eaton, Ohio
Click here for photos

Weston Zucha Walk
Walk-a-Thon
February 28, 2009
Crosby, Texas
Click here for photos

Have a Heart for EB
Disney World
Feb. 12-15, 2009
Orlando, Florida
Click here for photos



DebRA
 
  



Patient Art Exhibit
3068 Reads Printer friendly page
Posted by: DebRA on Mar 14, 2005 - 04:19 PM


The Society for Investigative Dermatology (SID) 2005 Annual Meeting will host the third annual patient art exhibit. Submissions are being accepted through March 31, 2005. The exhibit is an excellent opportunity for patients to present the impact of skin disease in a personal and creative manner to the researchers committed to finding treatment and cures.

The Exhibitor Release Form must be filled out for each submission. Click here for the release form. Then print and mail it with your artwork to the address on the bottom of the form.

The SID will pay all shipping charges and insure the piece for up to $200.00.

Please contact Becky Minnillo if you have questions or need additional information: 216.579.9300 or email Minnillo@sidnet.org.


DebRA
 
   11 Comments



News: 2004 DebRA National Patient Care Conference
5058 Reads Printer friendly page
Posted by: Flapjacks on Apr 29, 2004 - 01:44 PM


National Patient Care Conference Wrap Up

Thank you all so much for joining us at DebRA of America’s 2004 National Patient Care Conference. It was an incredible experience marked by reports on up-to-the-minute research, a wealth of helpful information, good times with old friends, the forging of new relationships and, finally, idyllic Northern California weather.

We hope you got everything you intended out of the experience. We did!

Look for DebRA Currents: the Official NPCC Wrap Up in your mailbox in mid-May.

A Picture is Worth a Thousand Smiles
Did you take some great photos at the Conference? DebRA would like to see them. Please email them to staff@debra.org. Put “NPCC Photos” in the subject heading. Please let us know if it’s okay to post them on the DebRA Web site or in the newsletter!

Can We Talk?
Would you like to stay in touch with the friends you made at the conference? We are starting a running email list to post on the DebRA Web site. If you agree to participate, write us back at staff@debra.org and let us know which email address we should use. Make sure you include your first and last name in the body.

Here's the list so far:

Keith & Patricia Bevacqui kotic5@comcast.net
Deb Bracken RN mountaingran@yahoo.com (personal) or Bracken.Debra@tchden.org (work)
Kimberley A. Denue denuekim@hvcc.edu
Jennifer Deprizio rdebbutterfly@usa.com
Shannon Evans EBparents@hotmail.com
Bruce Gunn LB33JG24@tiptontel.com
Alex Melkic (and family) maddymelkic@sympatico.ca
Jim and Lesley Minkey camperminkey1@aol.com
Cristina Perez UnicornGirl1983@aol.com
Mohammad Usman Sadiq Mohammad_U_Sadiq@dot.ca.gov
Terra Weckherlin terra_lynn1957@yahoo.com

How Did We Do?
We hope you will take a moment and fill out this Conference Evaluation Form. This is your opportunity to tell us your feelings about the Conference. This is valuable information for us to have when we begin our planning for 2006.



DebRA
 
  



News: DebRA Advocacy Campaign
5416 Reads Printer friendly page
Posted by: Flapjacks on Apr 29, 2004 - 01:40 PM


DebRA of America Grass Roots Advocacy

In this election year, launch your own grassroots advocacy campaign and get Epidermolysis Bullosa on your representative’s agenda:

Step One: identify your elected officials @ www.house.gov. You can also call DebRA of America’s national headquarters at 212.868.1573 and we’ll send you a current copy of the American Academy of Dermatology Association’s Guide to Washington, D.C. It has everything you need to know to launch an advocacy campaign.

Step Two: Request a meeting.

Step Three: Send a thank you letter.

Check back for more information coming soon!

DebRA
 
  



News: New York DebRA Support Group
2901 Reads Printer friendly page
Posted by: Flapjacks on Apr 13, 2004 - 10:21 AM


Please join the New York EB Support Group for
"Research Update 2004"

Hosted by the Columbia University Dept of Dermatology:

Dr. Maria Garzon, Associate Professor of Clinical Dermatology and Clinical Pediatrics at Columbia University.

Dr. Angela M. Christiano (PhD), Associate Professor of Dermatology and Genetics & Development at Columbia University.

The overall theme of the research in Dr. Christiano's laboratory at Columbia is to develop rationally designed genetic therapies for cutaneous diseases through understanding the underlying pathogenetic mechanisms. The emphasis is on prevention of genetic disease through early diagnosis, and treatment when prevention is not possible. Her research efforts are supported in part by the NIH-National Institute of Arthritis, Musculoskeletal and Skin Diseases and the National Alopecia Areata Foundation.

Laura J. Morris, Leader of Connecticut DebRA Support Group, Candidate for Master of Public Health Degree May 2005

Laura is also employed at Connecticut Children’s Medical Center in their Injury Prevention Center and currently is working on the Safe Transport for Children With Special Needs project. As part of Laura’s Thesis for her MPH degree, she would like to promote epidermolysis bullosa through advocacy by developing, planning and implementing an advocacy training program for Support Group Leaders for each state and to advocate for funding for skin disease research through the Department of Defense and National Institutes of Health, Reactivation of the Wound Care Bill and Medicaid Waiver Program.

Saturday, April 24th, 2004.
9:00 - 12:00
Breakfast will be provided!
Columbia University

161 Fort Washington Avenue (at 165th Street)
Suite 1252 (12th floor)
New York

PLEASE RSVP to Faye Dilgen at Kalilla@aol.com / 718-227-3201

SAVE THE DATE!!

On June 27 we’ll be having another fun get together highlighted by a RAFFLE DRAWING.
Details to follow...



DebRA
 
  



Traveling With an Electric Wheelchair
2194 Reads Printer friendly page
Posted by: Flapjacks on Jan 29, 2004 - 08:45 AM


Traveling with an electric wheelchair is easier than you think, but it takes preparation.

Booking your flight: tell the agent about your chair, and the type of assistance you need. Make sure you tell them the type of batteries the chair requires. If you don’t know, call the company.

Boarding the plane: you can take the power chair to the door of the airplane. The Luggage Loaders will put it underneath with baggage. The chair is brought back up to the door of the airplane when you land.

Do not get out of the wheelchair until you hand it over to the Luggage Loader: You will need to instruct the Luggage Loaders on how to put the chair in manual mode and disconnect the battery. This ensures the least possible amount of damage. It is also a good idea to have written instructions on the back of the chair (cloth ribbon holds the tag) and appropriate places marked with stickers to help them when landing at the destination.

Make sure the chair is Gate Tagged: Don't let anyone deliver the chair anywhere other than the airplane door! If you have a connecting flight where the connection time is less than one hour, you probably won't get the chair back between flights, but be sure to have the head flight attendant ask the pilot to make sure the chair is on the plane before your connecting flight leaves the gate. Be kind but firm.

You will need accessible travel to the hotel: Your best option is SuperShuttle. Call at least two days in advance to reserve a pickup for a wheelchair shuttle: www.supershuttle.com.



DebRA
 
  



The Many Faces of EB
12935 Reads Printer friendly page
Posted by: adminjackie on Apr 22, 2003 - 02:39 PM




DebRA
 
  



DebRA Surveys
3949 Reads Printer friendly page
Posted by: Admin on Apr 01, 2003 - 06:45 AM


DebRA Surveys

Below is the current list of DebRA Online Surveys.

Thank you for your support!



DebRA
 
  



About EB - Supportive Care
173911 Reads Printer friendly page
Posted by: Admin on Mar 30, 2003 - 01:27 PM


Supportive Care

The following list of suggested methods of care has been compiled from several sources and addresses all forms of EB. Because suggestion may not pertain to every form of EB, discretion and experimentation will guide the parents and the physician in choosing those methods that apply.

Skin Care and Wound Healing

Protection of the Skin

In EB, even slight friction can produce blisters, so minimal and gentle handling is absolutely necessary. A cool environment, avoidance of overheating, and skin lubrication to reduce friction can help lessen blister formation. A water or air mattress padded with foam may help reduce friction, as will a soft fleece covering or percale sheet placed over the mattress. Sheepskin is excellent for padding car seats, infant seats, or other hard surfaces. The young child with moderate or severe EB should never be picked up under the arms, but should be lifted from the bottom and the back of the neck and carried on soft, nonirritating material.

Clothing must be made of soft, nonirritating fabric, easy to put on, and simple in design. Socks and mittens can be used to prevent the infant from rubbing his hands and feet and scratching his face. It may not be advisable to use a diaper on a baby with severe EB; instead a pad can be placed under the buttocks and the diaper area left uncovered. When a diaper is used, the area must be kept dry and clean.

Skin Care and Bandaging

The purposes of good skin care and bandaging are to reduce the incidence of infection, assist healing of involved areas, and serve as a protective cushioning against friction. The best times for skin and dressing changes are following a bath, after a lesion has been cleansed, or before bedtime. Prior to dressing changes analgesia may be given for comfort as ordered by physician. Daily cleansing may include a bath with mild soaps or cleansers. For infant bathing some caregivers may choose to cleanse limited areas at a time to keep the child from losing their body temperature.

Helpful wound care hints:

  • Always wash hands before starting.
  • Do not pull off any soiled dressings or clothing that may be sticking to the skin. Soak off in warm water. The physician may suggest adding an antibacterial agent to the water.
  • Release fluid in blisters by cutting a small slit on the side of the blister using a sterile scissor or scalpel blade. Many people prefer to puncture the blister in several places with a sterile needle.
  • May keep the blister roof intact upon the wound.
  • To help drain the fluid and dry the blister, wet soaks can be placed over punctured blister.
  • If prescribed by the doctor, an antibiotic ointment may be applied.
  • Nonadherent dressings or other dressing recommended by the doctor can be placed over the open areas. A soft, rolled type of gauze or netting can be used to secure the dressings in place. Loose ends can be secured with paper tape. NEVER apply tape directly to the skin. In milder or localized EB, it is preferable to leave the area open to the air. If desired, a non adherent dressing can be placed over an oozing wound.

The Art of Wound Healing

The importance of good wound care cannot be stressed enough. Due to the nature of Epidermolysis Bullosa, blistering and open wounds compromise the integrity of the skin, which is the first line of defense against infection. As soon as a break in the continuity of skin occurs, the healing process begins. In order to effectively treat a wound we must keep in mind that EB wounds are all in various stages of healing and that those wounds may require different treatments to optimize the wound bed for healing.

What happens during wound healing?

  • Clotting is one of the first in a series of reactions. It occurs to reduce blood loss.
  • The warmth, redness and swelling that appears is due to leakage of fluid into the wound.
  • White blood cells called Leukocytes and Macrophages gang up to destroy bacteria.
  • Macrophages stimulate growth factors and other important materials that are necessary for the formation of scar tissue.
  • Epithelial (skin) cells travel across the wound to prepare for closure.
  • The formation of new collagen, blood vessel formation and pulling together of tissue occurs to reduce the size of the wound.
  • The last phase of healing involves the reorganization of collagen to maximize tensile strength of the affected area

The stages of wound healing among each wound may differ somewhat leading to variations in wound treatment. For instance wounds with minimal drainage may require additional moisture to enhance healing. Some wounds may drain heavily and require more absorptive dressings or an increase in the frequency of changes to help manage the drainage. Each wound has its own personality. Keeping that in mind may help when choosing wound products that may optimize healing. The parents and caregivers usually become the wound care experts.

Opening blisters

It is important to understand that if the blister is left intact, it can grow bigger and create a larger wound. It may be helpful to pat the blister gently with an alcohol pad prior to popping with either a sterile needle, sterile scissors or sterile lancet. Gently pierce the side of the blister and allow the fluid to drain onto a sterile gauze. After the blister is popped, the blister roof may be left intact. After popping the blister you may cover with a sterile non-adherent dressing.

Prevention of infection

Any open area on the skin or mucous membranes is a potential site for infection. The best way to prevent infection is to keep the area clean. Gentle cleansing of the skin, various anti-biotic ointments and soaks may be ordered by the physician. Remember it is always important to wash hands before and after wound care. It is important to note that over use of topical antibiotics may increase chances of resistant strains of bacteria. Mild topical antibiotics may be rotated every two to four weeks to discourage bacterial resistance.

Signs of infection may include the following. Redness surrounding the wound, or a red streak that spreads toward a more central part of the body, unexplained fever or chills, evidence of pus or yellow drainage or crusting on wound surface or draining from EB wound. A fever may or may not be present. The physician may obtain a wound culture. A wound culture is done by gently swabbing the open area with a long cotton tipped applicator to see what bacteria grows on the wound surface. These culture results are helpful in order for the physician to determine the best course of treatment. Treatments may include various topical soaks and /or antibiotic ointments that reduce bacterial growth upon the wound. Fever is an indicator that there is systemic infection. This usually warrants a visit to the physician for oral antibiotic therapy. In some instances systemic infection may require a hospital visit for intravenous antibiotic therapy. Soiled wounds and wounds covered with antibiotic ointment may need to be cleansed prior to culturing in order to increase the accuracy of the culture result. Itchy skin (pruritus) may be caused by infection, sensitive nerve endings or healing. Scratching of the area will cause further damage to the wound bed. Consult physician about medications to manage itch.

Monitor nutritional status

Factors such as poor nutritional intake, possible mal absorption of nutrients and anemia can contribute to poor wound healing. (Need for vitamins, minerals and trace elements needs to be determined by physician and dietitian).

Dry wounds

If the wound is desiccated (dried out) the use of various ointments (as ordered by physician) in conjunction with non-adherent dressings, contact layers or hydrogels may allow a better environment for healing. Remember, maintaining a moist environment will enhance re-epithelialization (repair of damaged skin) on the wound bed. In addition, many of these dressings have been shown to be less traumatic to the wound upon removal. In some instances people with EB Simplex have found it helpful to allow their wounds to dry out, preferring not to moisten or cover them. Different situations warrant different treatments, and what works well for some individuals doesn’t always work for others. More importantly some dressings may be referred to as non-adherent yet they may react differently on an EB wound so please monitor carefully.

Moderately draining wounds

If a wound is wet and the drainage sits on the wound too long, the skin in that area may become over-hydrated, irritated (macerated). In such instances foam dressings may be helpful since they have the ability to wick away drainage. Some of these types of dressings may stay on the wound for a couple of days. In the presence of infection the physician may modify the frequency of dressing changes.

Heavily draining wounds

These wounds may require more absorbent dressings (Breakaway, Exudry) to wick away some of the excess drainage/moisture. The frequency of dressing changes may need to be modified in the presence of infection and if there is heavy drainage.

Non-healing wounds

In some instances wounds remain for a long time and the very properties that stimulate healing have relinquished to causing further breakdown and even more inflammation. For these chronic ulcerations it is important to seek advice from your physician to rule out the possibility of pathology (disease) within the wound. If there is no pathology of the wound, the physician may suggest a wound covering device, such as grafts or bioengineered skin (eg. Apligraf, Organogenesis Canton MA) to give the wound a jump start toward healing.


Listed below are some wound care products that some people affected with EB have found helpful:

Note: Many of the dressings listed below are prescribed by the physician after evaluation of wounds. Please review appropriate use of the product prescribed with your physician. This is just a small list of the various wound care products helpful to some people affected with EB.

Some of the companies listed below do not sell products directly to customers, so please check with your distributor.

Contact Layers:

These dressings are made up of a single layer, non-adherent woven mesh like material. Contact layers sit on the base of a wound protect against trauma during dressing changes and allow for the passage of exudate through the holes onto an outer secondary dressing. (Exudate is fluid consisting of proteins and cellular debris that has escaped from blood vessels onto tissue surfaces).

Contact layers can be used as primary dressings for many types of wounds. One of the benefits of using contact layers is the fact that they can stay on the wound bed for several days without disturbing the newly healed skin. Depending on the condition of the wound, the surrounding skin and the presence of infection, the physician may modify the frequency of dressing changes.

N-Terface and Conformant 2 are made of a high density polyethylene. Mepitel is made of a silicone safetac material.

  • Mepitel Molnlycke Health Care (1-877-460-5888 ext. 1107) (www.MepitelforEB.com)
  • N-Terface Winifield Laboratories, Inc (1-800-527-4616)
  • Conformant 2 Smith & Nephew (1-800-876-1261) (www.snwmd.com)

Impregnated Gauze:

The gauze dressings listed below are impregnated with either Vaseline or Aquaphor. They can be used as primary or secondary dressings.

*Please note Xeroform dressing contains a medication called Bismuthtribromophenate. Please consult physician prior to using . It may not be appropriate for infants and children.

"Direct Medical Inc. is one distributor among many that sells the products listed above. Customer service number is 1-800-659-8037. Website is (www.ebdressings.com)."

Non Adherent Gauze:

Provides a non-stick covering for the wounds.

Specialty Absorptive Dressings:

These dressings provide a non shearing, non-adherent, absorbent environment that allows for the wicking away of drainage. They can be utilized on wounds with mild or heavy drainage.

Breakaway’s first layer is known as a non-adherent, contact layer (N Terface) which stays on the wound. The outer more absorbent layer can be removed while the contact layer remains in place for visualization of the wound’s progress.

Exudry has two non adherent wound contact layers which helps to prevent friction and shear. The drainage is wicked away into an absorbent layer.

These dressings can also be used to provide a cushion/padding for crib, playpen, high chair and play areas.

  • Breakaway Winfield Laboratories (1-800-527-4616)
  • Exudry Smith & Nephew (1-800-876-1261) (www.snwmd.com)

Foams:

These dressings are non-adherent and absorbent. Most foams provide insulation and a moist environment. Foam dressings are used on wounds with light to heavy amounts of drainage. Please keep in mind if the dressing becomes saturated with drainage, it could irritate the surrounding skin. May consider use of foams for heavier draining, non-infected wounds.

Depending on the condition of the wound, the surrounding skin and the presence of infection, the physician may modify the frequency of dressing changes.

*Careful, make sure the correct side of the dressing is put against the wound. (Not indicated for dry superficial wounds)

Polyurethane Foam Dressings:

  • Lyofoam ConvaTec (1-800-422-8811)
    (Not indicated for dry superficial wounds)

Hydrogels:

Hydrogels may be in the form of either a gel, impregnated into gauze or in the form of a hydrated sheet dressing. Basically made up of glycerin or water. They hydrate wounds providing a moist environment enhancing re-epithelialization. Maybe kept in the refrigerator to provide a cooling and soothing effect on painful wounds. Hydrogels may be helpful as primary or secondary dressings to a varied number of wounds. They are not usually recommended for wounds with heavy exudate. Please note in some instances hydrogels may dehydrate if not covered appropriately. Please review product application carefully.

Hydrofiber Wound Dressing:

A sterile, absorbent pad made from sodium carboxymethylcellulose fibers. When applied to a wound creates a gel after coming into contact with wound exudate. This provides a moist environment. Helps reduce damage of newly forming tissue upon removal. Should only be used on moderately to heavily draining wounds. Not indicated for dry (non-draining) wounds. Depending on the condition of the wound, the surrounding skin and the presence of infection, the physician may modify the frequency of dressing changes.

  • Aquacel ConvaTec (1-800-422-8811)

Collagen Dressings:

These dressings stimulate the development of new tissue, organization of granulation tissue and helps to form collagen fibers which induce healing upon the wound bed.

May be used in conjunction with other non adherent dressings for partial or full thickness wounds, they require a secondary dressing. They are absorbent, conform to the wound surface and maintain a non-adherent, moist environment. Collagen dressings may be used on wounds with minimal to heavy exudate in infected or noninfected wounds. May be used in combination with topical agents.

  • Kollagen-Medifil Biocore Medical Technologies (1-888-689-5655) (www.biocore.com)
  • Kollagen-Skin Temp Sheets Biocore Medical Technologies (1-888-689-5655) (www.biocore.com)

Gauze:

Cotton mesh interwoven material used for cleansing and covering. They are available in different forms such as rolls, pads as well as various length and widths.

Elastic Retention Gauze:

Stretch mesh material helps anchor bandages to appropriate areas on limbs and trunk.

  • Promed Elastic Net ProMed, Inc. (1-800-888-6143)

SNOGG soft 1:

Was introduced to us by Napier Quill in England.

This comfortable, cohesive, low allergy bandage has been known to be helpful in anchoring non-adherent dressings to areas such as fingertips. (May order from Direct Medical Inc. 1-800-659-8037. (www.ebdressings.com).

Simply apply your non-adhesive dressing over the wound then cover with SNOGG. May change once a day or as needed.

Cleansers (mild):

  • Cetaphil mild non soap cleanser
  • Dove mild soap

Ointments:

  • Aquaphor, A&D and Vaseline are non-medicated topicals that when used alone, or on a dressing, help maintain a moist environment on wound bed. When used on dressings it helps to prevent them from sticking to the wound.

Antibiotic Ointments:

  • Bacitracin and Polysporin are mild over the counter topical antibiotics.
  • Bactroban (strong antibiotic ointment needs a physician’s prescription).

The additional products listed below have been known to be helpful to some people affected with EB:

  • Pressure relief products such as gel sheeting promote a cool and soft environment in the shoe or other areas of pressure. (Keep in mind not for direct application to open wounds, it is for pressure relief.) (Silipos 800-229-4404). May call for a catalog.
  • Since high environmental temperatures have been known to induce blistering, keeping cool is very helpful. (Air conditioner)
  • Pedors and weeBors are shoes made for sensitive feet. (www.pedors.com) or call toll free 1-800-750-6729 for a brochure.
  • Comfort Socks for Sensitive skin: These seamless socks are made of a teflon material that reduces friction. You may visit their website at (www.sensitivefeet.com) - phone number is (503) 245-0105.

Itching and Epidermolysis Bullosa

In many instances, people affected with Epidermolysis Bullosa may suffer with itchy skin or pruritus. Itching may be due to a number or reasons such as healing during periods of rest, irritation caused by a wound infection and/or sensitivity from exposed nerve tissue. It is helpful to minimize discomfort to avoid further trauma to the skin caused by rubbing and scratching.

Some of the interventions listed below, have been found helpful by some parents of EB children and some adults affected with EB:

  • Eliminate wool and rough garments
  • Launder clothing and linens in mild detergent.
  • Keep a cool environment (Air conditioner)
  • Wash with mild soaps such as Dove or mild cleansers such as Cetaphil.
  • Have questionable wounds evaluated by a physician. If there is evidence of infection physician may perform a wound culture and determine a course of treatment that may include topical and/or systemic antibiotics.
  • Apply cool compresses. (Use caution especially with infants since widespread application of soaks may cause temporary decrease in the body’s core temperature.)

Please consult physician about the following treatments and medications. Though some of these may be sold over the counter it is important to consult with the physician for specific application of product, dosages, possible interactions and side effects.

  • Hydrogel dressings. Since a major component of many of these dressings is water, they may help soothe and cool wounds. May be refrigerated (minimum of 1 hour) to help reduce localized discomfort. Please note that a higher room temperature may cause hydrogel to evaporate at a faster rate. Be careful, in some instances they can dry out and stick to the wound. If this occurs, gently soak dressing off to reduce trauma during removal. Hydrogels are not usually indicated for heavily draining wounds. Frequency of the dressing change will need to be determined by the physician; it will depend on the condition of the wound.
  • Burow’s solution/Domeboro powder are drying agents (astringents). Diluting the medication as directed, and then applying it on a compress upon the draining wound, may dry up the wound. This may be used on infected wounds to reduce bacterial growth (it may or may not help with the itch). Skin irritation has been noted if dilutions are not correct. Concentration of the diluted agent changes over time, so it is best used within the first few hours of being made.
  • Epsom Salts, normal saline and/or vinegar dilutions have been known to be soothing to skin irritations.
  • Localized bacterial infections such as pseudomonas may be treated with (vinegar) dilutions.
  • Topical Bactroban ointment has been used to treat various staphyloccocal infections.
  • Application of non-medicated ointments such as Aquaphor, Vaseline and/or A&D may decrease the dryness of healed and healing skin. Some people prefer moisturizers such as Lubriderm. (Since most of these are greasy it may be helpful to apply at bedtime.)
  • Antihistamines such as Benadryl, Atarax, Periactin, Zyrtec and Claritin. These medications have been known to be helpful in reducing itch. Please note some antihistamines may cause drowsiness, dry mouth and increased appetite. It is important to note that the way individuals react to certain medications vary from person to person. Some individuals may experience nervousness and/or irritability.
  • Doxepin Hydrocholoride. Although no formal clinical studies have been done with regards to pruritus (itchy skin) in EB patients and the use of this antidepressant, some patients have found that in low doses this medication has been helpful in reducing the itch. This medication may cause drowsiness and dry mouth as well. Please note, the use of Doxepin cream is not recommended for people affected with EB since over absorption of the medicated cream is a concern.
  • People affected with EB may want to avoid topical preparations such as Benadryl and Caladryl since they are common sensitizers. Sensitizers have the potential to cause an allergic reaction. You may also want to avoid using preparation such as Benzocaine and Lanacaine since they have the potential to cause skin reactions.

For additional information about itch, infection and wound care please refer to "General Guidelines to the Routine Mangement and Care of Inherited EB".

Genetic Counseling

Genetic counseling provides and interprets medical information based on expanding knowledge of human genetics. A genetic counselor will work with a couple to review their family history and explore the likelihood of recurrence of EB in subsequent children or relatives. Often the genetic counselor is a physician who will participate in the diagnosis, examine family members and provide ongoing medical care. In other instances, a geneticist (someone with an advanced degree in human genetics) may work with the child's pediatrician, dermatologist, or primary physician. The counselor, perhaps with close family advisors, such as a minister, priest or rabbi, can help a family make informed decisions about child- bearing and help them cope with the impact of a genetic disorder. Genetic counselors and social workers often work together to ensure that patients and families receive all the services and benefits to which they are entitled.

Prenatal Diagnosis for Epidermolysis Bullosa

By Ellen Pfendner
By Dr. Ellen Pfendner Ph.D, Director, EB Diagnosis Program, GeneDx http://www.genedx.com

In 1993 mutations in the collagen 7 gene, the gene involved in dystrophic EB (DEB), were identified and the first prenatal diagnosis was performed for a family with a DEB child. Since that time over 100 successful prenatal diagnosis have been performed in the US as well as a large number in the UK. Today, a small fetal sample can be obtained by either chorionic villus sampling or amniocentesis, which is performed in the physician’s office and shipped to the DebRA Diagnostic Laboratory where mutations studies can begin on the fetal DNA, extracted from these samples. The perinatologist will determine which prenatal test to do and what time frame to perform the testing. Prenatal diagnosis can tell whether the fetus is affected with EB, unaffected but a mutation carrier or unaffected and not a carrier. This can allow parents to make family planning choices and be prepared for the birth of an affected child by choosing the type of hospital for delivery and the support they will need after birth. Prenatal diagnosis can also relieve anxiety, when parents know early in pregnancy that their baby is unaffected.

It is important to realize that prior knowledge of the mutations found in a particular family is necessary to ensure a correct and timely prenatal diagnosis result. If the mutations are known in a family, the prenatal diagnosis usually only takes one week to complete. Since mutation detection can take up to several months to complete, depending upon the family, it is very important to know the mutations in advance of a pregnancy.

Before mutation testing and subsequent prenatal diagnosis can be performed, the type of EB in a particular family member must be determined. This can be achieved through studies of a skin biopsy taken from the affected family member. The skin sample is then sent to a laboratory, usually at the National EB Registry, where electron microscopy and immunofluorescence can be performed to identify the proteins missing and the level at which blister formation occurs in the skin of the patient. These skin biopsy studies will determine the type of EB the patient has and by identifying the skin protein that is affected in the patient, along with the symptoms the patient has, the candidate genes for mutation studies can be determined. At least ten different genes are involved in the three forms of EB. By determining the type of EB, the number of genes that must be studied for mutation detection in a particular family can be narrowed down from ten to as few as one for DEB, two for EB Simplex and four for JEB. Use of biopsy results along with patient symptoms, have also allowed scientists to identify two genes involved in JEB with pyloric atresia and one in EB Simplex with muscular dystrophy.

After the type of EB is determined, the mutation studies can begin. It is often believed that mutation studies must be used to diagnose EB, but that is not their primary role. Mutation detection is a very expensive and labor intensive method that is not always able to identify mutations in all patients. Mutation studies are most useful in determining the EB inheritance pattern in most families and to provide the basis for prenatal diagnosis in future pregnancies in a given family. To begin mutation studies, a family physician or dermatologist will arrange to have blood drawn from the patient as well as parents and sent to the diagnostic Laboratory. DNA will be extracted from the blood samples and from this DNA mutation studies will be performed. This process may take several months to complete and involves screening methods and direct DNA sequencing of the candidate genes in the patient and other family members. Once the family mutations are identified the risk to a future fetus can be determined and when a pregnancy occurs, DNA taken from the fetus can be studied for the presence of these mutations.

Finally, prenatal diagnosis, like any other laboratory procedure, is not 100% accurate. Very infrequently, new mutations can occur or recombination between chromosomes can lead to a faulty predication. While there is also the possibility of laboratory error, the laboratory takes great precautions to ensure this does not happen. In general, prenatal diagnosis is a safe and effective method to determine whether the fetus has EB and has been used for eight years to predict pregnancy outcome for many families who are coping with this devastating disease.


Other Health Care Problems

The following material describes a variety of problems that can be associated with EB. It is important to bear in mind, however, that not all of these problems occur in each EB patient. Some will have none or a few; others may have nearly all of these.

Nutritional Concerns

Good nutrition is essential for all children, but may be more difficult to achieve for a child with a chronic disease such as epidermolysis bullosa.

Nutritional research on EB is in an early stage. However, knowledge gained from working with people with similar conditions, such as skin ulcers or burns, can be helpful for people with EB. Patients with skin ulcers or burns need increased protein and calories. Thus, a person with EB also may need to increase both calories and protein, depending on the severity of the disease. These extra nutritional demands on the body are due to tissue regeneration, fluid replacement and protein loss associated with blistering.

Attention to the nutrition of the child may be important from the beginning. Immediately after birth, fluid and protein loss, which may cause chemical imbalances, can be a major complication in recessive and some dominant types of EB. Unless the baby requires isolation for medical reasons, closeness of the mother and child should be encouraged and will help make early feedings successful. Oral or breast feedings can begin as soon as the sucking reflex is demonstrated, unless the doctor indicates otherwise. If the infant has difficulty sucking because of blisters in the mouth, use a preemie nipple (a soft nipple having holes large enough to permit milk to drop into the mouth), a rubber-tipped medicine dropper or a syringe. Powdered nutritional amplifiers, which can add calories and protein, are now available that can be mixed with mother's milk, and there are formulas that have higher than average calorie and protein concentrations. Follow the physician and/or dietitian's instructions in the use of such products and in the selection of an appropriate formula.

When the child is about six months old and pureed food has been introduced, it can be helpful to add extra liquid to the pureed food to facilitate swallowing in those who have mouth blisters. Hot drinks or foods can be irritating; if so, beverages and foods should be served lukewarm, at room temperature, or cold.

Dysphagia (difficulty in swallowing) can be a major complication, as EB can cause blistering in the mouth and/or the esophagus. A parent should watch when hard-crusted foods such as toast or crackers are introduced in the child's diet to see if they provoke blistering or a problem when swallowing. Acidic foods and drinks can also be irritating when an ulcer in the mouth is active; therefore, tomatoes and citrus juices may need to be avoided. If the child can tolerate milk, whole milk can be enriched by adding an "instant breakfast" mix or flavorings. A "fortified milk" can be prepared by adding nonfat dry milk powder to whole milk. "Fortified" milk can be served plain, flavors added or used to make sauces, cream soups, warm, not hot cereals, mashed potatoes, milkshakes, custards, puddings, and cocoa; it can be used in any recipe calling for milk to add extra calories and protein. If milk is not tolerated, liquid nutritional supplements may be recommended. These can be purchased at a pharmacy upon advice of a physician and/or dietitian. Most liquid supplements can be used in recipes such as custards, puddings, and soups and are available in a variety of flavors. It is wise to interchange products and flavors to offer variety so the child will not become bored. Some have found it helpful to start and complete each feeding with a cool, not cold, good tasting liquid including ice cream or cool liquid frozen yogurt.

Even when a child with EB does not have oral blistering or swallowing problems, he or she may need supplements of high-calorie, or high-protein drinks or of vitamins, minerals and trace elements.

The physician should be consulted as to whether a supplement is needed and, if so, the amount to be prescribed. Large doses of vitamins and minerals (megadoses) are not recommended. Caution should be exercised in terms of any diet or supplement that promises miraculous results. Such approaches are often attractive to parents of children with chronic diseases, but such alternatives to a varied, nutritious diet can result in malnutrition.

Esophageal stricturing may be experienced by the more severely affected individual. Scarring within the esophagus can reduce the size of the lumen, causing difficulty in the passage of food, even liquids. Many times children will experience episodes of food impaction with the expectoration of copious amounts of mucous. Though this problem is usually of no immediate danger to the child's airway it is always helpful to contact the physician when in question. Poor toleration or the refusal to eat compromises nutritional status. Studies may be ordered by the gastroenterologist to assess the need for treatments such as esophageal dilatation. Dilatation is a procedure done under light sedation that incorporates the use of a small balloon to increase the size of the esophageal opening.

In instances where esophageal stricturing is so severe, dilatation may not be helpful, a gastrostomy tube or gastric button device may be indicated to increase the individual’s nutritional intake. A gastrostomy tube is inserted to an opening (stoma) into the stomach for the delivery of nutrients, fluids and medications. The procedure is usually done by a surgeon or a gastroenterology surgeon. In many instances feedings through the gastrostomy tube are given overnight using a pump. (Please note the head of the bed should be slightly elevated when infants/ children are receiving feedings.)

The use of gastrostomy tubes may be helpful in the nutritional management of infants and small children in EB who do not have esophageal involvement but need nutritional enhancement intake for growth purposes and wound healing.

If naso gastric tubes are used it is usually short term due to risks of esophageal erosions and infection.

Gastroesophageal reflux is the back up of stomach acid into the esopohagus in many instances this may cause discomfort and reduce desire to feed.

Symptoms of gastroesophageal reflux may include:

  • Cranky and pushing away bottle after a few minutes of feeding.
  • Reluctance to feed.
  • Coughing.
  • Milk may be present in mouth between feeds.

If gastroesophageal reflux is suspected it is helpful to consult a Pediatric Gastreonterologist. Physician may order various diagnostic tests such as endoscopy, pH testing and/or various radiographic studies to rule out the presence of reflux.

Interventions may include the following:

  • Feeding with head slightly elevated.
  • Physician/ Gastroenterologist may prescribe various medications that decrease gastric acid production. ( Some medications that control acid reflux are sold over the counter, however, since dosages vary it is important to consult with physician prior to using over the counter medications.)

Lactose Intolerance

Lactose intolerance (or more properly, lactase deficiency, a condition in which enzyme production is insufficient to digest lactose, the sugar in milk products) has been observed in some children with EB. Milk can be treated with a commercial enzyme product called Lact Aid which, if added to a quart of milk, breaks down the sugar lactose and the milk can then be tolerated. Some stores also sell milk that has already been treated with the enzyme and is therefore more easily digested. In addition, in yogurt most of the lactose is broken down and thus is usually well tolerated Lactose-free formulas and liquid supplements are also available. Your physician and/or dietitian can help you in the selection of an appropriate product.

Constipation:

Constipation is difficulty passing stool. Contributing factors may include discomfort during the passage of stool caused by blistering in the anal margin, suppression of bowel movements due to pain and a diet low in fiber and fluids.

Symptoms of constipation may include:

  • Reluctance to feed
  • Loss of appetite
  • Abdominal discomfort
  • Abdominal bloating

Goal: Soften stool to reduce discomfort and constipation.

Constipation may be due to:

  • Erratic eating patterns, low fluid and fiber intake.
  • Soft tissue injury in mouth, trouble chewing, swallowing, problems with dentition, esophageal scarring and/or webbing all contribute to poor dietary intake of fiber containing foods such as cereals, breads, fruits and vegetables.
  • Most iron supplements have been known to contribute to constipation.
  • Since the gastrocolonic reflex is stimulated by ingestion of food, avoidance of eating, apathy and loss of appetite worsen the nutritional status.
  • Extensive blistering leads to increased fluid requirements.

Interventions may include the following:

  • Input by a pediatric dietitian/nutritionist many times can be helpful in formulating a dietary regimen that reduces constipation and/or fecal impaction.
  • For infants it may be helpful to offer fluids such as cooled boiled water. If you want to add flavor, try one teaspoon of fruit juice in 100 milliliters of water.
  • Liquid enteral formulas like Pediasure with fiber may improve gastro-intestinal function.
  • Offer fruits such as prunes, pears, peaches and apricots.
  • Prepare foods in forms that are easier to swallow such as broth, pureed meats, vegetables and fruits.
  • Some have found it enjoyable to liquefy depitted fruits and freeze them into the form of an ice pop.
  • Try not to sieve foods, it will decrease the fiber content.

Below is a list of various medications used for constipation. Please consult physician prior to using any medications. Though some of these may be sold over the counter it is important to check with the physician for specific dosages, possible interactions and side effects.

  • Stool softeners such as (Docusate Sodium) allow for easier passage of stool.
  • Hyperosmotic laxatives such as (Lactulose) and osmotic agents such as (Miralax) help move water into intestines, soften stool and stimulate peristalsis.
  • Stimulant laxatives such as (Senekot, Bisacodyl) stimulate peristalsis allowing for the movement of feces through the intestines.
  • Psyllium containing bulk laxatives such as (Metamucil)when in contact with water produces a lubricating gelatinous bulk which promotes peristalsis and natural elimination.
  • Fiber and bulk laxatives need to be taken with good amounts of fluid in diet to mobilize the bulk through the intestines.
  • Discuss different types of iron supplementation with physician. Some iron complexes were found to be less irritating to the gastrointestinal tract than others.
  • If a medication for constipation is prescribed by a physician, it is helpful to administer them regularly to avoid worsening of the problem.

Sometimes a child may be fecally impacted, but have diarrhea. If laxatives and stool softeners are discontinued (due to the diarrhea) this will worsen the problem. Consult your child’s physician when in doubt.

Hard stools lodged in the large intestine (fecal impaction) usually requires a hospital visit. Fecal impaction is usually seen on abdominal xray.

Anemia

Many children with EB become anemic due to a chronic loss of blood from blisters and open skin lesions and perhaps due to poor ingestion and absorption of blood-building substances. Specific treatment for iron deficiency anemia is often necessary. Many children have to keep taking supplemental iron even after the anemia has been corrected to prevent it from occurring again. Many commercial nutritional supplements contain iron. Use iron supplements only when recommended by the physician. An adequate intake of protein is also important.

Scarring, Contractures and Syndactyly:

Though scarring may occur in rare instances in other types of EB it is important to keep in mind that these manifestations are more likely to occur in a person affected with Recessive Dystrophic Epidermolysis Bullosa.

Repeated friction and trauma on hands and feet causes blistering, in the more severe forms of EB, these blisters heal causing scarring, side to side fusing or webbing together of fingers and toes (syndactyly).

Contractures ( shortening of the skin ) of the hands and feet may also contribute to loss of function. Flexion contractures can occur on joints in the feet, knees and hips. Muscle atrophy (weakening) develop as a result of disuse of a joint. Scarring may decrease opening of mouth (microstomia). Scarring may limit movement of the tongue (ankyloglossia).

Interventions may include the following:

  • Wrapping in between digits using strips of contact layers such as Mepitel (Molnlycke Health Care) and/or impregnated gauze such as Vaseline gauze (Kendall) may help delay the process of webbing.
  • Whenever possible during the day, infants should be encouraged to discover and manipulate their hands to allow for better movement. Due to the possibility of rubbing and potential injury this should be done under supervision. During night time hands may be re-wrapped.
  • Some people have found it helpful to use splints during the night to reduce chance of contractures. Splinting varies with age of person affected. Splints are made using a very heat labile moldable material.
  • Consult with an Occupational therapist. They are very helpful in creating programs of activity that optimize hand function. The OT may be helpful in teaching methods of wrapping that allow for range of motion of fingers and hands. Ask the OT about range of motion exercises that you can perform on your infant/child throughout the day. Specially designed equipment such as scissors and pencils with foam padding reduce discomfort while children participate in arts and crafts.
  • If the function of the hand is impaired it is advisable to consult with either a Plastic Surgeon or a Hand Surgeon. The Surgeon will determine if it is in fact necessary to perform surgery or to wait. The surgical procedure involves separating the fused digits and releasing contractures while under anesthesia. Skin grafts or various bioengineered skin products may be used to cover wounds and/or donor sites. Hand splints are used to help keep fingers separated and hands in extended position post surgically. Careful instructions for post care should be given by the surgeon. Healing usually takes several months for this reason, only one hand is done at a time.
  • The child with EB should be encouraged to be as active as possible, and physical therapy is often beneficial. Swimming is a good form of exercise for children with EB.
  • If child has difficulty speaking and/or eating parents may consult with a speech therapist. Mouth and tongue excercises can help improve speech. (Early intervention programs provide occupational therapists, speech therapists and physical therapists for children under three years of age. For more information contact early intervention in your state.)

Dental Problems

The infant or young child should begin to see the dentist (or pediatric dentist, if available) shortly after the teeth begin to emerge through the gums. Regular visits will ensure the most preventive care. When the teeth begin to appear, they should be brushed gently with a small, soft multi- tufted toothbrush. Discourage the child from eating sweets. If the water supply is not fluoridated, the dentist may suggest the use of nonirritating fluoride supplements. Some recommend oral swishes after the feeding at the completion of the meal to protect the dentition.

Eye Problems

Because many of the tissues of the eyes develop from the same fetal tissue as the skin, the eyes can be involved in EB, particularly in the dystrophic forms of EB. The cornea (the clear outer layer) and the conjunctiva (the mucous membrane covering the eyeball and the underside of the lids) can be damaged. Symptoms are pain, excessive formation of tears or discharge.

The goal of therapy for this problem is to protect the eye from irritation by increasing the amount of moisture. Eye drops can be useful as can lubrication with a specially prescribed antibiotic ointment. It may be helpful to put the ointment on the eye and patch it for a day or so.

Immunizations

Every child, including those with epidermolysis bullosa, should receive the normal immunization shots.

Please consult with physician if child is receiving steroid therapy or other immunosuppressive agents. Physician may reschedule live attenuated vaccinations such as Varicella and MMR for a later date if child is receiving immunosuppressive agents.

What Does the Future Hold For a Patient With EB?

As described earlier, EB can range from a relatively mild condition to a severely disabling, and sometimes fatal, disease. Patients with milder forms may have periods of "temporary disability," but can lead a relatively normal life. In more severe forms, EB can be emotionally and physically devastating and cause the person to be disabled and deformed. Proper care and family support, however, can greatly enhance the quality of life for EB patients.

Despite the physical problems the disorder can cause, there is no impairment of intelligence.

There are many psychological problems that patients with EB must learn to cope with: the teasing of classmates, the stares from others, the jokes, the loneliness of being different. Many patients overcome these problems with the support of well-informed, caring parents and friends. As all children do, those with EB need love and acceptance.

Children's tissues become less delicate with age; many forms of EB begin to lessen to some degree as the child gets older. Patients given good, consistent, and intensive care early on have the best chances of doing well.

Support Groups

When one or more children in a family has a chronic disease that requires constant or almost around-the-clock care, the entire family is affected. Family therapy or support groups can:

  • Help each member of the family accept and deal with long-term chronic illness;
  • Help relieve guilt;
  • Make it easier to cope with the child's and the parents' feelings;
  • Make a difference because the parents, attitude can affect the way a child copes, handles his own care, and interacts socially with peers and people in general.
  • Help to deal with siblings and spouses, feelings.

Click on (Support Groups) for a listing of DebRA support groups.

What Can Research Tell us About EB?

By Alan Moshell MD, Skin Diseases Program Director - National Institutes of Arthritis and Musculoskeletal and Skin Diseases.

Research in Epidermolysis Bullosa and related areas are being supported by the National Institute of Arthritis and Musculoskelatal and Skin Diseases, other components of the federal government’s National Institutes of Health, and voluntary agencies such as DebRA of America.

Essentially all forms of hereditary Epidermolysis Bullosa are due to structural molecule abnormalities in the skin. These molecules may either be present but abnormal in structure, or greatly reduced or absent. Skin has two principal layers, the outermost layer known as the epidermis and the lower layer known as the dermis. The area where these layers come together is called the basement membrane zone. The molecules involved and abnormal in Epidermolysis Bullosa are located either in the bottommost portion of the epidermis, the basal layer, within the basement membrane zone, or in the uppermost part of the dermis.

Under the microscope, skin from patients with the simplex or epidermal forms of EB develop blisters within the basal layer of the epidermis. In most of these forms of EB the abnormality is in a molecule called keratin which forms the internal structure of the basal cell. The abnormalities in these proteins result in a weakness in the cells and they disintegrate under mechanical stress resulting in the blister in this area.

The basement membrane zone of skin is a very molecule rich area with many molecules involved in the attachment of the epidermis above to the dermis below. Defects in quite a number of these molecules have been associated with the junctional forms of Epidermolysis Bullosa. The most severe forms are usually associated with defects in a molecule called laminin 5. Less severe forms of the disease may be associated with a variety of other molecules found in this area.

The dystrophic forms of EB, both recessive and dominant, are usually due to defects in a molecule of the upper dermis called collagen VII. Under the electron microscope, this molecule forms a structure called anchoring fibrils. In the recessive form of the disease, the defect is usually more severe than in the dominant form of the disease.

A variety of techniques have been developed and used over the years to visualize these molecules and assist in the diagnosis of patients with hereditary blistering diseases. Electron microscopic techniques along with immunofluorescence and immunoelectromicroscopy were the mainstays of research until these specific genes for these various molecules were identified. With the identification of the genes, it is now possible to specifically and directly examine the various potential genes involved and identify specific defects in individual patients and in families. This allows for both a much more specific diagnosis and for the further studies now ongoing to correlate specific gene defects with the protein abnormalities that they produce. These investigations will allow a better understanding of exactly how the molecules function and make interventions designed to strengthen these molecular interactions or bypass them by getting other molecules to take their place possible. These studies are still in their infancy but therapeutically useful approaches can result from these investigations.

With the specific genes known, it is possible to very accurately perform prenatal diagnoses on infants at risk to assist those families who want such information in making decisions. There is also research making use of this technology as part of in vitro fertilization to select embryos that do not contain the abnormal gene for implantation in an attempt to assure normal offspring in families at risk without the need for abortions.

In addition, there is investigation of gene therapy approaches for the treatment of these diseases. These are still at the preclinical stage meaning that the baseline studies have been done proving feasibility but as yet no human trials have resulted. Human trials are to be expected in the near future but when and even if this approach ever proves feasible as a corrective therapy for any form of Epidermolysis Bullosa is still an open question.

Much of science is unpredictable. There is no way to know when and from where useful approaches will be forthcoming. Basic research advances are constantly reshaping science and its application. The cardinal objectives are to understand the basic underlying mechanism that lead to this distressing disabling disease and to develop therapies directed at correcting these mechanisms or developing interventions that improve the resistance to blistering by other means.

BIBLIOGRAPHY

Fine JD, Bauer EA, McGuire J, Moshell A. Epidermolysis Bullosa: Clinical, Epidemiologic, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry Baltimore: The Johns Hopkins University Press 1999.

Fine JD, Eady RAJ, Bauer EA, et al. Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 2000;42:1051-66.

Lin AN, Carter DM eds. Epidermolysis Bullosa: Basic and Clinical Aspects New York: Springer-Verlag 1992.

Schober-Flores C Epidermolysis Bullosa: A Nursing Perspective Dermatology Nursing 1999;11:4:243-256.


*Please note that all medical information given by DebRA is for informational purposes only. Our information is not intended to substitute the care and guidance given by a qualified physician. All regimens of care should be discussed with the patient's physician. Always check with your physician prior to starting any medications or treatment regimens.



DebRA
 
  



About EB - Subtypes
207269 Reads Printer friendly page
Posted by: Admin on Mar 30, 2003 - 11:58 AM


EB Simplex

What is the cause of EB Simplex?

Through research it is now known that the genes that carry the instructions necessary to produce the proteins in the top layer (keratins) are faulty. This results in incorrectly formed keratins, deeming them unable to perform their normal role as a 'scaffolding' for the top most layer of skin. It appears as though there is a mutation (a change in the genetic material) within Keratin genes K5 or its partner K14. So as a result, the top layer of skin falls apart, resulting in a blister. Although EB Simplex is considered a non-scarring form of EB, secondary infection may cause scarring.

How is EB Simplex Inherited?

EB Simplex is usually inherited as an autosomal dominant condition. One parent of an affected person will usually also have the condition, though it is possible for EB simplex to appear 'sporadically' (to appear for the first time in a person who has no other affected family member). Anyone who has EB simplex whether male or female, can pass the condition on to his or her children. Each time a pregnancy occurs, there is a 1 in 2 chance that the child will inherit EB simplex.

Some precipitating factors that may cause an outbreak of blistering may include the following:

  • Physical stress
  • Emotional stress
  • Warmer climates
  • Infections
  • Sexual maturation

Even though some forms of EB Simplex are localized it is important to know that all skin cells are affected. Therefore, all skin surfaces are prone to develop generalized blistering.

Weber-Cockayne Subtype of EB Simplex:

This form is also termed localized EB simplex. This disorder usually presents in childhood or adolescence. It may also occur in an infant or adult life. In many instances it presents itself in infancy from friction induced by shoes and starting to walk.

People with Weber Cockayne EB Simplex develop blisters on their feet and hands, (usually palms and soles) in response to friction. These wounds usually heal without scarring. Walking even short distances is often enough to cause blisters. They may experience thickening of the skin (keratoderma) on the soles of the feet. This type of EBS usually does not involve nails or mucous membranes. Most individuals seem to be more prone to blisters in warmer climates and during periods of strenuous activity such as jogging, marching or walking. With trauma or friction rarely the blistering can be (generalized) or appear on other parts of the body.

Mutations are in the genes encoding K5 or K14.

Koebner Subtype of EB Simplex:

This is a form of generalized EB simplex. This disorder usually presents at birth or infancy. Blisters are noted to be widespread over the body's surface. Though it is not a common feature of this type of EB to scar on rare occasions it does happen. There may be mild involvement of mucous membranes. Fingernails and toenails are sometimes involved. Localized thickening of the skin (keratoderma) on the soles of the feet and the palms of the hands may occur especially as one gets older.

Mutations are in the genes encoding K5 or K14.

Dowling Meara Subtype of EB Simplex:

EBS-DM is a generalized form of EB simplex. This type of EB is probably the most severe form of EB Simplex.

Infants are often born with widespread grouping of blisters on the face, trunk and limbs. Blisters on hands and feet often eventually cause confluent keratoderma (thickening of the skin). In many cases these calluses form complete thickening of the palms and soles. If the thickening is severe enough it may limit the range of motion of a joint. In such cases, consultation from a surgeon may be necessary to determine the best course of treatment.

Heat may exacerbate blistering. Milia (tiny cysts on skin) may be present after blisters have healed. Nail thickening and discoloration is a common feature.

Blistering in Dowling Meara EBS can involve organs including the oral cavity, gastrointestinal tract and rarely, the upper respiratory tree.

Electron microscopy shows clumps of keratin filaments, which are not seen in other forms of EB simplex.

Mutations are usually in the genes encoding K5 or K14.

Since EBS-DM is the most severe form of EBS, the widespread blistering may lead to death in infancy. However, blistering tends to become smaller and less problematic for most patients as they grow older.

*Since EB varies in severity these manifestations may or may not be experienced by the individual affected.

Common Manifestations of EBS:

  • Blisters
  • Keratoderma - Thickened skin on palms of hands and soles of feet. Confluent keratoderma in EBS-DM.
  • Nail dystrophy - The presence of rough, thickened or absent finger or toenails.
  • Problems with the soft tissue inside the mouth.

Uncommon Manifestations of EBS:

  • Milia - Tiny skin cysts.
  • Atrophic scarring - Depressions in skin as a result of thinning in epidermis or dermis.
  • Anemia - A reduced amount of red blood cells, volume of red blood cells, amount of hemoglobin. Hemoglobin is the oxygen carrying portion of the red blood cell. The heme aspect of hemoglobin, is the iron compound that makes up the pigment part of the hemoglobin molecule. Anemia is more common in the severely affected individual.
  • Growth retardation. This is more common in a severely affected individual.
  • Gastrointestinal tract - Involvement of the GI tract may include blisters in mouth, esophagus and/or anal margins.

Rare Manifestations of EBS:

  • Granulation tissue - The appearance of red fleshy tissue which is capillary formation during tissue healing This would be a rare occurrence in a person affected with EBS. This is more commonly seen in a person severely affected with Junctional EB.
  • Dental caries (cavities) - This is more common in people affected with RDEB or JEB however, if mouth care is not performed regularly it will increase chances of cavities.
  • Ocular (eye) involvement is more commonly seen in people with RDEB or JEB however, it has been reported in some forms of EBS.
  • Pseudosyndactyly - Fusion of fingers and/or toes. This manifestation is more commonly seen in RDEB. In rare instances it has been reported in EBS-DM.
  • Enamel hypoplasia - Underdeveloped enamel upon the teeth. This is more prevalent in patients with JEB.
  • Respiratory tract involvement. Rare occurrences have been noted in the more severely affected individual.
  • Genitourinary tract involvement. Rare occurrences involving the GU tract have been reported in some forms of EBS.

There is no evidence that people with EBS are at a higher risk for developing squamous cell carcinoma or malignant melanoma, however, suspicious wounds/lesions should always be evaluated by your dermatologist.

Other Subtypes of EB Simplex include:

EB Simplex Superficialis, EB Simplex with Mottled Pigmentation and Kallin’s Syndrome.

There is a recessively inherited simplex that accompanies Muscular Dystrophy which appears to be a mutation in the Plectin gene.


Junctional EB

What is the cause of Junctional EB?

Through research it is now known that mutations in the genes encoding alpha 6, beta 4 integrin, collagen XVII or one of the three chains of Laminin 5 contribute to defects in the formation of hemidesmosomes or anchoring filaments.

Defects within any of those components of the skin allows for the separation of tissue and blister formation whenever there is friction or trauma to an area. In many instances blistering can occur spontaneously.

There are three major sub-types of Junctional EB. Herlitz, non-Herlitz and Junctional EB with associated Pyloric Atresia. Though Junctional EB is considered a non-scarring form of EB, tightening and thinning of the skin does occur. In many instances residual atrophic scarring occurs.

How is Junctional EB Inherited?

JEB is an autosomal recessive condition. This means both parents are healthy carriers. Healthy carriers are non-symptomatic and will never develop the illness. When each parent has a copy of the altered gene, there is a 25% or 1 in 4 chance the child will be affected by Junctional EB. Unfortunately, there is no test to detect carriers for JEB. We are made aware that the parents are carriers after the child is born.

Junctional Herlitz EB:

Junctional Herlitz EB is a very severe form of EB. These infants often die during infancy due to overwhelming infection (sepsis), malnutrition, dehydration, electrolyte imbalance or complications resulting from blistering in the respiratory, gastrointestinal or genitourinary tract.

Some babies develop a hoarse cry and breathing difficulties which indicates internal involvement as well. These infants often fail to gain weight. These are usually symptoms of the severe form of Junctional EB.

Blistering is usually present at birth, however, there have been instances of infants being discharged to home, with a small blister on the finger or lip. After they are home, the blistering becomes more apparent warranting a visit to the physician. Skin blistering and ulcerations can occur spontaneously on the arms, hands, finger tips, back of the head, neck, shoulders, trunk, buttocks, legs and feet and toes (generalized distribution). Nails may be ulcerated or dystrophic. Warmer climates can exacerbate blistering. Blistering is noted on perioral (around the mouth) and mucosal surfaces as well. Oral lesions may affect eating causing weight loss.

Electron microscopic evaluation of the structure of the skin in a patient affected with JEB-H usually shows skin separation in the lamina lucida within the basement membrane zone. Absent or reduced amounts of hemidesmosomes may also be apparent.

Junctional Herlitz EB mutations are present on the genes encoding one of the three chains of Laminin 5.

Junctional non-Herlitz EB:

Generalized blistering and mucosal involvement may be evident at birth or soon after. Blistering may be mild to severe. Erosions on finger and toenails, nail dystrophy or absence of nails may be evident. Erosions and loss of hair (alopecia) upon the scalp may occur. Granulation tissue around mouth and nares may be seen. There may be some scarring and thinning of the skin on affected areas (atrophic scarring). Warmer climates can exacerbate blistering. Though laryngeal involvement (hoarse cry) may be experienced in early infancy, respiratory distress is a rare occurrence in this type of Junctional EB.

The infant may suffer complications such as infection, dehydration, electrolyte imbalances, respiratory, gastrointestinal, and/or genitourinary tract involvement. These complications may lead to death.

Electron microscopic evaluation of the structure of skin in a patient affected with JEB-nH shows skin separation at the level of the lamina lucida of the basement membrane zone. Variable appearance of hemidesmosomes may be visualized as well.

JEB-nH mutations usually involve the genes encoding type XVII collagen also called (BP 180 ). Occasionally mutations in laminin 5 are seen.

Junctional EB with Pyloric Atresia:

Some infants are born with Junctional EB and have been observed to have pyloric atresia, in which the opening between the stomach and the intestines fails to form. Surgery is necessary to repair the anomaly.

Generalized blistering, ulcerations of skin and mucous membranes is usually evident at birth. Blistering may be mild to severe. Erosions on finger and toenails, nail dystrophy or absence of nails may be evident. Erosions and loss of hair (alopecia ) upon the scalp and granulation tissue around mouth and nares may occur. There may be some scarring and thinning of the skin on affected areas (atrophic scarring). Warmer climates can exacerbate blistering.

The infant may suffer complications such as infection, dehydration, electrolyte imbalances, respiratory, gastrointestinal, and/or genitourinary tract involvement. These complications may lead to death.

Electron microscopic evaluation of the structure of the skin of a person affected with JEB-PA reveals skin separation at the level of the lamina lucida, small hemidesmosomal plaques and reduced amount of keratin filaments with hemidesmosomes.

Mutations in JEB-PA are within the genes encoding either alpha 6 or its partner beta 4 integrin. These components of the hemidesmosome are found both in skin and the stomach, explaining the failure of formation of the first part of the intestine (the pylorus).

*Since EB varies in severity these manifestations may or may not be experienced by the individual affected.

Common Manifestations of JEB:

  • Blisters/erosions
  • Dystrophic nails - The presence of rough, thickened finger or toenails.
  • Atrophic scarring - Depressions in skin as a result of thinning in epidermis or dermis.
  • Granulation tissue is the appearance of very red fleshy tissue, which is capillary formation during tissue healing. (More apparent in the perioral region and the nares.)
  • Scalp abnormalities. Presence of blisters on scalp and/or scarring alopecia (areas of scarring with absence of hair growth).
  • Respiratory tract involvement. May be present in the more severely affected individual.
  • Anemia - A reduced amount of red blood cells and volume of red blood cells, amount of hemoglobin. Hemoglobin is the oxygen carrying portion of the red blood cell. The heme aspect of hemoglobin is the iron compound that makes up the pigment part of the hemoglobin molecule. The globin portion of hemoglobin is made up of protein. (This is more common in the severely affected individual.)
  • Growth retardation and malnourishment.
  • Problems in the soft tissue inside the mouth.
  • Enamel hypoplasia - The presence of underdeveloped enamel upon the teeth.
  • Dental caries is the development of cavities in teeth.
  • Gastrointestinal tract involvement (blisters in mouth, esophagus and/or anal margins).
  • Ocular (eye) involvement.

Rare Manifestations of JEB:

  • Genitourinary tract involvement may include scarring and/or urethral stenosis.
  • Milia - Small skin cysts
  • Pseudosyndactyly - Fusion/ webbing of fingers and/or toes. On rare instances this has been reported in JEB patients.

There is no evidence that people with Junctional EB are at higher risk for developing malignant melanoma. In rare instances squamous cell carcinoma has been reported.

Any suspicious lesions should be evaluated by a determologist.

For additional information about JEB, you can view the Revised classification system for inherited epidermolysis bullosa. On the NEBR web site: http://www.daklex.com/.


Dystrophic Epidermolysis Bullosa

What Is The Cause Of Dystrophic EB?

Through research it is now known that the genes that carry the instructions necessary to produce the proteins in the basement membrane zone of the skin, are faulty. This results in incorrectly formed anchoring fibrils, deeming them unable to perform their normal role as a 'stable interweave' between the dermal and epidermal layers of the skin.

Mutation (a change in the genetic material) occurs within the collagen VII gene, which encodes the protein of the anchoring fibril. Anchoring fibrils hold together the two layers of skin. As a result, there is a lack of adherence and disruption of the skin when any friction or trauma occurs to an area. Where the two layers separate there is a blister. Blistering in the various types of dystrophic EB causes scarring.

There are two major types of DEB:

  • Dominant Dystrophic Epidermolysis Bullosa
  • Recessive Dystrophic Epidermolysis Bullosa ( Major subtypes of RDEB are listed below.)
  1. Recessive Dystrophic Epidermolysis Bullosa- Hallopeau Siemens
  2. Recessive Dystrophic EB-non Hallopeau Siemens
  3. Recessive Dystrophic EB inversa

How is Dominant Dystrophic Epidermolysis Bullosa Inherited?

DDEB is an autosomal dominant condition. One parent of an affected person will usually also have the condition. It is possible for DDEB to appear 'sporadically' (to appear for the first time in a person who has no other affected family member). Anyone who has DDEB whether male or female, can pass the condition on to his or her children. Each time a pregnancy occurs, there is a 1 in 2 chance that the child will inherit DDEB.

Electron microscopic evaluation reveals skin separation at the level of the sub lamina densa of the basement membrane zone, with normal or decreased number of anchoring fibrils.

Mutations are noted in the genes encoding collagen VII either the gene from the mother or from the father. The change that results, decreases the functioning of the anchoring fibrils, but does not eliminate the anchoring fibrils

Dominant Dystrophic Epidermolysis Bullosa :

There is usually generalized blistering noted at birth. Blistering may be generalized or appear only on the hands, feet, elbows or knees: this is usually due to mechanical trauma. Rarely does scarring cause immobility and deformity of the hands and feet. Small cysts or milia are seen at sites of scarring. There may be mild involvement of the mucous membranes, nails may be thick, dystrophic or destroyed. Some affected by this form of EB may note the presence of small, firm flesh colored or white skin elevations that appear spontaneously on the trunk and extremeties of their body, that are called albopapuloid lesions.

  • Transient Bullous Dermatosis of the Newborn *(TBDN) appears to be a form of DDEB noted by blistering and skin fragility that appears from changes in the collagen VII gene. For reasons unknown the problem seems to correct itself during infancy.

How is Recessive Dystrophic Epidermolysis Bullosa Inherited?

RDEB is an autosomal recessive inherited condition. This means both parents are carriers, yet they are unaffected. When each parent has a copy of the altered gene, there is a 1 in 4 chance or 25% that the child will be affected. Unfortunately, there is no test to detect carriers for RDEB. We are made aware that the parents are carriers after their child is born.

Electron microscopic evaluation reveals skin separation at the level of the sub lamina densa, with absence of anchoring fibrils in RDEB-HS.

There are reduced or occasionally abnormal appearing anchoring fibrils in RDEB-nHS.

Mutations in RDEB are found in both the mother’s and the father’s gene encoding collagen VII.

Recessive Dystrophic Epidermolysis Bullosa:

Although in some cases this form of EB can be mild with generalized blistering, typically the recessive forms of EB tend to be more severe. Onset is usually at birth with areas of missing skin. Generalized blistering then scarring can occur on skin surfaces and mucous membranes. Scarring may limit range of motion of extremities. Fusion of fingers and toes and contractures cause deformity and loss of function.

In some cases there is relatively mild blistering on hands, feet, elbows, and knees; these cases are very similar to dominant dystrophic EB. However, recessive dystrophic epidermolysis bullosa typically is characterized as follows:

Blistering onset is at birth or soon afterwards. In some cases, nearly all skin surfaces and mucous membranes (from mouth to anus) are covered by blisters. Large areas may be devoid of skin. There is widespread scarring and deformity. Fingers and toes may become immobile. With recurrent scarring, fingers and/or toes may fuse together. Hands and arms may become fixed in a flexed position with resulting contractures. There is usually loss of the nails of the fingers and toes. Teeth may be malformed and delayed in appearing through the gums. Because routine dental care can raise blisters, many persons with RDEB have a higher than normal incidence of cavities. Blistering on the mucosal surfaces often cause scarring within the mouth and gastrointestinal tract. The ingestion of food may be limited due to microstomia (inability to fully open mouth due to scarring and contractures of the perioral region), painful swallowing, difficulty chewing, (due to poor dentition) esophageal webbing. In many cases chronic malnutrition, growth retardation and anemia may ensue. Involvement of the eyes can include eyelid inflammation with adhesions to the eyeball, as well as inflammation of the cornea or the conjunctiva (the mucous membrane covering the eyeball and the underside of the lids).

RDEB inversa is a rare subtype of RDEB, blistering is noted on intertriginous (areas where skin rubs on skin i.e. axilla and groin) Lumbosacral areas may be affected as well.

Common Manifestations of DEB:

*Since EB varies in severity these manifestations may or may not be experienced by the individual affected.

  • Generalized blistering.
  • Absent or dystrophic nail - Presence of a rough, thick or changed finger or toenail.
  • Milia - tiny skin cysts.
  • Atrophic scarring - Depressions in skin as a result of thinning in epidermis or or dermis.
  • Anemia - A reduced amount of red blood cells, volume of red blood cells, amount of hemoglobin. Hemoglobin is the oxygen carrying portion of the red blood cell. The heme aspect of hemoglobin, is the iron compound that makes up the pigment part of the hemoglobin molecule. It is more common in the severely infected individual (RDEB Hallopeau Siemens). In some instances anemia may occur in (DDEB, RDEB non-Hallopeau-Siemens and RDEB inversa).
  • Growth retardation is more common in a severely affected individual (RDEB Hallopeau Siemens). In some instances this may occur in (DDEB, RDEB non-Hallopeau-Siemens and RDEB inversa).
  • Problems with the soft tissue inside the mouth.
  • Ocular (eye) involvement is more common in severely affected individuals (RDEB-HS). In some instances this may occur in (RDEB non-HS and RDEB inversa).
  • Dental caries - Presence of cavities. This is more common in (RDEB-HS and RDEB inversa).
  • Gastrointestinal tract: Involvement of the GI tract may include blisters in the mouth, esophagus and/or anal margins. (Problems may exist in those with DDEB however it is more commonly seen in RDEB.)
  • Pseudosyndactyly - Fusion of fingers and/or toes. This manifestation is more common in the severely affected individual (RDEB HS, RDEB non-HS and RDEB inversa).

Rare Manifestations of DEB:

  • Granulation tissue - Capillary formation during tissue healing. Would be a rare occurrence in a person affected with either form of DEB. (This manifestation may be seen in a person severely affected with Junctional EB.)
  • Enamel hypoplasia - Underdeveloped enamel upon the teeth. This is more prevalent in patients with JEB.
  • Respiratory tract involvement. Rare occurrences have been noted in the more severely affected individual.
  • Genitourinary tract involvement. Rare occurrences involving the GU tract such as urethral stenosis and/or scarring have been reported.

For additional information about DEB you can view the Revised classification system for Inherited epidermolysis bullosa (http://www.daklex.com/).

Skin Cancers and Dystrophic Epidermolysis Bullosa

It is important to note that skin cancers usually react differently in a patient with EB. The more severely affected individual (RDEB) appears to be more at risk for developing squamous cell carcinoma. These localized skin cell tumors have the ability to grow faster and spread to other areas of the body more rapidly then they would on a less compromised individual. Patients and caregivers need to examine skin carefully for any changes. It is important to perform self examinations of your skin at home. Many times it is helpful to have family members look at areas that are not often viewed by the affected individual, such as the back or upon the scalp. Mirrors can be helpful in detecting growths on the back of trunk and extremities when you are self examining.

Any suspicious lesions, moles or markings should be evaluated by a dermatologist. Yearly full body exams are usually recommended, however, in some instances your dermatologist may modify the frequency of skin exams.

  • Squamous Cell Carcinoma and Recessive Dystrophic EB: The incidence of squamous cell carcinoma is more common in the severely affected individual, RDEB Hallopeau-Siemens. There have also been reports of Squamous Cell Carcinoma in patients with RDEB non Hallopeau- Siemens.
  • Squamous Cell Carcinoma and Dominant Dystrophic Epidermolysis Bullosa: It is a rare occurrence for the person affected with DDEB to develop squamous cell carcinoma.
  • Melanoma and Dystrophic EB: Rare occurrences of melanoma have been reported in Dominant Dystrophic EB and Recessive Dystrophic EB.
  • Basal Cell Carcinoma and Dystrophic EB: Rare, but has been reported in a small percentage of individuals with Dominant Dystrophic EB.

Changes in skin that warrant visit to physician for prompt evaluation include the following:

  • Chronic non-healing wound.
  • Deep ulcers.
  • Any unusually thick, raised and/or crusted areas.
  • Make note of any changes in the pattern of healing. Although there are variations in healing rates among each wound, it is important to monitor and note any changes, especially to areas prone to blistering.
  • Any change in sensation on the non-healing area.
  • Any changes in size, shape, diameter and color on existing growths and development of new growths.
  • Pus or foul smelling odor.

Generally biopsies are obtained to confirm the presence of skin cancer. However, if a biopsy is obtained from a suspicious growth and the results are negative, please continue to monitor the area. If the area is still not healing please notify your physician, it may be necessary to re-biopsy the area.

For helpful hints on self examination please note the following web-site for the Skin Cancer Foundation

(http://www.skincancer.org/self_exam/spot_skin_ca ncer.html)

How is EB Treated?

Because EB involves many systems of the body, parents and health professionals must take a 'team approach' , to the treatment of an EB patient. Intense and total patient care often must be provided, particularly for young and growing children. The severe forms of EB require hours of intensive nursing care that in many ways is similar to that given to burn patients. Much of this care is often provided by the parents; however, the education of all people who have contact with the patient is essential. These people may include the primary care physician (often a pediatrician), the dermatologist, the nurse, the pediatric dentist, the specialist in gastrointestinal (digestive) diseases, the dietitian or nutritionist, the plastic surgeon, the psychologist or social worker, and the genetic counselor, as well as teachers, relatives, baby sitters, and others.

So far, research has not yet found a cure for epidermolysis bullosa or a treatment to completely control any form of EB. However, many complications can be lessened or avoided through early intervention. Many persons with milder forms have minimal symptoms and may require little or no treatment.

In all cases, treatment of EB is directed towards the symptoms and is largely supportive. This care should focus on prevention of infection, protection of the skin against trauma, attention to nutritional deficiencies and dietary complications, minimization of deformities and contractures, and the need for psychological support for the entire family.


*Please note that all medical information given by DebRA is for informational purposes only. Our information is not intended to substitute the care and guidance given by a qualified physician. All regimens of care should be discussed with the patient's physician. Always check with your physician prior to starting any medications or treatment regimens.



DebRA
 
  



News: Update Your Information
3612 Reads Printer friendly page
Posted by: Admin on Mar 20, 2003 - 02:31 PM


By editing your account preferences you can:

  • Change your Password
  • Update your Information
To edit your preferences please click (here)



DebRA
 
  



Ask the DebRA Nurses
9436 Reads Printer friendly page
Posted by: Admin on Aug 12, 2008 - 10:30 AM


The following are columns written by Geri Kelly-Mancuso, RN, DebRA Nurse-Educator:

Below are columns written by Madeline S. Weiner, RN, DebRA’s former Nurse-Educator and a member of DebRA's Scientific Advisory Board:

Breastfeeding and EB

Dear DebRA Nurse,
My daughter has EB and is expecting her first child. We were discussing her plans with the new baby and she would like to breastfeed. Will my daughter be able to or will the friction of nursing cause her to develop blisters on her breasts? And are there ways to treat this to make it more bearable?

Your daughter should certainly try breastfeeding if it is her desire. It is possible that she might do as well with breastfeeding as a non-EB mom.

The experience of breastfeeding varies widely in the EB population. Very few EB moms have successfully breastfed their babies without any problems. Most have difficulty because when a baby suckles, blisters tend to form around the nipple area.

I would suggest that your daughter ask her OB/GYN doctor to recommend a lubricant that is baby-safe. She can apply this to her nipples prior to feeding the baby. If that alone does not help to reduce/prevent blistering, she can try a silicone nipple shield on her lubricated nipple. This may offer her some additional protection as the baby feeds.

If these methods are problematic, she can consider using a breast pump on her well-lubricated nipple. This will widen the diameter of pressure on her nipple. The pumped breast milk can then be bottle-fed to her baby. It is also possible that hand expression of her breast milk will be less traumatic to her breast tissue.

Not every technique works for every woman. It is important to remember that some EB moms are not successful when it comes to breast feeding and/or pumping their breast milk. Your daughter needs to know it is okay to bottle-feed the baby with formula if necessary. If she is not able to breastfeed, her pediatrician can recommend a good formula for her child.

There is often concern expressed that bonding occurs during breastfeeding and that the inability to breastfeed may prevent bonding between mother and child. The truth is that the acts of cradling the baby, making eye contact and talking or singing to the baby will allow a mom to bond with her child, even when bottle fed.

Geraldine Kelly-Mancuso, RN
DebRA EB Nurse Educator


Tatoos and EB

Dear DebRA Nurse:
I have EBS and have been considering getting a tattoo, the only real hesitation being the skin issue. Do you have any advice on this?

There are a few people with EB who have had tattoos. What has been learned from these individuals is that the milder your EB is, the easier it will be for you to tolerate the tattoo. Some patients with very mild EB who have skin that is not as fragile do fine with tattoos. The more fragile your skin, the more of a problem you may have. The problems others have had are pain, increased healing time and scarring.

You need to consider that with the skin fragility of EB, there is no guarantee of a good outcome, even in the hands of an experienced tattoo artist, and you could blister from the procedure and end up with a wound requiring care. Proper wound care will be very important- you will need to follow the post-tattoo care guidelines carefully. After your wound heals, it is possible that your tattoo may not look as you originally intended.

Another concern is that, in the event that you ever wish to remove your tattoo, your EB may limit your ability to have this done.

Good luck with your decision. 

Best Regards, 
Geraldine Kelly-Mancuso, RN
DebRA EB Nurse Educator


Wound Care and EB - Spanish and English

Estimada Enfermera de DebRA,
Mi hija tiene de 20 años de edad; ella padece de E.B. Distrófica y desde hace un par de meses tiene lesiones que le cuestan mucho sanar; y en estos días la atendió un ayudante y le indico que siempre debe utilizar un antibiótico en sus heridas y le recomendó uno llamado Bactroban.

No sabemos si utilizar una crema antibiótica a diario es conveniente para estas personas con EB. Puede usted brindarnos su comentario al respecto…
-Una mama preocupado

Estimada Mama,
Estoy escribiendo para contestar su pregunta acerca de su hija con sus heridas que esta usando mupirocina (Bactroban). Si las heridas estan infectadas, es propio usar un antibiotico fuerte, como mupirocina (Bactroban) con recita de su doctor. Pero este antibiotico no es para usar diario. Si usa cualquier antibiotico, tiene riesgo de conviértase una bacteria resistente Puede aplicar antibióticos tópicos que son suaves en las lesions. Polysporin o Bacitracin son efectivos en prevenir la infección y pueden ser alternados cáda mes o dos para disminuir la resistencia de la bacteria. Mupirocina (Bactroban) como todos los antibióticos por receta médica, deben ser usados solamente cuando hay recomendación de su doctor.

Por favor déjeme saber si le puedo ayudar en algo adicional.

Atentamente,
Geri Kelly-Mancuso, RN
DebRA EB Nurse Educator

Dear DebRA Nurse,
My daughter is 20y/o, has Dystrophic EB and for the last few months she’d had lesions that are difficult to heal. She was told by an assistant recently to use an antibiotic on her wounds and recommended Bactroban.

We don’t know if using this cream daily is recommended for people with EB. Can you tell us your thoughts?
-A concerned mother

I am writing to answer your question about your daughter’s wounds and the use of mupirocin (Bactroban). If her wounds are infected, it is appropriate to use a strong antibiotic like mupirocin (Bactroban) with a prescription from her doctor. However, this is not an antibiotic that should be used daily. If you use any antibiotic too often, you run the risk of developing resistant bacteria. You may use mild topical antibiotics like Bacitracin and Polysporin on her lesions. These are effective at preventing infections, and you can alternate them every month or two to reduce the risk of resistant bacterial infections. Mupirocin (Bactroban), like all prescription antibiotics, should only be used on a physician’s recommendation.

Please let me know if I may be of further assistance.

Sincerely,
Geri Kelly-Mancuso, RN
DebRA EB Nurse Educator


Kidney Issues and EB

Dear DebRA Nurse Educator:
I have heard a great deal in the EB community about kidney problems that affect those with EB. Can you tell me more? Is there a way to screen for them? -Needing Answers

Dear Needing Answers-
Diseases in the urinary tract system, which includes the kidneys, ureters, bladder and urethra are not common, but can be serious, even life-threatening, when they do occur. There is a need in the EB community for practical guidelines for monitoring and management of urinary tract system issues.

Glomerulonephritis (both acute and chronic), renal amyloidosis, IgA nephropathy and obstructive uropathy have been reported in both Junctional and Recessive Dystrophic EB. Each can lead to chronic renal failure (CRF). There are no hard numbers on how many in the EB community develop CRF.

Jemima Mellerio, BSc, MD, FRCP discussed protocols for the screening and management of urinary tract system issues at the IV International Symposium on Epidermolysis Bullosa in Santiago, Chile in September of 2007. The following reflects these recommendations:

Recommended Screening for Urinary System Disease:

  • For RDEB and JEB patients:
  • Twice a year:
    Urea and electrolytes
    Urinalysis
    Blood pressure check
    If these are not normal:
    Urine microscopy
    Urine culture
    Consider:
    Renal ultrasound
    DMSA scan
    Functional tests like a MAG 3 (diagnostic imaging)
  • For JEB patients:
  • Annually:
    Renal Ultrasound
    If this is not normal: DMSA scan
    If this shows scarring or discrepancy, consider functional tests like a MAG 3
  • If obstruction is suspected, a renal ultrasound is recommended
  • If vesico-ureteric reflux is suspected, consider a MAG 3 or a micturating cystourethrogram (MCU)

General Principles of Management:

  • Avoid instrumentation and surgery if possible
  • Urethral catheters are tolerated short term
  • Supra-pubic catheters are well-tolerated longer term
  • Avoid constipation and dehydration
  • Encourage toilet training at a normal age

Geraldine Kelly-Mancuso, RN
DebRA EB Nurse Educator


Preimplantation Genetic Diagnosis (PGD) and EB

Dear DebRA Nurse-
My firstborn child has a severe form of EB. Our genetic test results say it is a recessive form and both my husband and I carry the gene mutation. I have been told that there is a method, PGD, which can ensure I have an EB free baby when I have our next child. Can you tell me how it works? - New to EB

Dear New,
Having the genetic mutation of your child’s EB identified is the first step in Preimplantation Genetic Diagnosis (PGD), improving your chances of having an EB free child.

PGD is accomplished with in-vitro fertilization, in which the mother takes hormones to increase the number of eggs she produces during her monthly cycle. These matured eggs are surgically removed and then fertilized with the father’s sperm. When the fertilized egg reaches the eight cell stage, one of the cells is removed and analyzed at a special laboratory to see if it carries the EB mutations that were identified in the family. The fertilized eggs that do not carry the mutations can then be implanted. If pregnancy results from the implantation process, the child will be EB free, but may also be a carrier like the parents.

This process has been used successfully in a number of EB families. However, it is very expensive and not always covered by standard health insurance. Successful pregnancy with live birth is achieved in approximately one third of PGD cycles. As with any medical procedure, you should discuss with your medical provider whether PGD is right for you.

Geraldine Kelly-Mancuso, RN
DebRA EB Nurse Educator

For more information on Genetics and EB, you can go to www.genetests.com and at GeneReview, search for Epidermolysis Bullosa. Currently there are articles by Ellen G Pfendner, PhD and Anne W Lucky, MD on EBS, DEB, JEB and EB-PA available.


Dealing with Blisters

Dear Madeline,
I have a five month old daughter with dystrophic EB. It seems like her blisters grow larger right before my eyes. Is this possible? I’m wondering why does this happen?

Dear just wondering,

The fluid in the blister puts pressure on the surrounding skin, causing this skin to separate and the blister to increase in size. If blisters are very small or flaccid, they can be left alone. Large or tense blisters, or any that are painful or interfere with daily activities should be sterilely drained. The preferred approach is to first gently cleanse the blister's surface with isopropyl alcohol and then lance the surface (or blister roof) with a small sterile needle or sterile lancet. Sterile needles can be prescribed by the patient's physician for this purpose. If sterile needles cannot be obtained, then a reasonable alternative is to use a fine, clean, sewing needle which has been kept immersed in isopropyl alcohol and then briefly sterilized by careful heating over a lit match or flame until its tip is yellow. It can then be used as soon as it is cool. Once the punctured blister has been drained of its contents by the gentle application of pressure with a clean gauze pad, a tiny dab of a mild antibiotic ointment should be placed over the puncture site. This will reduce the risk of secondary infection. The application of a sterile non-stick dressing may be needed to further protect the wound and prevent infection. Remember, there are no nerve endings in the blister roof, so lancing or puncturing this area will not cause pain.

Madeline


No- Stick Picks

Dear Madeline,
Occasionally, dressings and clothing get stuck to my child’s wounds. These areas bleed and take longer to heal. How can I prevent this from happening?

Dear concerned mom,

We recommend the use of non-stick dressings such as Mepitel, Telfa dressings or Vaseline Gauze on EB wounds. These products will provide protection of the wound and will also facilitate healing. Because new blisters form and because dressings will slip out of place at times, you will not always be successful in preventing the situation you described. When dressings or clothing are stuck to a wound, the least traumatic method of removal is to soak the area and loosen the stuck-on matter before removing it. If you aren’t able to submerge your child in a tub to soak off clothing or dressings, try applying a wet compress to the area. This will take a little longer but will loosen the stuck-on substance and should prevent or minimize bleeding.

Madeline


Growth Hormones?

Dear Madeline,
My son has Recessive Dystrophic EB and has always been small for his age. He hasn’t grown any taller or gained any weight in the past year and a half and is now below the fifth percentile on his growth chart. Our pediatrician is considering prescribing growth hormone to see if this will help. Is this a good idea for people with EB?

Dear growing concerned,

You are describing growth retardation. Growth hormone will not correct this problem in people with EB. Growth retardation is a common finding in people with severe junctional (JEB) and recessive dystrophic EB (RDEB). According to the current research, approximately 30% of JEB and 42% of RDEB National EB Registry participants reported growth retardation. This is understood to be a reflection of chronic malnutrition, most likely due to the disruption in the lining of the gastrointestinal tract, where absorption occurs. Other contributing factors noted were the severe disease activity of the oral mucosa as well as unmet nutritional needs. (Fine, et al, 163). A consult with a Registered Dietician and the possible placement of a gastrostomy feeding tube should be considered.

Fine J-D, Bauer EA, McGuire J, and Moshell A. Epidermolysis Bullosa. Clinical, Epidemiologic, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry. Johns Hopkins University Press, Baltimore, May 1999.

Madeline


School Staff Needs Some Lessons

Dear Madeline,
My child gets blisters in school and the teachers just don’t understand. Should we consider home schooling? Being in school is so difficult for both my daughter and the teachers.

Dear EB Mom,

We encourage parents to mainstream their children as much as possible and to encourage participation in whatever activities are physically tolerated. Teachers and other school authorities must be educated about EB and activities that may cause painful blistering. If the teacher has difficulty understanding your child’s condition and needs, obtain the assistance of the school nurse. Often, the school nurse will have to familiarize herself with EB, but she will have the resources to do so. You should refer school officials to our website, (www.debra.org) and provide them with my phone number if needed (866-332-7276). I am available as a resource and for consultation in these circumstances. You child must also be taught to speak up and assert herself in situations where injury and blisters may result. In circumstances where a child is regularly unable to tolerate activities such as physical education classes, games, and sporting events, a letter explaining this should be provided by her pediatrician.

Madeline


Immunization Shots for EB Kids?

Dear Madeline,
I am a nurse in a pediatric office and we have just started caring for a baby with EB. Are regularly scheduled immunizations contraindicated in children with EB?

Dear Pediatric Nurse,

We recommend all children receive regularly scheduled immunizations. The following recommendations are noted on our website (www.debra.org):

Extreme care should be employed in handling the skin of any patient with EB. This includes avoiding friction and excessive manipulations, as well as any firm handling of the skin.

Healthcare workers should avoid the following as much as possible in patients with EB, since these actions may result in the induction of blisters.

  • Rubbing the skin (routinely done in preparing the site for injection or blood-draw)

    When alcohol or another cleansing agent is required, it should be gently dabbed onto the affected area rather than rubbed or wiped. When administering IM injections, there should be no vigorous massaging. Gentle pressure should be held to insure the medicine doesn’t leak out of the site.
  • Application of any adhesive or tape to the skin

    Wounds should be covered with an appropriate non-adhesive dressing (to include Vaseline Gauze, Mepitel or Telfa) and then wrapped loosely with sterile rolled gauze and secured with a tubular elastic dressing retainer. Tape and adhesive dressings should not be used.

Madeline


To Tattoo or Not to Tattoo

Dear Madeline,
I suffer from dystrophic EB. I am 18 and really want a tattoo. I was wondering if you have had any experience with other people having tattoos and whether it is a good idea or not.
Thanks.

Dear Anxious to Tattoo,

I have encountered a few people with EB who have had tattoos. What I have learned from these individuals is that the milder your EB is, the easier it will be for you to tolerate the tattoo. Some patients with very mild disease activity and skin that is not quite so fragile do fine with tattoos. The more fragile your skin, the more of a problem you may have. The problems others have had are pain, increased healing time and scarring. Since you have dystrophic EB, you probably heal with some residual scarring. If your skin is very fragile, you will probably blister from the procedure and then you may wind up with a tattoo on a scar . . . probably not what you had in mind.

Good luck with your decision, and if you follow through with this, please share your experience with me so I will have more information to help others who ask the same question.

Thanks,
Madeline


Fever

Dear Madeline,
I have a child with EBS-Dowling Meara. Recently, she had a fever and I noticed her blistering seemed to improve. The blisters she had healed up and she didn’t develop any new ones until days after the fever went away. Do you think there is any correlation between the fever and her improvement?

Dear EB Mom,

Yes, a decrease in blistering during febrile episodes is a finding reported by some patients with EBS-Dowling Meara. It is a rare phenomenon, though and has not been reported by many. Your daughter was fortunate not to have to deal with a fever and blisters at the same time.

Madeline


Shoes

Dear Madeline,
I have a 13 month old with mild recessive DEB who is trying to pull to stand. I am concerned about shoes. What type of shoe is best for him? It will need to be one he can wear with bandages.

Dear EB Mom,

Many parents find moccasins to be a good solution to the shoe dilemma at this age. They are soft and supple and will accommodate dressings. The Minnetonka Moccasins are one brand you may try, although others may work as well for your son. You can visit www.minnetonkamoccasin.com or www.pueblosouthwest.com to purchase or look at these.

Pedors and Weebors are also a good choice. They have a seamless, stretch upper portion to accommodate dressings, but a harder inner sole. Some parents prefer these for outdoor and school wear. Adding a soft inner sole helps make these shoes more comfortable. You can visit www.pedors.com to purchase or look at these items.


Inheritance – a roll of the Dice, each and every time

Dear Madeline,
I had EB Simplex as I child. I’m still sensitive to new shoes, elastic bands, etc. My three sisters also had it. We got it from my mother. I’m pregnant with my first child and I’m very concerned. Even though my family has the mild form, is it possible for my child to have the severe Dystrophic form? My mother is certain that I have nothing to worry about. I hope she is right.
Thank you, An Anxious Mom-to-be

Dear Anxious Mom-to-be,

Your mom is correct. If your children have EB, they will have the same type that you and the rest of your family have. The different types of EB are caused by specific genetic mutations. You can only pass on the genes (and mutations) that you have.

The way EB is transmitted in your family is called ‘dominant inheritance’. What this means in relation to EB is that if you have the disease, you have a 50:50 chance of passing it on with EACH pregnancy. This means that every time you get pregnant, you flip a coin. It does not mean that only half of your children will have EB.

Good luck with your pregnancy and please let me know if your child is born with EB

Madeline


AFP Testing and EB

Dear Madeline,
Have you heard of women who have had babies with EB and who had high levels of the Alpha Fetal Protein that they test for around the 16th week of pregnancy?

I know that it can indicate the possibility of other diseases, such as Down syndrome or spina bifida, but I have also read of women having high levels of this protein and having babies with EB.

Can you tell me more about this?,
Curious about the AFP Test

Dear Curious,

Elevated alpha-fetoprotein (AFP) levels have been reported in some second trimester EB pregnancies. Elevations in this protein are not definitive evidence that the fetus is affected with EB. Screening is primarily done to rule out neural tube defects, but an elevation is not diagnostic of those either. An elevation is merely a marker to the physician that additional diagnostic testing should be done.

Prenatal testing for EB is possible. First, the genetic mutation present in the affected family member must be identified. This can be done by a molecular diagnostic lab, such as the one at Thomas Jefferson University. Next, a chorionic villi sampling (part of the outer membrane surrounding the fetus) can be taken in the later part of the first trimester or amniotic fluid can be collected during the second trimester. The sample can then be sent to the lab, where it will be matched against the previously identified mutation. If the mutation is found, this indicates the fetus is affected with EB.

Additional information regarding prenatal testing is available through the DebRA Molecular Diagnostics Laboratory at Thomas Jefferson University (215) 503-2176.

Madeline



DebRA
 
  



About Us
53421 Reads Printer friendly page
Posted by: Admin on Feb 24, 2003 - 07:28 AM


Debra of America, Inc.

16 East 41st Street, 3rd Floor
New York, NY 10017
Telephone: (212) 868-1573
Email: staff@debra.org

Debra is dedicated to finding a cure for EB, which affects 1 out of every 50,000 live births in the United States today. EB is a genetically based disease characterized by chronic, painful blistering. The skin and mucous membranes are so fragile that the slightest touch can cause severe blistering inside and outside the body. Present at birth, EB affects men and women of all races and ethnic groups and sometimes, when there is no family history, it occurs as the result of a spontaneous genetic mutation. Today, there is no cure or treatment for EB, except daily wound care and bandaging. Genetic research is making progress towards treatments and a cure.

Debra was organized more than 25 years ago to help patients and their families. Its activities include:

  • Promoting and supporting extensive scientific research to achieve a cure for EB.
  • Assisting, supporting and guiding families in the physical and emotional treatment of individuals with EB. Debra's programs include the daily services of an experienced Nurse/Educator, a national physician referral service, a network of regional support groups and an information filled website.
  • Representing families and patients to the public and government institutions.

We're here to help you understand.


Staff
  • Mary Sprague, Executive Director

  • Pennie Cannon, Executive Assistant

  • Alecia Baker, Business Manager


Board Of Trustees
  • Faith Daniels, President, New York, NY

  • Warren T. Buhle, Esq., Vice President, New York, NY

  • Charlee M. Miller, Treasurer, New York, NY

  • Richard Gallagher, Jr., Secretary, Gurnee, IL

  • Alan R. Shalita, M.D., Chairman SAB, Brooklyn, NY

  • Kathleen Brown, Westport, CT

  • Angela Christiano, Ph.D., New York, NY

  • Gregg Cuvin, New York, NY

  • Tom Gillespie, Newtown, PA

  • Jeanne Humphrey, San Francisco, CA

  • Frank Kacmarsky, Anthern, AZ

  • Brett Kopelan, New York, NY

  • Robert Meirowitz, M.D., West Windsor, NJ

  • Laurence Miller, M.D., Potomac, MD

  • Thomas M. Misisco, Greenwich, CT

  • Paul Nunnari, Eagleville, PA

  • Leslie Rader, Louisville, KY

  • Daniel Siegel, M.D, Smithtown, NY

  • Alexander J. Silver, New York, NY

  • Jouni Uitto, M.D., Ph.D., Philadelphia, PA

  • Timothy Wiebe, Moon Township, PA

  • Sonya Wilander, Hailey, ID


National Honorary Advisory Board 1999
  • H.R.H. Princess Elizabeth of Yugoslavia, New York, NY

  • Ronald Kulkin, Neutrogena Dermatologics, Los Angeles, CA

  • Irwin Redlener, M.D., New York Children's Health Fund, New York, NY


Scientific Advisory Board
  • Alan R. Shalita, M.D., SUNY Health Science Center (Chair)

  • Alan Arbuckle, M.D.,University of Colorado at Denver and Health Sciences Center;

  • Eugene A. Bauer, M.D., Stanford University School of Medicine

  • Susan Bayliss, M.D., Washington University School of Medicine

  • Gary Bellus, M.D., University of Colorado at Denver and Health Sciences Center

  • Anna L Bruckner, M.D., Lucille Packard Children’s Hospital at Stanford

  • Angela Christiano, Ph.D., Columbia University

  • Richard A.F. Clark, M.D., SUNY Stonybrook

  • Jonathan Alden Dyer, M.D., University of Missouri Health Care

  • Ervin Epstein, Jr., M.D.,Children's Hospital Oakland Research Institute

  • Nancy B. Esterly, M.D., Medical College of Wisconsin

  • Jo-David Fine, M.D., Vanderbilt University

  • Elaine V. Fuchs, Ph.D., Rockefeller University

  • Sharon Glick, M.D., SUNY Downstate Medical Center

  • Paul Honig, M.D., Children's Hospital of Philadelphia (CHOP)

  • Gerald S. Lazarus, M.D., Johns Hopkins University

  • Moise L. Levy, M.D., Baylor College of Medicine and Texas Children's Hospital

  • Anne W. Lucky, M.D., Children's Hospital of Cincinnati


  • Joseph McGuire, M.D., Stanford University School of Medicine

  • Laurence Miller,M.D., Potomac, MD

  • Kimberly D. Morel, M.D., New York-Presbyterian Hospital

  • Amy Paller, M.D., Children's Memorial Hospital, Chicago

  • Francis Palisson, M.D., La Universidad del Desarrollo, Chile

  • Neil S. Prose, M.D., Duke University Medical Center

  • Elena Pope, M.D., Hospital for Sick Children, Toronto

  • Juliette Prendiville, M.D., University of British Columbia

  • Dennis R. Roop, Ph.D., Baylor College of Medicine

  • Lawrence Schachner, M.D., University of Miami School of Medicine

  • Tor Shwayder, MD, Henry Ford Hospital

  • Daniel Siegel, M.D., Dermatologic Surgery Institute

  • Mary K. Spraker, M.D., Emory University Clinic of Woodruff Medical Center

  • Jouni Uitto, M.D., Ph.D., Thomas Jefferson University

  • Madeline Weiner, RN, Chapel Hill, NC

  • Timothy Wright, D.D.S., University of North Carolina at Chapel Hill


Debra Founder
  • Arlene Pessar, R.N., Brooklyn, NY



DebRA
 
  



Join DebRA
9769 Reads Printer friendly page
Posted by: Admin on Feb 21, 2003 - 04:23 AM


Register for an account on to the DebRA Website

  • Once registered you will have access to enhanced website content including more detailed information and the ability to participate in our online forums. Registration is fast and free.
  • You can register for an account by clicking (here)

Subscribe to receive the quarterly DebRA Newsletter

  • DebRA publishes a quarterly newsletter to our members that is filled with the most current EB research and treatment information, gives helpful advice on caring for those with EB, and includes stories from all over the US. We mail our newsletter to your home or office free of charge to members, and membership is free, so please become a member and subscribe!
  • You can subscribe or update your subscription by clicking (here)



DebRA
 
  



Support and Resources
37526 Reads Printer friendly page
Posted by: Admin on Feb 21, 2003 - 04:08 AM


Read How do you say it?, a personal story of growing up with EB by Julieann Morabito.

Regional DebRA Organizations

International DebRA Organizations



DebRA
 
  



Nurse Educator
34603 Reads Printer friendly page
Posted by: Admin on Aug 12, 2008 - 04:04 AM


DebRA's Nurse Educator

DebRA provides a Nurse Educator to serve as a point of contact to assist new parents and patients, as well as to help healthcare professionals manage the care of EB patients. This program provides general informa